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The following thesis contains the results of my own research, and was 
written and composed by myself. 
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In memory of Janet, who was always an inspiration. 
"God has also set eternity in the hearts of men, yet they cannot fathom what 
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Adrenergic and Cholinergic Stimulation of Cortisol Production in 
Primary Cultures of Bovine Adrenocortical Zona Fasciculata / 
Reticularis Cells 
In addition to the classical hormonal regulators of adrenocortical 
steroidogenesis, adrenocorticotrophic hormone (ACTH) and angiotensin II 
(ALI), there is evidence that the adrenal cortex may also be influenced by 
adrenergic and cholinergic control. 
Initial characterisation of primary cultures of bovine adrenocortical 
zona fasciculata / reticularis cells, prepared by a collagenase digestion 
procedure, showed that ACTH1_24 and All stimulated cortisol production 
from both freshly isolated (day 1) and cultured (day 2 - day 5) cells. Peak 
cortisol production was seen between days 3 and 4 for these agonists. 
Morphological analysis, by light and electron microscopy, of day 1 and 3 
cells, showed that day 3 cells had improved integrity of ultrastructure and 
increased lipid deposits compared to day 1 cells. 
Adrenergic agonists stimulated cortisol production in a dose - 
depende nt manner from cultured cells, but failed to stimulate cortisol 
product=m from freshly isolated cells. Cholinergic agonists stimulated 
cortisol production in a dose -dependent manner from both freshly isolated 
and cultured cells. Adrenergic and cholinergic agonists also showed peak 
cortisol production between days 3 and 4. 
Using specific alpha and beta -adrenergic agonists and antagonists, it 
was shown that adrenergic stimulation of cortisol production from cultured 
cells was mediated by beta -adrenergic receptors. Schild analysis, using the 
specific betal- adrenergic antagonist, practolol, and the specific beta2- 
adrenergic antagonist, ICI118,551, identified these receptors as betai- 
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adrenoceptors. Adrenergic agonists were shown to stimulate steroidogenesis 
in cultured cells via a cyclic AMP dependent mechanism. These agonists had 
no effect on turnover of cellular phosphoinositides. Additionally, the 
adrenergic response of these cells exhibited homologous desensitisation. 
Using specific cholinergic agonists and antagonists, it was shown that 
M3- cholinergic receptors were responsible for mediating stimulation of 
cortisol production from cultured cells produced by cholinergic agonists. It 
was also shown that cholinergic agonists stimulated steroldogenesis in 
cultured cells via activation of phospholipase C, and that these agonists had 
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The work in this thesis is based on a study of steroidogenesis 
(primarily cortisol production) in bovine adrenal zona fasciculata / 
reticularis (ZFR) cells both after initial collagenase isolation and during 
primary culture, concentrating particularly on mechanisms of adrenergic 
and cholinergic control. 
Many reviews exist already on steroidogenesis in the adrenal cortex of 
different species, and its regulation by the classical secretagogues: 
adrenocorticotrophic hormone (ACTH); angiotensin II (Ali); potassium ions 
(K +) and serotonin. Comparatively little is known, however, about the effects 
of adrenergic and cholinergic agonists on steroidogenesis in the adrenal 
cortex. 
By way of an introduction, a general description of the adrenal gland - 
structure and function - will be given, followed by a more detailed review of 
the current knowledge of the control of cortisol production in the zona 
fasciculata / reticularis. As the main concerns of this thesis are 
mechanisms of adrenergic and cholinergic control of adrenal 
steroidogenesis, an introduction will be given to adrenergic and cholinergic 
mechanisms in general, the literature on adrenergic and cholinergic 
mechanisms in the adrenal cortex will be reviewed and the physiological 
relevance of these mechanisms will be discussed. 
In addition to a detailed description of the setting -up and 
characterisation of a primary culture system for bovine adrenocortical zona 
fasciculata / reticularis cells, this thesis aims to address the following two 
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questions:- 
(1) What molecular mechanisms are involved in adrenergic and 
cholinergic stimulated cortisol production in the zona fasciculata 
/ reticularis, and how do these relate to the mode of action of 
other adrenocortical secretagogues? 
(2) What relevance do adrenergic and cholinergic stimulation of cortisol 
production have to the overall picture of control of cortisol 
production in the adrenal zona fasciculata / reticularis? 
1.2 The Adrenal Cortex - General background 
1.2.1 Anatomy 
The adrenal glands (ad: to, reses: kidney. Latin) lie in close proximity 
to the kidney in mammals. In humans, they are found in the 
retroperitoneum: the left gland at the tail of the spleen, and the right gland 
close to the inferior vena cava in the supra -renal berth (Silverman & Lee, 
1989). The gland consists of two morphologically and functionally distinct 
regions, the outer steroid - synthesising cortex, and the inner catecholamine- 
producing medulla. In most species there is a clear distinction between 
these regions, though in the human the cortex and the medulla are 
convoluted (Neville & O'Hare, 1982, Ch 4). Though the medulla and cortex 
terrestrial 
form a single body in matureAmammals, in the early stages of embryonic 
growth they are separate, the cortex of mesodermal origin, and the medulla 
of ectodermal origin (Weinkove & Anderson, 1985, Ch 10) 
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1.2.2 Interactions Between the Adrenal Cortex and Medulla 
In the human The adrenal receives its blood supply from direct branches of the 
aorta, and from the inferior phrenic and renal arteries. Blood flows inwards, 
draining from a central vein, to the t psilateral renal vein on the right hand 
side, and to the inferior vena cava on the left hand side (Silverman & Lee, 
In rat and 
1989).AIt is bieved that the medulla receives its blood supply almost 
exclusively from the cortex (Vinson et al, 1985), and, indeed, corticosteroids 
are known to have effects on adrenaline synthesis and release in the 
medulla (Ungar & Phillips, 1983). 
It is possible that the cortex and medulla are linked in other ways. 
For example, Carballeira & Yenning (1964) have suggested that the medulla 
has the ability to complete glucocorticoid biosynthesis and Soliman & Kolta 
(1981) have shown that, though adrenaline apparently had no effect on 
intact adrenal glands in vitro, it did stimulate steroidogenesis in regenerating 
medulla- ectomised rat adrenal gland. Also, the medulla and cortex are both 
involved in the mammalian stress response: the medulla producing 
adrenaline in the "flight or fight" response, and the cortex releasing cortisol 
classically in response to raised ACTH levels after, for example, surgery 
(Weinkove & Anderson, 1985, Ch 10). Although both cortex and medulla 
may display this concerted reaction to stress, these responses are not 
necessarily linked. Goldstein et aI (1982) have shown that the stress induced 
by dental extraction produces a rise in plasma catecholamine concentration, 
but no significant rise in plasma cortisol levels. 
1.2.3 Zonation of the Adrenal Cortex 
The human adrenal gland was described as early as 1611 
(Bartholinus), although little was then known of its function. In 1856, 
* In the human, in the region of the adrenal cuff, the zona glomerulosa is next to the adrenal 
vien and blood flow is likely to be from medulla to cortex. 
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Brown- Sequard demonstrated that the adrenal was essential to life, and 
Wheeler and Vincent showed in 1917 that the ability to sustain life was due 
to the outer cortex and not the inner medulla. The now accepted division of 
the cortex into the three zones, namely, zona glomerulosa (ZG), zona 
fasciculata (ZF) and zona reticularis (ZR), was first recognised by Harley 
(1858), though it was Arnold (1866) who named the zones. Originally these 
divisions were made on the basis of morphological differences between cells, 
but now it is clear that the cells also perform different functions (Tait et al, 
1980). Fig 1.1 shows a diagrammatic representation of the bovine adrenal 
cortex (Bravo, 1989). 
The zona glomerulosa is the outermost zone of the cortex, adhering to 
the adrenal capsule. It consists of ball-like cells with relatively small 
cytoplasmic volume, and characterised by transverse foldings of the cristae 
of the mitochondria. 
The zona fasciculata comprises the bulk of the cortex. The cells of this 
zone are dispersed in columns and contain abundant lipid deposits. Many 
more mitochondria are present in these cells than in glomerulosa cells. 
The zona reticularis is the innermost zone, adjacent to the medulla, 
consisting of interconnecting cells of different appearance. Generally they 
contain less lipid than zona fasciculata cells. 
human 
In contrast to the adultAadrenal cortex, the fetal adrenal consists of 
only two zones, the fetal zone and the definitive zone. It is still not 
completely clear how full development of the cortex occurs, but a 
combination of the effects of ACTH and steroid on the immature cells is 
probably involved (Winter, 19P). Several theories have been proposed to 
suggest the origins of zonation but the currently accepted view is that cells 













Fig 1.1 Diagram of the bovine adrenal gland (Not to scale). 
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between the zona glomerulosa and the zona fasciculata (Hyatt, 1981. 
Hornsby (1987) has proposed that the steroid gradient across the cortex is 
responsible for affecting cell type and zonation. This theory, though 
plausible, cannot readily explain the sharp change between the zona 
glomerulosa and the zona fasciculata. 
1.2.4 The Adrenocortical Steroids 
The adrenal cortex in mammals is the main source of 
mineralocorticoids and glucocorticoids. Androgens are also produced in 
small amounts, and these are further metabolised by other tissues to active 
hormones. Fig 1.2 shows the relative amounts of each steroid produced by 
the human adrenal cortex. 
1.2.4.1 Mlneralocorficolds 
Aldosterone is the main mineralocorticoid in all mammals, and is 
produced solely by the zona glomerulosa (Neville & O'Hare, 1982, Ch 8). Its 
production is controlled by the renin- angiotensin system (Jones, 1973), the 
principal stimulant of its release being angiotensin II. The renin- angiotensin 
system regulates primarily the extracellular volume through regulating Na+ 
and H2O handling by the kidney. Renin production from the kidney is 
stimulated by several factors, in particular by a reduction in renal perfusion. 
Renin acts on alpha2- globulin (formed by the liver) releasing angiotensin I, 
which is in turn converted to angiotensin II by angiotensin converting 
enzyme, present in the lungs. Angiotensin stimulates aldosterone production 
from the zona glomerulosa cells of the adrenal cortex. Aldosterone acts 
primarily on the distal tubule of the kidney to promote Na+ reabsorption. 
Na+ (and an osmotic amount of H2O) is reabsorbed for an electroneutral 






11- deoxy- cortisol 3 
Deoxy -corticosterone 1.2 
Androstenedione 3 
Dehydro -epiandrosterone sulphate 125 
Dehydro -epiandrosterone 8 
Testosterone 0.06 
Oestrone 0.02 
Fig 12 Daily human adult adrenal steroid production rate relative to cortisol 
( =100) (Normal adult human cortisol production rate = 18 -30 mg /day) 
(Neville & O'Hare, 1982, Ch 8). 
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Plasma [K+] also regulates aldosterone production, though this effect 
is probably of secondary importance when compared to the control exerted 
by the renin- angiotensin system (Bravo, 1989). ACTH can also promote its 
production in the zona glomerulosa, but normal aldosterone levels may be 
maintained in the absence of ACTH (Ganong et al. 1968). The importance of 
ACTH as a physiological regulator of aldosterone levels is still uncertain 
(Muller, 1988, Ch 4) 
1.2.4.2 Glucocorticolds 
Glucocorticoids are produced primarily by the cells of the zona 
fasciculata, but the zona glomerulosa cells are also capable of their 
synthesis (Tait et al, 1980). Cortisol is the main glucocorticoid in most large 
mammals, including man and cattle, whereas corticosterone is the major 
glucocorticoid produced by rats, mice and rabbits. 
Glucocorticoid production is stimulated by the action of ACTH on the 
cells of the cortex. The levels of ACTH, and hence cortisol, follow a diurnal 
rythm, and are also raised during periods of prolonged stress, such as after 
surgery. ACTH is released from the anterior pituitary by the action of 
corticotropin releasing hormone (CRH). CRH is derived from the 
hypothalmus and its release is controlled by innervation. Its secretion is 
subject to feed -back regulation by endogenous gucocorticoids. Thus the 
hypothalmo- pituitary- adrenocortical axis controls plasma cortisol levels 
(Jones, 1973). The production of glucocorticoids from the zona fasciculata / 
reticularis and their control will be discussed fully in the next section. 
Glucocorticoids have a multitude of different effects on the body. In 
the liver, they promote gluconeogenesis by stimulating the synthesis of 
gluconeogenic enzymes. This serves to maintain plasma [glucose] for 
essential body functions, during periods of prolonged stress or in the fasted 
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state. Glucocorticoids also act on adipose tissue, promoting lipolysis. In 
other peripheral tissues, such as muscle, they mobilize amino acids by 
breakdown of protein. The glucogenic amino acids are then transported to 
the liver to be used in gluconeogenesis. In addition to these metabolic 
effects, gucocorticoids also have an important anti -inflammatory effect, and 
act as immuno- suppressants by inhibiting lymphokine release. 
At the molecular level steroids generally exert their effect by binding 
to specific intracellular receptors capable of altering the rate of transcription 
of DNA. Glucocorticoids act in this way, and a cytosolic receptor has been 
identified in many tissues by the use of 3H- labelled steroids and 
recombinant DNA techniques (Gustafsson et at 1987). 
1.2.4.3 Androgens 
Androgens are produced in small amounts by the cells of the zona 
reticularis (Winter, 1987; Hyatt, 1980. The major androgens produced are 
androstenedione and, dehydro- epiandrostenedione. Dehydro- 
epiandrostenedione sulphate is produced in large amounts in humans 
(Fig 1.2), but, as a sulphated steroid, it is thought to be inactive (Neville & 
O'Hare, 1982, Ch 8). Androstenedione and dehydro- epiandrostenedione are 
metabolised further by other body tissues to estrogens and testosterone 
depending on the sex of the mammal. It is possible that androgen 
production plays a part in fetal development of adrenal zonation (Hornsby, 
1987). It is not clear what factors are responsible for control of androgen 
production, but ACTH and a putative androgen stimulating hormone have 
been suggested as possible candidates (Odell & Parker, 1984 -85). 
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1.3 Cortisol Production and its Control in Zona Fasciculata Cells. 
1.3.1 Steroidoaenic Pathways 
Fig 1.3 shows a diagram of the steroid pathways present in 
adrenocortical cells (Simpson & Waterman, 1988; Tait et al, 1980). The 
enzymes responsible for adrenocortical steroidogenesis are present in the 
inner mitochondrial membrane and in the endoplasmic reticulum. They 
consist mainly of cytochrome P -450 - containing proteins and have linked 
electron transport systems to provide reducing equivalents (electrons). 
The rate determining step of steroid synthesis is the supply of 
cholesterol to cyt P- 450SCC and its conversion to pregnenolone (Jefcoate 
et al, 1986). Cyt P- 450SCC resides on the inner face of the mitochondrial 
membrane and receives electrons from mitochondrial NADPH via 
adrenodoxin and adrenodoxin reductase. Pregnenolone is then transferred to 
the endoplasmic reticulum. In humans, sheep, cows and pigs, cyt P- 
45017a1pha is present, which converts pregnenolone to 17- alpha - hydroxy- 
pregnenolone. A 3- beta- hydroxy- steroid dehydrogenase / isomerase then 
converts either pregnenolone to progesterone or 17- alpha -hydroxy- 
pregnenolone to 17- alpha -hydroxy- progesterone. P- 450021 then converts 
these products to the 11 -deoxy versions of either corticosterone or cortisol. 
11- deoxy -cortisol and 11- deoxy -corticosterone are transported back 
to the mitochondria where the final reaction, utilising cyt P -4501 ibeta' 
produces either cortisol or corticosterone respectively. It has been suggested 
by Jefcoate et at (1986) that the relative amounts of final steroid products of 
adrenocortical cells are regulated by the relative amounts of steroid 
synthesising enzymes present in each pathway. Several alternative pathways 




















































































































































































































































































































































































































of a contribution they make to overall steroid output (Tait et al, 1980). 
In glomerulosa cells of all . species, corticosterone is converted to 
aldosterone by an 18- hydroxylation reaction. In species containing P- 
45017a1pha in their fasciculata / reticularis cells, a lyase activity present on 
this enzyme allows formation of dehydro- epiandrostenedione and 
androstenedione. These steroids can serve as precursors for sex hormones 
produced by other tissues. 
There have been suggestions of an alternative pathway for aldosterone 
biosynthesis in the zona glomerulosa. The two steroids, 18- hydroxy- 
corticosterone and 18- hydroxy . 11- deoxy- corticosterone, have both been 
suggested as intermediates in the pathway between deoxy- corticosterone 
and aldosterone (Muller, 1987). 18- hydroxy 11- deoxy -corticosterone is 
secreted by rat adrenals, The exact 
physiological significance of these two steroids is unclear. 
1.3.2 Control of Steroldooenesis 
In general, in any biochemical pathway, the amount of final product 
is controlled by several factors, including: supply of substrate, alteration of 
enzyme activity and turnover of enzymes in the pathway. In the case of 
adrenocortical steroidogenesis all of these factors are present. 
The major source of cholesterol for adrenocortical cells is via 
lipoprotein uptake (Toth et al. 1986). Cholesterol esters are then 
incorporated into cellular lipid deposits, from which free cholesterol can be 
released by the action of cholesterol esterase. Cholesterol esterase is 
activated following an increase in intracellular cyclic AMP (Vahouny et al, 
1984). Synthesis of a labile protein, most likely to be sterol carrier protein 
(SCP) facilitates transport of, cholesterol to P- 450scc (Jefcoate et al, 1986). 
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Supply of cholesterol to P- 450scc, and its conversion to pregnenolone is the 
major rate determining step in adrenocortical steroidogenesis. 
Longer term control of steroidogenesis is exercised by an increase in 
steroidogenic enzyme synthesis. This is also probably controlled by 
increased cellular cyclic AMP. Protein kinase A is activated which 
phosphorylates specific proteins, leading eventually to increased 
transcription of mRNA's responsible for coding most of the enzymes shown 
in Fig 1.3 (Simpson & Waterman, 1988). 
1.3.3 Stimulation of Steroldoaenesis 
Fig 1.4 shows a highly schematic diagram of some of the possible 
effectors (both positive and negative) of the adrenal cell. Not all effectors are 
active in all species or zonal cell type. The following sections describe some 
of these effectors and their mechanism of action, concentrating on their 
ability to promote or inhibit steroidogenesis. 
1.3.3.1 ACTH 
The action of ACTH on adrenocortical cells produces the effects 
described in section 1.3.2, leading to increased steroidogenesis (Simpson & 
Waterman, 1988). The classical picture of ACTH action on adrenocortical 
cells - The Sutherland hypothesis - is that ACTH causes an increase in 
intracellular cyclic AMP which leads directly to steroid synthesis (Grahame - 
Smith et al, 1967). This is seen in all species studied. 
The activation of adenylate cyclase and synthesis of cyclic AMP is a 
common means of signal transduction for many hormones (Rodbell, 1980). 
In many cases the hormone receptor is linked to the cyclase unit via a GTP 
binding protein (G protein) which acts as a regulator of hormone action by 



























































































































































































































































































































proteins mediating the effects of many agonists (Stryer & Bourne, 1986; 
Ross, 1989). The three best characterised are: GS which mediates hormonal 
stimulation of adenylate cyclase, GI which mediates hormonal inhibition of 
adenylate cyclase, and Gp which mediates hormonal activation of 
phospholipase C. 
It is not clear whether a G protein is involved in mediating the ACTH - 
stimulation of adenylate cyclase in adrenocortical cells, though this would 
seem plausible. In the classical model of ACTH action, raised intracellular 
cyclic AMP levels stimulate protein kinase A which activates cholesterol 
esterase and promote transfer of cholesterol to the steroid synthesising 
enzymes (Tait et al, 1980). As described above, cyclic AMP also has longer 
term effects, promoting the synthesis of steroidogenic enzymes. 
It has been proposed that, in the rat, ACTH may also act via a 
phospholipase C -mediated second messenger system to promote 
steroidogenesis. At doses of ACTH1 -39 above 10 -11 M, the steroid and cyclic 
AMP dose -responses are similar, but at doses of 10 -11 M and below, steroid 
can be produced without a significant increase in cyclic AMP (Schulster et al, 
1984). Also, high and low affinity receptors for ACTH have been identified 
using 125I- labelled fragments of ACTH (Yanagabashi, 1978). Low doses of 
ACTH 1 -39 have been shown to stimulate breakdown of [3H)- inositol labelled 
phospholipids via phospholipase C activation (Whitley et al, 1987), 
producing inositol phosphates and di- acyl -glycerol. 
Phospholipase C activation by agonists is now a well characterised 
mechanism of signal transduction for a number of hormones and 
neurotransmitters, such as acetylcholine, serotonin, vasopressin and 
thyrotropin releasing hormone (Berridge, 1984). The commonly used term 
"PI response" originally referred to 32P incorporation into membrane 
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phospholipids, but is now frequently used (and will be throughout this 
thesis) to refer to hormonal activation of phospholipase C causing the 
breakdown of inositol- containing membrane phospholipids to inositol 
phosphates and di- acyl -glycerol (Fig 1.5). Di- acyl -glycerol can stimulate 
protein kinase C, leading to phosphorylation of various proteins, while 
inositol 1,4,5 -tris phosphate (the product of the action of phospholipase C 
on phosphatidyl- inositol 4,5 -bis phosphate) is known to cause release of 
Ca2+ from intracellular (non- mitochondrial) stores. 
It is possible, in the rat, that ACTH action is mediated by both cyclic 
AMP and phospholipase C activation, but the precise significance of 
phospholipase C activation is unclear in relation to the cellular action of 
ACTH (for review see Bird et al, 1990). In the bovine adrenal cortex, there is 
no reported evidence for low dose effects of ACTH on phospholipid turnover 
in either glomerulosa or fasciculata / reticularis cells. 
There appears to be very little literature on the actual mechanism by 
which activation of phospholipase C stimulates steroidogenesis. In the 
currently accepted view of the PI response, phospholipase C cleaves 
phosphatidylinositol 4,5- bisphosphate to give inositol 1,4,5 -tris phosphate 
and di -acyl glycerol (Berridge, 1984). Inositol 1,4,5 -tris phosphate then acts 
on receptors on the endoplasmic reticulum to release Ca2+, while di -acyl- 
glycerol activates protein kinase C. In the glomerulosa cell, it is possible that 
the Ca2+ released activates a chain of phosphorylation steps, initially via a 
calmodulin- dependant protein kinase, and acting finally on the enzymes of 
the 'early' (cholesterol to pregnenolone) and 'late' (corticosterone to 
aldosterone) pathways, while protein kinase C acts primarily on the 'early' 














Fig 1.5 The PI response - hormone activation of phospholipase C. 
Abbreviations are: 
PI Phosphatidylinositol 
PIP Phosphatidylinositol 4-phosphate 
PIP2 Phosphatidylinositol 4, 5- bisphosphate 
DAG Di -acyl- glycerol 
CDP -DAG Cytidine diphosphate - DAG 
1,4,5 -IP3 Inositol 1,4,5 -tris phosphate 
1,3,4,5 -IP4 Inositol 1,3,4,5- tetrakis phosphate 
1, 3, 4 -IP3 Inositol 1,3,4-tris phosphate 
1,4-IP2 Inositol 1,4-di phosphate 
1 -IP 1 Inositol 1- phosphate 
4 -IP 1 Inositol 4- phosphate 
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It is not completely clear why two mechanisms exist capable of 
mediating steroidogenesis - cyclic AMP and phospholipase C - and how they 
interact. The mechanisms described above explain how each sytem works, 
but do not explain why both exist. One possibility may be that the 
phospholipase C second messenger sytem is responsible for the fine- tuning 
of cyclic AMP mediated steroidogenesis, or vita- versa. Alternatively, it may 
be that the different systems produce different degrees of steroidogenesis - 
the phospholipase C system acting when less than maximal steroid is 
required, and the cyclic AMP sytem acting when maximum steroid output is 
needed. 
In addition to its action on phospholipase C, ACTH may also 
stimulate a phospholipase A2, leading to the release of polyunsaturated fatty 
acids, which can be further converted by cyclo- oxÿgenase enzymes to 
prostaglandin and leukotrienes. It is not clear if either of these classes of 
compounds directly regulate steroidogenesis in vivo. 
1.3.3.2 All 
AII is the main stimulant of aldosterone production in rat and bovine 
glomerulosa cells (Kaplan & Bartter, 1962). While ACTH acts on the early 
pathway, promoting supply of cholesterol to cyt P- 450SCC and its 
conversion to pregnenolone, All acts on both the early and the late pathway 
(Tait et al, 1980). In rat glomerulosa cells All promotes a rise in intracellular 
[Ca2 +) consistent with the involvement of a phospholipase C response 
(Williams et al, 1981). All has no steroidogenic effect on rat fasciculata / 
reticularis cells, but bovine fasciculata / reticularis cells do respond, 
producing cortisol and corticosterone. The only evidence for an effect of All 
on glucocorticoid production in the human is from McKenna et al (1978) 
who have shown that in isolated human adrenocortical zona fasciculata / 
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reticularis cells, All' can stimulate production of cortisol. AII has also been 
shown to potentiate ACTH - stimulated androgen production from isolated 
canine adrenocortical cells (Parker et al. 1983). 
In both bovine and rat fasciculata / reticularis cells, All produces an 
increase in phospholipase C -mediated inositol phosphate production, 
though only in the bovine cells is there a subsequent increase in steroid 
output (Whitley et al, 1987; Bird et al. 1989). It has been shown recently 
that in bovine fasciculata / reticularis cells, phospholipase C is the sole 
mediator of AII- stimulated cortisol production (Bird et al, 1989). The 
involvement of phospholipase C has been confirmed by Walker, Strachan, 
Lightly, Williams & Bird (1990) who have shown that All produces an 
increase in intracellular Cat+ in bovine zona fasciculata / reticularis cells. 
Thus ALI- stimulated cortisol production from bovine fasciculata / reticularis 
cells is mediated by stimulation of a phospholipase C. 
AII stimulation of phospholipase C in glomerulosa cells is known to 
involve a G protein which links the activation of the receptor to 
phospholipase C (Catt et al, 1988). There is also evidence to suggest that All 
links to a G1 protein in these cells leading to inhibition of adenylate cyclase. 
In zona fasciculata I reticularis cells it is not known if All activates 
phospholipase C via a G protein. 
1.3.3.3 K +, Serotonin and Dopamine 
In addition to ACTH and AII, several other hormones, 
neurotransmitters and ions affect steroidogenesis. Of these, one of the best 
characterised is K +. An increase in plasma [K +) leads to aldosterone 
production from zona glomerulosa cells (Tait et al, 1980). K+ is thought to be 
responsible for opening voltage gated Cat+ channels in the plasma 
membrane (Quinn et al, 1988). Hence, both All and increased extracellular 
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[K +] cause an increase in intracellular Ca2 +, though the mechanisms appear 
to differ (Spat et al, 1989). It is also possible that elevated extracellular K+ 
increases cyclic AMP formation, but this view is not universally accepted 
(Quinn & Williams, 1988). 
Activation of steroidogenesis by All and raised extracellular [K +], and 
their effects on intracellular Ca2+ concentration, are complex. In the rat, 
they appear to cause raised intracellular [Ca2 +] in the glomerulosa cells, 
but to have very little effect on intracellular [Ca2 +] in fasciculata cells 
(Braley et al. 1986). Additionally, again in the rat, changes in extracellular 
[K +] can modulate the effect of All action. At low (approx 2mM) [K+], K+ 
inhibits stimulation of aldosterone production by All (by inhibiting a rise in 
intracellular [Ca2 +]). This is thought to be a safety device in the body, 
preventing aldosterone production and K+ excretion when plasma [K+] is low 
(Barrett et al, 1989). 
Plasma membrane Ca2+ channels appear to be implicated in the 
action of several, if not all, of the steroidogenic agonists. All itself and a rise 
in extracellular [K +] both open plasma membrane calcium channels in rat 
glomerulosa cells, but appear to have different effects on intracellular [Ca2 +] 
(Spat et al, 1989). This is not unexpected, as there may be direct and 
indirect effects operating here, as is the case in other cell types. For 
example, a direct action of the effector (eg. K+) opening plasma membrane 
channels and raising intracellular [Ca2 +] hence producing steroidogenesis, 
or an indirect action, where the initial rise in intracellular [Ca2 +] is caused 
by the release of Ca2+ from endoplasmic reticulum stores via inositol 1,4,5 - 
tris- phosphate, followed by the opening of plasma membrane channels via 
inositol 1,3,4,5- tris -phosphate (Irvine & Moor, 1986). 
Serotonin and dopamine, both of which are known neurotransmitters, 
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have also been shown to have effects on steroidogenesis. In the rat, 
serotonin stimulates aldosterone production from rat glomerulosa cells via a 
cyclic AMP dependent mechanism (Muller & Ziegler, 1968). Dopamine can 
inhibit All- stimulated aldosterone production from bovine glomerulosa cells 
(Racz et al, 1984), but has no effect on ACTH -stimulated aldosterone 
production (Connell et ai, 1986). Thus, dopamine may be directly blocking 
All receptors or may be interacting with the phospholipase C dependant 
second messenger system. 
1.3.3.4 Adrenergic and Choiineraic Aaonists 
There is no evidence that K+, serotonin and dopamine have any effect 
on steroidogenesis in bovine fasciculata / reticularis cells. However, it has 
been shown that bovine fasciculata / reticularis cells respond 
steroidogenically to both adrenergic and cholinergic agonists (Hadjian et al, 
1981, 1982, 1984; Kawamura et al, 1984, 1985). This opens up the 
possibility that, in addition to the control of steroidogenesis by blood borne 
secretagogues (ACTH and All), there may also be a case for innervative 
control or direct interaction of catecholamines from the medulla with 
adrenocortical cells. One of the aims of this thesis, stated in section 1.1, is 
to examine this question and to consider the physiological relevance of 
adrenergic and cholinergic control of adrenocortical steroidogenesis. 
Additionally, it is important to investigate the mechanisms of action of 
adrenergic and cholinergic agonists and to consider how these integrate into 
the known mechanisms of action of ACTH and All. 
The following two sections (1.4 & 1.5) introduce the adrenergic and 
cholinergic mechanisms found in mammals, paying particular attention to 
the receptors and second messenger systems responsible for mediating their 
effect. Finally, section 1.6 gives a summary of the current literature on 
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adrenergic- and cholinergic -stimulated steroidogenesis in the bovine adrenal 
cortex. 
1.4 The Adrenergic Response 
Adrenaline (epinephrine) and noradrenaline (norepinephrine) are 
important transmitter substances involved in control bf mammalian body 
function. They can act as localised neurotransmitters in the peripheral or 
central nervous system, they can have a paracrine function, or, particularly 
in the case of adrenaline, can act as blood -borne hormones. Noradrenaline 
adrenergic- 
acts as the transmitter substance in 
A 
synapses at the neuromuscular 
adrenergic- 
junction of smooth muscles and in the terrnina11synapses of the sympathetic 
division of the autonomic nervous system. It also acts as one of the 
neurotransmitters in the central nervous system (CNS). Catecholamines are 
also released into the blood by the adrenal mediilla. In the human this is 
mainly adrenaline (80 %) with some noradrenaline (20 %) (Ungar & Phillips, 
1983). 
1.4.1 Adrenergic Receptors 
At the molecular level, the catecholamines, whether adrenaline, 
noradrenaline or synthetic derivatives such as isoprenaline, interact with 
receptors on the cell surface of the target tissue, and, through various 
means of signal transduction, produce the final measured cellular response. 
Research into catecholamines and their effects on cells is extensive 
and adrenergic mechanisms are some of the best characterised to date. As in 
all areas of biochemistry and pharmacology, the development of new 
techniques has been one of the major factors responsible for significant 
advances in the understanding of the adrenergic response. 
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Two reviews produced in the last 20 years: by Furchgott in 1972 
(Furchgott, 1972) , and by Wolfe and Molinoff in 1988 (Wolfe & Molinoff, 
1988) provide a comprehensive picture of adrenergic receptors and 
mechanisms. The review by Furchgott gives the historical perspective of 
adrenergic receptor classification up to 1972. The requirements set out by 
Furchgott for adequate receptor classification in this paper are still 
universally accepted. The review by Wolfe & Molinoff in 1988 summarises 
the advances in adrenoceptor research between 1972 and 1988, and deals 
with aspects of receptor regulation. Both of these reviews, however, are 
outdated by recent advances in gene cloning, in the understanding of the PI 
response, and in the discovery of further adrenoceptor subtypes. 
As early as 1906 Dale (Dale, 1906) showed that ergot alkaloids had 
different effects on the stimulation of smooth muscle from different organs 
by adrenaline. This research introduced the use of different agonists and 
antagonists for distinguishing tissue responses. Langley (1905) had 
suggested the idea of a "receptive substance" and together with Dale's work 
established the earliest ideas of receptor classification. 
In 1948, Ahliquist (Ahliquist, 1948) looked at the relative potencies of 
a series of sympathomimetic amines and argued for separate alpha and beta 
classes of adrenoceptors. The development of synthetic sympathomimetic 
amines and derivatives of adrenaline and noradrenaline greatly facilitated 
the clarification of receptor classes. Ahliquist & Levy (1959) used a di- chloro 
derivative of the synthetic adrenergic agonist isoprenaline to show that the 
small intestine of the dog contains both alpha and beta -adrenoceptors. 
Schild (1947a,ó, 1949) produced a significant advance in receptor 
classification by introducing the idea of pA2 values for antagonists (see 
chapter 7 for definition), a means for classifying receptors independent of the 
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actual effect the drug had on the tissue (its efficacy) and dependent only on 
its binding characteristics (the affinity). Hence much of the recent work in 
adrenoceptor and general receptor research has used determination of pA2 
values for selective antagonists as a means of receptor classification. 
Furchgott (1960) found a discrepancy in the relative potencies of 
agonists for the beta -adrenoceptor of rabbit duodenum, and suggested that 
there may be more than one class of beta -adrenoceptor. In 1967, Furchgott 
(Furchgott, 1967), again on the evidence of relative potencies of adrenergic 
agonists and also on the selectivity of adrenergic antagonists, suggested 
three classes of beta -adrenoceptor and one class of alpha -adrenoceptor. 
Shortly afterwards, Lands (1967a,b), Arnold & McAliliff (1968,1969) and 
Arnold & Selberis (1968) firmly established the existence of two classes of 
beta -adrenoceptor - these were then named beta 1 and beta2. 
The development of various techniques for attaching radioactive 
isotopes to drugs and small molecules provided a means for more accurate 
determination of the binding characteristics of various receptors. In 1979, 
Minneman (Minneman, 1979) used [125i] -iodo- hydroxy -benzyl -pindolol to 
show that beta -antagonists varied in their ability to displace the radio - ligand 
from the two types of beta -adrenoceptor. The radio- ligands: [1251] -iodo- 
cyano- pindolol, (125i]- iodo- pindolol and [3H]- dihydro- alprenolol are now 
commonly used for the investigation of beta -adrenoceptors. 
In 1984, the development of new beta -adrenoceptor agonists by the 
pharmaceutical company Beechams Ltd. led to the discovery of a possible 
third class of beta -adrenoceptor - beta3 - in the brown fat adipocytes of rats 
(Arch et al, 1984). The discrepancy in agonist potency ratios which 
included the new agonist also suggested the presence of beta3- 
adrenoceptors in the atria of various mammals ( Kaumann, 1989). Although 
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some workers still dispute its existence, evidence suggests that in certain 
tissues the effects of adrenergic agonists cannot be explained by two beta - 
adrenoceptors alone. Physiologically the presence of a third beta - 
adrenoceptor can be questioned. Adrenaline and noradrenaline are unable 
to distinguish between a beta3 -heart adrenoceptor and a beta 1 heart 
adrenoceptor, so unless a further hormone or neurotransmitter exists or 
beta3- adrenoceptors operate by a different second messenger system, 
or are found at different nerve endings, beta, and beta3 adrenoceptors appear to have 
identical physiological functions. 
The understanding and characterisation of alpha- adrenoceptors has 
lagged behind that of beta -adrenoceptors, probably because of the lack of 
suitable specific antagonists in the past, and because the second 
messengers produced by these agonists were identified at a much later date 
to those produced by beta -adrenergic agonists. 
In 1965, Van Rossurn (Van Rossum, 1965) found that the relative 
potencies of a series of adrenergic agonists on rat vas deferens and rabbit 
jejunum and the determination of pA2 values for selective antagonists 
produced results that suggested the existence of two classes of alpha - 
receptor. At about the same time Bevan & Osher (1965) also postulated the 
existence of two classes of alpha- receptor. However, it remained until 1977 
for Langer et al (1977) to suggest that the pre- and post - 
synaptic alpha- adrenoceptors were of different types. These were named 
alpha 1 and alpha2. 
In 1978, Peroutka ( Peroutka et al, 1978) used [3H]- clonidine and 
radio -labelled catecholamines to show that two classes of alpha - 
adrenoceptor also existed in the CNS, thus supporting Langer's earlier 
evidence. The alpha- antagonists, prazosin and yohimbine, were beginning to 
be used at this time to distinguish between alpha -adrenoceptor subtypes. 
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Prazosin is more potent at alpha 1, while yohimbine is more potent at 
alpha2- adrenoceptors. (U'Pritchard et a1, 1977; Starke et al, 1975). 
The situation has become even more complex recently with the 
suggestion that several classes or subtypes of alpha]. and alpha2- 
adrenoceptors may exist. Bylund ( Bylund, 1988 and references therein) 
compared the binding characteristics of [31-1]- clonidine and [3H]- yohimbine 
in a variety of tissues to show that at least three subtypes of alpha2- 
adrenoceptors may exist. This is supported by several other pieces of work 
(Neylon & Summers, 1985; Michel et al, 1989). Functional determination 
of pA2 values using selective antagonists also appears to support the 
conclusions obtained with radio- ligand binding studies. Additionally, the 
alpha1-subclass may be divided into two further subclasses. 
With so many new subtypes appearing from different areas of work 
the adrenoceptor classification scheme has become increasingly complex. 
How many different types of adrenoceptor really do exist? Both the 
pharmacological approach of subtyping using agonists and antagonists, and 
the binding approach using radio- ligands do not give a definitive answer. 
Gene cloning of adrenoceptors is helping to answer this question. Kobilka 
et al (1987) have cloned two alpha -adrenoceptor genes, and there is 
evidence that at least four exist. One of the beta -adrenoceptor genes. has 
also been sequenced and the membrane topology of the receptor analysed 
(Dixon et al, 1986; Yarden et al, 1986). There are few reports on 
identification of beta -adrenoceptor subtypes by molecular cloning of the 
receptor genes, although the beta3-adrenoceptor has been isolated recently 
by this technique (Emorine et al, 1989). 
A whole new set of nomenclature is arising from the molecular genetic 
approach. One of the problems which may emerge is the question of whether 
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different sequences mean different subtypes or whether this is purely due to 
species variation. Obviously it is important to match up pharmacological 
results with those of gene cloning and structure analysis. A combination of 
methods is likely to lead to a better understanding of the adrenergic 
receptors. 
1.4.2 Adrenergic Receptor Mechanisms 
Alpha and beta -adrenoceptors are linked to different signal 
transduction systems within cells. Both betas and beta2- subtypes are 
coupled via a GS protein to stimulation of adenylate cyclase (Schulster & 
Levitzki, 1980, Ch 15)). This process is analogous to the rhodopsin 
activation of adenylate cyclase in the eye, and both G proteins involved 
share a high degree of sequence homology (Stryer & Bourne, 1986). It is 
probable that beta3- adrenoceptors share the same mechanism of signal 
transduction as beta 1 and beta2, because the partial agonist practolol 
produces both beta 1 and beta3 responses (Kaumann, 1989) and stimulates 
only adenylate cyclase. 
Beta -adrenoceptors are subject to homologous, and probably 
heterologous, regulation mediated by phosphorylation of the receptor, either 
by a specific beta - adrenoceptor kinase or via another cellular kinase (Leeb- 
Lundberg, 1987; Huganir & Greengard, 1987). Phosphorylation of the 
receptor leads to a desensitisation of response to further adrenergic stimuli, 
and this appears to affect beta1- adrenoceptors to a greater extent than 
beta2- adrenoceptors (Wolfe & Molinoff, 1988; O'Donnell & Wanstall, 1987). 
The different classes of alpha- adrenoceptors appear to be coupled to 
different signal transduction systems. Alphas- adrenoceptors are coupled to 
the activation of phospholipase C (Nichols & Ruffolo, 1988). Alpha2-agonists 
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produce an inhibition of adenylate cyclase activity (Wolfe & Molinoff, 1988) 
and may also produce changes in Cat+ metabolism (Nichols & Ruffola, 
1988). Alpha 1- adrenoceptors are linked, via the Go protein, to PI 
metabolism, while alpha2- adrenoceptors act, via the GI protein, to inhibit 
adenylate cyclase activity. There may also be a direct link to membrane Ca2+ 
channels through both of these subtypes. 
Differences in second messenger systems coupled to different 
receptors may provide an answer as to why so many subtypes exist - each 
individual cell can determine how it responds to an agonist by the 
proportion of each particular subtype it expresses, thus allowing fine tuning 
of the response. 
1.5 The Cholinergic Response 
A cetylcholine acts as a neurotransmitter at nerve - 
nerve synapses - principally in the pre west ganglionic synapses of the 
parasympathetic division of the autonomic nervous system, in the pre - 
ganglionic synapses of the sympathetic autonomic nervous system, in thé 
CNS and directly on synaptic terminals located on the adrenal medulla 
(Bowman & Rand, 1984, Ch 9). It also acts as a neuro- transmitter at the 
neuro- muscular junctions of striated or skeletal muscle. 
Dale (1914) discovered that certain effects of acetylcholine on smooth 
muscle could be mimicked by muscarine and blocked by atropine while 
some effects of acetylcholine on striated muscle could be mimicked by 
nicotine. Hence the broad division of cholinergic receptors into muscarinic 
acetylcholine receptors (mAChRs) and nicotinic acetylcholine receptors 
(nAChRs) dates from these experiments. This broad subdivision is still in 
use today. 
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1.5.1 Muscarinic Receptors 
Muscarinic receptors are found in the CNS and at neuro- effector 
junctions on exocrine secretory glands such as parotid, pancreas and sweat 
glands, as well as on many smooth muscles including those of the stomach, 
iris, ileum and gall bladder (Michell, 1980). 
As with adrenoceptors, much of the evidence for cholinergic receptor 
subtypes has come from the use of specific agonists and antagonists. 
In the 1970's there was 
work on mAChRs involving ligand binding experiments using radio- labelled 
compounds such as quinuclidyl- benzylate (QNB), atropine and scopolamine 
(Galper et al, 1977). However, the first really useful drug used for 
classification was pirenzipine. Using this antagonist, Goyal & Rattan (1978) 
showed that mAChRs could be divided into a subclass which had high 
affinity for pirenzipine (M1) and a subclass which had low affinity (M2). 
Hammer & Giachetti (1982) produced evidence to support this division, but 
certain groups (Eglen & Whiting, 1985) still debated the existence óf two 
subtypes. One of the main problems was that the evidence for separate 
subtypes mostly came from studies where pirenzipine had been used in 
radio - ligand binding experiments whereas very few supportive results 
existed from functional studies. 
Another problem related to the differences which had been observed 
between ileal and atrial receptors. The antagonist gallamine was shown to be 
more specific for atrial mAChRs (Mitchelson, 1984) and 4- diphenyl- acetoxy- 
N- methyl- piperidine methiodide (4DAMP) to be more specific for ileal 
receptors (Barlow et al, 1976). 
By 1987 (Levine et al, 1987), several subtypes had been postulated. 
M1 and M2 could distinguished by their different affinities for pirenzipine 
and a third, M3, receptor had been discovered. The ileal and atrial receptors 
* In certain species (not bovine) muscarinic receptors are found on the adrenal medulla. 
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were also recognised and termed M2 -alpha and M2 -beta respectively. It may 
be that M2 -alpha receptors can be equated to M2 and M2 -beta to M3 
receptors, thus simplifying the scheme to three classes of muscarinic 
receptor. By this stage, mAChR subtyping required the use of at least 5 
drugs - pirenzipine, 4DAMP, dicyclorerine, AF -DX116 and hexahydro -sila- 
difenidol (McN -A -343 was also useful) used in various combinations both in 
binding experiments and in functional studies (Cohen & Sokolovsky, 1987). 
Thus pharmacological analysis has shown the existence of at least 
three subclasses of mAChRs. From the biochemical point of view the signal 
transduction mechanisms utilised by these receptors is also of interest. 
Evidence from both electrophysiological studies (Bolton, 1976) and from 
investigations of the second messenger systems involved (Birdsall & Hulme, 
1976) has shown that, in cells responding to muscarinic agonists, one or 
more of the following effects may occur (Jary & Bartfai, 1988):- 
(1) Inhibition of adenylate cyclase 
(ii) Stimulation of guanylate cyclase 
(iii) Stimulation of the PI response 
(iv) Influx or efflux of specific cations (eg. K +) 
The question as to which receptor subtype couples to which response 
has not been fully answered, although the results of gene cloning 
experiments, to be discussed shortly, are helping to unravel these problems. 
It has also been suggested that stimulation of PI metabolism is actually the 
primary event and that all other effects are secondary to this (Michell, 1980) 
but this appears to be too much of a simplification and it is likely that other 
mechanisms are also involved (Christie & North, 1987). 
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1.5.2 Nicotinic Receptors 
Nicotinic receptors are located in the CNS, on sympathetic and 
parasympathetic ganglia, at the neuromuscular junction and on the adrenal 
medulla (Bowman & Rand, 1984, Ch 9; Ungar & Phillips, 1983). All these 
receptors appear to be different. Some of the main structural studies on 
nAChRs have been carried out on Torpedo electric organ (Maelicke, 1988), 
but again these appear to be different from the mammalian forms. 
At the neuromuscular junction of skeletal muscle acetylcholine is 
released in the synapse and binds to nAChRs on the muscle cells. 
Tubocurarine is a competitive antagonist of acetylcholine at these receptors. 
Using a series of specific antagonists, Paton & Zairnis (1951) first 
showed that nAChRs at the neuromuscular junction and on autonomic 
ganglia were different. One of the drugs they studied was suxamethonium, 
a depolarising nicotinic agonist, which is still used today as a muscle 
relaxant during certain surgical procedures. Tubocurarine is a naturally 
occurring, potent antagonist and is the only neuro- muscular blocking drug 
that has any significant effect on the nAChRs of ganglia/ neuromuscular 
junction. The alpha -neurotoxins, such as alpha- bungarotoxin, are virtually 
irreversible antagonists of neuromuscular nAChRs, but have no effect on the 
nAChRs of ganglia or those in the CNS (Colquhoun et al, 1987). Hence 
there appear to be differences between nAChRs in different tissues, although 
the evidence for putative subtypes in the literature has not occurred to quite 
the same extent as for mAChRs. Now that the genes for nAChRs are being 
sequenced the differences are becoming apparent and these will be 
discussed shortly. 
Most of the research on nAChRs has concentrated on structural 
studies and electrophysiology. Electrophysiological studies have shown that 
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and Ca' 
the nicotinic agonists produce an increase in Na+ and K-÷4 permeability of the 
target cells leading to the production of an action potential ( Prives, 1980). 
Patch -clamp and voltage -clamp techniques have been used to show that the 
nAChR is an ion channel which is opened by the action of a nicotinic agonist 
(Rang, 1975). 
Electron microscopy of the purified receptor from Torpedo electric 
organ has shown it to be a pentameric channel consisting of five 
transmembrane domains. Whether this is the case in vivo and to what extent 
the findings apply to the mammalian nicotinic receptor is not yet certain 
(Changeux, 1987). 
1.5.3 Advances In Molecular Bloloav 
Although traditional techniques of pharmacology and biochemistry 
have provided much information about cholinergic and adrenergic receptors 
the recent advances in molecular biology have given some of the detailed 
answers as to how these receptors work. 
From sequence analysis and hydropathy studies to determine the 
extent of protein folding in the plasma membrane, it is probable that there 
are three or possibly four general families of plasma membrane receptor 
proteins (Huganir & Greengard, 1987; Schofield & Abbott, 1989; Birdsall, 
1989):- 
(1) Ligand gated ion channels 
(2) Voltage gated ion channels 
(3) Receptors that link to G proteins 
(4) Receptors that have intrinsic tyrosine kinase activity 
Thus, in this scheme, nAChRs fall into category (1) while alpha and 
beta -adrenoceptors and mAChRs fall into category (3). This model may not 
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be quite as simple as described, because it may be possible for one receptor 
to be linked to more than one second messenger system - as could be the 
case with alpha -adrenoceptors - but it does provide a clear starting point for 
defining receptor function. 
Muscarinic AChRs share a high degree of sequence homology with 
both beta -adrenoceptors and the visual rhodopsins, all of which have seven 
trans - membrane domains and link to G protein effector systems (Bonner 
et al, 1987). At least four human mAChRs genes have been isolated and 
cloned, named HM1 - HM4 by Haga et al, 1988, or M 1 - M4 by Chuan, 
1989. Due to problems with nomenclature between groups it is not clear 
which gene corresponds to which subtype or which signal transduction 
system it is linked to. Haga et al (1988) suggest that HM1 most closely 
resembles M1 and HM2 corresponds to the M2 subtype. HM3 is similar to 
M 1 and produces inhibition of adenylate cyclase but has no effect on PI 
metabolism while HM4 is of glandular origin and may be the M2aipha 
subtype. Chuan (1989) argues, however, that the genes M 1, M3 & M4 
correspond to the pharmacologically defined M 1 subtype and the M2 gene to 
the M2 subtype. He also suggests that the receptor defined by the M2 gene 
couples to adenylate cyclase while M i , M2 & M3 couples to PI turnover. 
Cloning studies on the nAChR show that in one species as many as 
five subtypes (two muscle and three neuronal) may exist (Colquhoun et al, 
1987). These are simpler than the mAChRs, as they are all ligand -gated ion 
channels of similar structure with a high degree of homology between 
species. 
Gene cloning has helped to answer some of the problems posed by 
more traditional pharmacological and biochemical research. The structure, 
function and diversity of mAChRs & nAChRs is now becoming clearer 
* Mikhail & Amin (1969) showed the presence of sympathetic ganglionic cells close to steroid 
secreting cells from all zones of the human adrenal cortex, and parasympathetic ganglionic 
cells close to zona fasciculata cells. Migally (1979) showed the presence of autonomic nerve 
terminals in the zona glomerulosa of the mouse, some of which were associated with blood 
vessels in the zona fasciculata. Kleitzman & Holzwarth (1985) showed the presence of 
catecholaminergic nerve terminals in the zona glomerulosa of the rat, associated both with 
blood vessels and steroid secreting cells. They showed that these terminals were not 
associated with the splanchnic nerve. 
Thus adrenergic innervation could be controlling blood supply to the adrenal (and hence 
affect steroid secretion by a flow dependant process) and /or may directly influence secretion 
by catecholaminergic stimulation of cellular steroidogenesis. 
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through a combination of methods. 
1.6 Physioldgical Relevance of the Adrenergic and Cholineroic 
Responses In the Adrenal Cortex 
1.6.1 Introduction 
As described in section 1.3, the classical agonists ACTH and AII have 
been known to promote steroidogenesis in several species for some time. 
This is seen in whole animal studies, in perfused whole gland and tissue 
studies, in enzymically dispersed cells and in culture. In addition, the 
steroidogenic responsiveness of the cells to these agonists depends on which 
zone, and from which species, they come. Discovery of possible adrenergic 
and cholinergic stimulation of the adrenal cortex is less well documented 
and its physiological relevance correspondingly less clearly defined. 
1.6.2 The Adrenergic Response 
Positive evidence exists to suggest innervation of the adrenal cortex, 
both in humans (Mikhail & Amin, 1969), in the mouse (Migally, 1979) and in 
the rat (Kleitman & Holzwarth, 1985) However, it has proved difficult to 
demonstrate any in vivo effect of catecholamines. No reports appear to 
exist of innervation, or the lack of it, in the bovine species. 
Vogt (1944) observed increased levels of corticosteroid production 
upon intravenous infusion of adrenaline in cats and dogs, but this was later 
explained (Pickford & Vogt, 1955) by the stimulatory effect of catecholamines 
on ACTH production from the anterior pituitary. The efforts of Sandberg 
et al (1953) to show a direct effect of adrenaline also proved fruitless. 
In contrast, Inaba et al (1975) showed a significant increase in 
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plasma corticosterone in hypophysectomised rats injected with adrenaline. 
More recently Edwards and Jones (1987) have looked at the effect of 
splanchnic nerve stimulation on the adrenal, and provided evidence that 
this type of stimulation produced steroidogenesis that could not be 
explained solely by the action of ACTH. 
Edwards and Jones (1988) have also shown release of small amounts 
of CRH from the adrenal medulla in response to splanchnic nerve 
stimulation, thus suggesting the possibility of a mini CRH -ACTH- 
glucocorticoid axis (Charlton, 1990). This would require the CRH released to 
reach the cortex, and there is still some debate as to whether this is 
possible. (and whether CRH is able to directly stimulate steroidogenesis). 
Much of the work on freshly isolated, enzymically dispersed, cells has 
e 
shown no effect of the catecholamines on steroidogenesis. Sequira and 
McKenna (1985) using bovine adrenal zona glomerulosa cells and Kawamura 
et al (1984) in a mixed adrenocortical cell preparation both found no 
response to catecholamines. DeLean et a/ (1984) also showed no effect of 
catecholamines on freshly isolated bovine adrenal zona fasciculata cells. 
Although the most obvious conclusion from these observations is that 
there is no direct adrenergic control of steroidogenesis, the evidence 
supporting adrenergic innervation and the results from primary cultures (to 
be discussed later) appear to contradict this. 
One possible explanation for the failure to observe an adrenergic 
response in freshly isolated cells is that the enzymic digestion of the 
adrenocortical tissue, either using trypsin or collagenase, has destroyed any 
receptors that may have been present. 
Shima et al (1984) have shown that in an adrenocortical membrane 
preparation from rat adrenal cortex, adrenoceptors can be detected by the 
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binding of (3H]di -hydro alprenolol to both capsulated (glomerulosa) and 
decapsulated (fasciculata / reticularis) portions. They further identified the 
receptors as being of the betas- subtype and showed that, in the 
decapsulated membranes, adenylate cyclase was stimulated by isoprenaline. 
These membranes were produced from whole tissue, and are therefore not 
subject to any enzymic digestion. 
A further possible explanation for the lack of any response in freshly 
isolated cells iá that catecholamines present in the medulla, after removal of 
the adrenal gland from the animal, may have produced receptor 
desensitisation. Increased levels of catecholamines in the highly stressed 
animal prior to killing may produce this effect. There is some evidence for 
the presence of catecholamines in the bovine adrenal cortex after death 
(Racz et a1, 1984). Adrenal blood supply is centripetal and after death 
simple diffusion may lead to significant catecholamine levels in the cortex. 
In vivo it is uncertain whether catecholamines released from the 
medulla could stimulate steroidogenesis in the cortex. It is a well known fact 
that glucocorticoids from the cortex influence catecholamine synthesis 
(Ungar & Phillips, 1983; Weinkove & Anderson, 1985), but evidence for the 
transfer of medullary products to the cortex are few. There has been debate 
as to the nature of blood supply to the cortex (Vinson et a1, 1985), yet no 
clear indication that blood could flow from medulla to cortex. The only 
possibility appears to be local effects on zona reticularis cells. 
After primary culture of several types of freshly isolated 
adrenocortical cells, the adrenergic response becomes evident: Kawamura 
et al (1984) showed that although a mixed bovine adrenocortical cell 
preparation produced no response to adrenaline immediately after isolation, 
the cells would respond after 3 days of primary culture. This was also 
* Treatment of animals prior to death with adrenergic antagonists may theoretically stop this 
effect and may show the presence of an adrenergic response in freshly isolated cells. 
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reported by DeLean et al (1985) in cultures of rat subcapsular cells. 
DeLean et a1 (1984) also showed that co- culture of rat adrenocortical and 
medullary cells prevented the cortical cells from developing a response to 
adrenergic stimulation, supporting the idea that in vi vo, if catecholamines 
from the medulla could be transferred to the cortex, they may down -regulate 
the adrenergic receptors in the cortex. 
Appearance of the adrenergic response may thus have the following 
possible explanations: - 
(1) Recovery of cells from the harsh isolation procedure, back to the in 
vivo state. 
(2) Resensitisation of adrenergic receptors which had been desensitised by 
high levels of catecholamines present in the animal prior to, or after, killing. 
(3) Appearance of an entirely new response. 
Evidence from adrenergic innervation (Mikhail & Amin, 1969; 
Kleitman & Holzwarth, 1985) mentioned earlier and the presence of beta - 
adrenoceptors on membranes isolated from rat adrenal cortex (Shima 
et al, 1984) support (1) and (2). 
Beta -adrenoceptors have been detected on transformed adrenocortical 
cells from the rat (Brush et a 1, 1974; Schor et al, 1971) and from the 
human (Hirata et al, 1981; Katz et al, 1985). Coupling to adenylate 
cyclase and production of steroid was also seen in cells isolated from some 
of the tumours. However, in 3 normal human adrenocortical cell 
preparations studied by Katz et al (1985) no response was seen. These 
observations, in contrast, support the appearance of an abnormal response 
ìF 
in the cultured cells, akin to transformation (ie. point (3), above). 
Therefore, though there is evidence for an adrenergic response in the 
adrenal cortex from studies of innervation of the cortex, radio - ligand binding 
* Or support (2) - desensitisation may have occured. 
* Robinson et al (1977), using a histochemical technique, reported the presence of fine 
cholinergic fibres in the adrenal cortex, with small cholinergic bodies in the zona reticularis. 
Aminergic axons were also observed in the outer zones, some associated with blood vessels. 
Using electron microscopy, Robinson et al (1977) also showed axons adjacent to 
adrenocortical cells. 
Cholinergic innervation may be indirectly affecting steroidogenesis by control of blood flow 
(via innervation of blood vessels) and /or may directly influence secretion by cholinergic 
stimulation of cellular steroidogenesis. 
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containing phospholipids) and the cholinergic response was shown to be 
calcium dependent (Hadjian et al, 1984). Kojima et al (1986) showed 
stimulation of aldosterone secretion by acetylcholine in bovine zona 
glomerulosa cells. They also showed that this was mediated by an increase 
in phosphoinositide turnover. 
There is therefore evidence to suggest that acetylcholine - stimulated 
steroidogenesis is mediated by some form of increase in inositol- containing 
phospholipid turnover in both zona glomerulosa and zona 
fasciculata /reticularis cells. 
Choiinergic effects are not limited to the mammalian system. 
Benjamina et al (1987), demonstrated that the cholinergic response of 
isolated frog adrenocortical cells was mediated by muscarinic receptors.. 
Benjamin et al also reported homologous desensitisation of this 
response. 
The first evidence for the effects of cholinergic agonists on 
adrenocortical cells in primary culture was that of Kawamura et a/ (1985). 
In a mixed adrenocortical preparation, acetylcholine stimulated production 
of corticosteroids (measured fluorometrically) in both freshly isolated cells 
and in cells after 48 hours of primary culture. 
Hence, there is strong published evidencé for a cholinergic response 
in vitro, with supporting evidence of cholinergic innervation. There is 
also, evidence for muscarinic receptors on bovine adrenocortical cells and for 
a cholinergic response mediated by increased phosphoinositide turnover. 
There is no knowledge, however, of the subtype of muscarinic receptor 




The current body of published evidence suggests that, in addition to 
the steroidogenic effect of ACTH and All on bovine zona fasciculata / 
reticularis cells, adrenergic and cholinergic agonists may also be involved in 
modulation 
some form of 
A 
of adrenocortical steroidogenesis. 
In addition to a full description of the characterisation of a primary 
culture system for bovine adrenocortical zona fasciculata / reticularis cells, 
this thesis presents the results of a detailed investigation into the adrenergic 
response of bovine zona fasciculata / reticularis cells in vitro, and the 
results of a brief study of the cholinergic response of these cells. This allows 
conclusions to be made about the relevance of adrenergic and cholinergic 
control of adrenocortical steroidogenesis, and of the mechanisms of action of 
these agonists. 
2 Materials & Methods 
2.1 Materials 
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The materials used in the experiments detailed in this thesis were 
obtained from the sources listed below. The sources of specific chemicals, 
reagents and equipment are given beside the appropriate place in the 
methods section. In addition, general laboratory reagents were obtained 
from Sigma Chemical Company Ltd. or BDH. 
Company Address:- 
Aldrich Chemical Company Ltd, The Old Brickyard, New Road, 
Gillingham, Dorset,SP8 4JL 
Amersham International plc, Amersham Place, Little Chalfont, 
Buckinghamshire, HP7 9NA 
BDH, Burnfield Avenue, Thornliebank, Glasgow, G46 7TP 
Bio Rad Laboratories Ltd, Caxton Way, Watford Business Park, 
Watford, Hertfordshire, WD1 8RP 
Boehringer Corporation (London) Ltd, Boehringer Mannheim 
House, Bell Lane, Lewes, East Sussex, BN7 1LG 
Canberra Packard Ltd, Brook House, 14 Station Road, 
Pangbourne, Berkshire, RG8 7DT 
Gorgie Abattoir, Edinburgh District Council, 2 Newmarket Road, 
Edinburgh, EH 14 1RH 
Hawksley & Sons Ltd, 68 Boston Road, Leicester, LE4 lAW. 
Henry Simon Ltd, P.O. Box 31 Si ,ckport, Cheshire, SK3 ORT 
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ICN Biomedicals Ltd., Lincoln Road, Cressex Industrial Estate, 
High Wycombe, Buckinghamshire, HP12 4XJ 
Immunodiagnostics, Washington, Tyne & Wear. 
Jencons, Cherry Court Way Industrial Estate, Stanbridge Road, 
Leighton Buzzard, Bedfordshire, LU7 8UA. 
Lab M, Topley House, P.O. Box 19, Bury, BL9 6AU 
LIP (Equipment and Services) Ltd, Dockfield Road, Shipley, 
West Yorkshire, BD 17 7AS 
LKB /Pharmacia, Pharmacia House, Midsummer Boulevard, Milton 
Keynes, MK9 3HP 
Lorne Diagnostics, P.O. Box 6, Tywford, Reading, Berkshire, RG10 
9NL 
Mackay & Lynn Ltd, 2 West Bryson Road, Edinburgh, EH 11 1EH 
May & Baker Ltd, Liverpool Road, Eccles, Manchester, M30 7RT 
MDE Ltd, Walworth Road, Andover, Hampshire, SP 10 5AA 
Northumbria Biologicals Ltd, South Nelson Industrial Estate, 
Cramlington, Northumberland, NE23 9HL 
Roche Diagnostics Ltd, P.O. Box 8, Welwyn Garden City, 
Hertfordshire, AL7 
Sarstedt Ltd, 68 Boston Road, Beaumont Leys, Leicester, LE4 lAW 
Scotlab, Unit 15 Earn Avenue, Righead Industrial Estate, Bellshill, 
ML4 3JQ 
Scottish Antibody Production Unit, Law Hospital, Carluke, 
Lanarkshire, ML8 5ES 
Sigma Chemical Company Ltd, Fancy Road, Poole, Dorset, BH17 
7NH 
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V.A. Howe, 12 -14 St. Ann's Crescent, London, SW 18 2LS 
2.2 Methods 
2.2.1 Cell Isolation and Culture 
Primary cultures of bovine adrenocortical ZFR cells were established 
as follows: Bovine adrenal glands were obtained from freshly slaughtered 
cattle (18 months - 2 years old, Gorgie Abattoir), collected into saline (0.9% 
w /v) on ice and transported within 20 minutes to the laboratory. All further 
procedures were carried out sterile (in a class II laminar flow cabinet, MDH 
Ltd.) and at room temperature unless otherwise stated. 
After removal of the surrounding fat, the glands were sectioned into 
100um slices using a Stad to -Riggs microtome. The first slice, consisting of 
capsule and ZG tissue, was discarded and the second slice, consisting of 
ZFR tissue, was collected into Earle's balanced salt solution (EBS, 
Northumbria Biologicals Ltd.) containing 0.2% Reagent Grade bovine serum 
albumin: Fraction V (BSA, ICN Biomedicals Ltd.). Routinely a total weight of 
3 -5g of tissue slices was used for each primary cell isolation. 
After finely chopping the ZFR tissue with scissors, it was digested for 
1.5 - 2 hours, at 37 °C, in EBS containing 2% (w /v) BSA, 0.1mg /m1 DNAase 
I (Sigma) and 1.5 - 2 mg /ml Worthington collagenase type 1 (Lorne 
Diagnostics). The tissue was mechanically disrupted by vigorous shaking 
every 30 minutes. At the end of the incubation, undigested tissue was 
removed by filtration through 250um nylon gauze (All gauzes, Henry Simon 
Ltd.) and the cells pelleted by centrifugation in an Heraeus Sepatech 
Minifuge T (V.A. Howe) at 450g for 20 minutes at room temperature. After 
resuspension in EBS /BSA the cells were filtered through 100um and then 
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30um gauze. 
Further purification of the ZFR cells was achieved using the column 
filtration method of McDougall, Williams et al (1979), which also served to 
free the cell suspension from contaminating red blood cells and subcellular 
debris. Fig 2.1 shows a diagram of the column system described below. 
Gentle suction using a syringe was used to pull liquid through the column. 
A scintered glass Allinn funnel (100mm,x 20mm disc / 16 -40um pore size, 
BDH) was filled with approx 5ml Sephadex G10 (Sephadex, 40 -120um bead 
size, Sigma) and approx 2ml of Sephadex G50, (100 -300um bead size) (both 
suspended in 0.9% (w /v) saline) layered on top. The column was 
equilibrated with 15ml of EBS /BSA solution prior to application of the cell 
suspension. The cell suspension was applied to the top of the column and 
loaded onto it using gentle suction. The column was then washed with 
approx 20m1 of EBS /BSA. The cells that were trapped between the Sephadex 
beads were harvested by resuspending the gel (plus trapped cells) in 
EBS /BSA and then filtering the solution through 30um gauze, which 
trapped the gel while allowing the cells and EBS /BSA to pass through. Cells 
prepared in this way were substantially free from debris, red blood cells and 
clumps of cells. 
Cells were centrifuged at 450g /30minutes as before and the resulting 
pellet resuspended in growth medium. Growth medium was prepared by 
combining 10% (v /v) fetal calf serum (FCS, Northumbria Biologicals Ltd.) or 
serum replacement (Various companies, mentioned specifically later), 
penicillin (50 IU /ml), streptomycin (50 ug /ml), amphoterin B (2.5 ug /ml) in 
Ham's F10 medium (all additives and Ham's F10 from Northumbria 
Biologicals Ltd.). The growth medium was warmed to 370C before use. 
After counting the cells using an improved Neubauer haemocytometer 
Allihn Funnel 









Fig 2.1 Column filtration apparatus used for further purification of the cells 
(adapted from original method by McDougall, Williams et al, 1979. 
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(Hawksley & Sons Ltd.), they were plated at a density of 250,000 cells /well 
(1ml /well) in 12 well multiwell cluster plates. (Northumbria Biologicals Ltd.) 
and incubated at 37°C in an atmosphere of 5% CO2 and 100% humidity 
(Scotlab VSL incubator). The medium was changed on the second day, and 
the cells used between day of plating (day 1) and day 5. 
2.2.2 Agonist/Antacionist Studies on Freshly Isolated Cells 
For some experiments the effects of different agonists and /or 
antagonists on cortisol secretion were studied on freshly isolated cells in 
suspension. Experiments were carried out in bicarbonate buffered EBS 
solution containing 0.2% BSA and 0.1% added glucose (Glucose, BDH) 
(EBS /BSA /Glc). This was pre -warmed to 37 °C in the cell incubator in an 
atmosphere of 5% CO2, thus'allowing the buffer to equilibrate to pH 7.4. For 
short-term incubations of less than 15 minutes, HEPES (N- 2- hydroxyethyl 
piperazine N'- 2- ethanesulfonic acid) buffered EBS solution was used (20mM 
with respect to HEPES ( HEPES, Sigma)), treated in the same way as above. 
This allowed a more stable pH to be maintained when the cells could only be 
in the cell incubator for a short period. 
Stimulation was carried out in 3m1 plastic tubes (LIP) containing 
approx 250,000 cells in 900u1 of EBS /BSA /Glc. Agonists and antagonists 
were made up in the same EBS /BSA /Glc solution and added in 100u1, or as 
appropriate, to give a final volume of lml. Uncapped tubes were placed at 
37°C in the cell incubator. Incubations were terminated by centrifugation of 
tubes for 15 minutes at 450g in an Heraeus Christ Labofuge 6000 (V.A. 
Howe). The supernatants were decanted and stored separately at -20 °C 
prior to cortisol assay or immediately acetylated in preparation for cyclic 
AMP assay. If measurement of intracellular cyclic AMP was required, pellets 
* Observation of cells, using phase contrast light microscopy, showed that 
the cells attached 
to the cell culture plate between 12 -18 hours after initial plating. Initially 
cells were round, but 
they adopted a flattened appearance as attachment occured. 
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were treated with lml of 75% ethanol and the sample processed as 
described in section 2.2.4. 
Short term incubations (<15 minutes) were terminated by plunging 
the bases of the plastic tubes into a methanol /dry-ice bath. The liquid was 
then thawed as required and treated as above. 
2.2.3 Aaonist/Antacionlst Studies on Cultured Cells 
Experiments on cultured cells were carried out in pre -warmed 
bicarbonate or HEPES buffered EBS /BSA /Glc, depending on the time of 
incubation, as outlined above. 
Routinely, the overlying growth medium was removed from each 
culture well and the cells were washed (x2) with 1m1 of EBS /BSA /Glc. 900u1 
of EBS /BSA /Glc was added to each well and the experiment initiated by 
addition of agonists and /or antagonists in 100u1 of the same buffer, or as 
appropriate to give a final volume of 1ml. Where antagonists were used, 
these were added before agonists. Plates of cells were incubated at 370C in 
an atmosphere of 5% CO2. 
Stimulation was terminated by removal of the overlying liquid into 
3.5ml polystyrene tubes and stored at -200C, for cortisol measurement, or 
immediately acetylated for cyclic AMP measurement. If intracellular 
estimation of cyclic AMP was required, cells were extracted by immediate 
addition of 500u1 of ice -cold 75% ethanol. Plates were left for at least 5 
minutes before scraping the base with the rubber end on a plunger from a 
lml syringe barrel. Liquid was removed to plastic tubes, a further 500u1 of 
75% ethanol added to each well, and the washings combined. The extracts 
were further processed as described in section 2.2.4. 
* at least 1 minute 
64 
2.2.4 Preparation of Samples for Assay 
Cortisol, corticosterone, aldosterone and androstenedione assays 
could be carried out directly on the cell -free liquid removed from 
incubations. Routinely the EBS /BSA /Glc containing solution was frozen 
immediately at -20 °C. Prior to assay, samples were thawed and centrifuged 
in an Heraeus Christ Labofuge 6000 (V.A. Howe) at 4200g for' 15 minutes to 
remove any precipitate which may have formed during storage. 
Where cyclic AMP measurement was required, samples were 
acetylated within 1 hour of the end of an experiment. 500u1 of the cell -free 
liquid removed from the incubations was transferred to a glass tube and 
acidified to pH 5.0 by the addition of 5u1 of 20% (v /v) acetic acid (BDH). 
Acetylation was carried out as follows: a 2:1 (v /v) mix of 
triethylamine and acetic anhydride (both BDH) was prepared in a glass tube, 
and 15u1 added to each sample tube. The contents of the tubes were mixed 
immediately after addition of the acetylating mixture. These samples were 
stored frozen at -200C ready for assay. 
Measurement of intracellular cyclic AMP was carried out on cells that 
had been extracted with 75% ethanol as described above. The extracts were 
prepared by centrifuging the sample tubes containing the combined ethanol 
washings for 15min at 4200g in an Heraeus Christ Labofuge 6000 
(V.A.Howe). The supernatant was decanted into a glass tube and solvent 
evaporated under a stream of air while being warmed simultaneously to 
370C on a heating block (Techne Dri- block:DB -3 fitted with sample 
concentrator:SC -3, Jencons). This process took about 1 - 2 hoúrs. After 
evaporation to dryness, 500u1 of 50mM acetate buffer, pH 5.0, was added to 
each tube to reconstitute cell extracts, and after mixing to ensure complete 
solubilisation, acetylation was carried out as described above. Samples were 
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stored frozen at -20 °C until ready for assay. 
2.2.5 Radlolmmunoassavs 
2.2.5.1 Cortlsol 
Cortisol production by the cells was measured by a modified in -house 
radioimmunoassay (RIA), originally developed to determine patient cortisol 
levels in urine and plasma (Gray et al, 1983). The assay employed a double 
antibody preprecipitate to separate bound from free cortisol. 
Cortisol standards were prepared in EBS /BSA /Glc solution from 
stock cortisol (hydrocortisone, Sigma) - 10mM dissolved in ethanol - and 
frozen after verification against previous standards. Prepared in this way, 
standards were stable for up to 3 months. The standard range was 1 - 2000 
nmol /1 cortisol, with 3 quality control values to check for intra -assay drift 
and inter -assay precision. 
A 0.1M citrate buffer was used throughout the assay, made from 
citric acid and trisodium citrate (both BDH), pH 4.0, 0.2% gelatine (BDH), 
gQ 
65mgazide / litre (azide, Sigma) for storage at 4 °C. The second antibody 
preprecipitate was prepared from 650u1 reconstituted sheep anti -cortisol, 
530u1 normal sheep serum, 15ml donkey anti -sheep (all Scottish Antibody 
Production Unit), 10m1 0.1M citrate buffer and left overnight at 4 °C to 
equilibrate. This solution was centrifuged, at 230g for 15minutes, and the 
loose pellet reconstituted in a total volume of 1 litre of 0.1M citrate buffer. 
Tracer solution was obtained from Amersham as cortisol -3(o- 
carboxymethyl)oximo -(2 -(125 I]Iodohistamine) in methanol: water (9:1), 
approx 2000 Ci /mmol, 0.1 uCi /ul. 
The assay was set up with a Clinicon Dilutrend automatic diluter 
(Boehringer Corporation), using standard 90 tube RIA racks (V.A. Howe), 
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and 12 x 75 mm polystyrene tubes (LIP). 700u1 of O.1M citrate buffer, pH 
4.0, containing approx 10,000 cpm of cortisol tracer, was added to each 
tube, along with 100u1 of either standard solution, quality control or 
unknown sample. 250u1 of preprecipitate was then added to each tube from 
a constantly stirred stock solution of the same. Using this method, with 
standards and unknowns in duplicate, placing the standard curve at the 
beginning of the assay and quality controls throughout the assay, it was 
possible to set up a maximum of 90 samples in duplicate (12 standards, 6 
quality controls and 72 unknowns) without significant intra -assay drift of 
quality control values. To avoid drift the preprecipitate had to be added in 
less than 10 minutes to all the tubes. 
After mixing the racks of tubes on a multivortex they were incubated 
in a water bath (37 °C) for 70 minutes, centrifuged in an Heraeus Christ 
Cryofuge 6 -4S (V.A. Howe) for 30 minutes at 1800g, and the supernatant 
decanted. 
Pellets were counted for a minimum of 120 seconds on an 
LKB /Wallac 1261 Multigamma counter linked to a dedicated IBM computer. 
Calculations were carried out by LKB /Pharmacia RiaCalc program or WHO 
RIA package, and the standard curve fitted by a 4 parameter binding site (4 
parameter logarithmic) model. Intra -assay %CV values were <10% over the 
working range of the assay and the unknown values falling in this range 
were considered to be valid. Fig 2.2 (left panel) shows a representative 
cortisol RIA standard curve. 
2.2.5.2 Corticosterone 
Corticosterone was measured, as required, in the medium from cell 
stimulations. The RIA method was essentially that of Al- Dujaili & Edwards 



































































































































































































































































































































































































































































Standard concentrations were prepared from corticosterone (Sigma), 
and dissolved and diluted in EBS /BSA /Glc. Standard values were in the 
range 0.05 - 200 nmol /1 (equivalent to 0.2 - 64 ng /ml). 
0.05M sodium phosphate buffer (pH 7.4, 20 °C) containing 0.1% BSA 
was used as the assay buffer. Antibody was supplied by Dr B.C. Williams of 
the Western General Hospital, Edinburgh and used at dilutions that gave 
approximately 50% binding of the zero standard. The tracer, Corticosterone- 
3( o- carboxymethyl )oximo- (2- [125I]Iodo- histamine), was obtained from 
Immun- diagnostics Ltd. 
Assays were set up with a Clinicon Dilutrend automatic diluter 
(Boehringer Corporation), using standard 90 tube RIA racks (V.A.Howe) and 
12x75mm polystyrene tubes (LIP). 200u1 of assay buffer containing approx 
5000 cpm of tracer and the appropriate dilution of antibody was added to 
each tube together with 50u1 of standard or sample. Repeat analysis 
controls (RAC's) were placed within the assay to check for inter -assay drift 
Tubes were incubated overnight at 4CC and then the bound separated from 
the free tracer by addition of lml of a charcoal suspension (0.3% charcoal 
(Sigma), 0.03% dextran (Sigma), 0.03% gelatin (BDH) in assay buffer 
(premixed). Tubes were centrifuged at 1800g in an Heraeus Christ Cryofuge 
6 -4S (V.A.Howe) for 30 minutes and the supernatant carefully' decanted. 
Pellets were counted for at least 200 seconds in an LKB /Pharmacia 
1261 multigamma counter linked to an IBM computer. Calculations were 
performed by LKB /Pharmacia RiaCalc package and the standard curve fitted 
by a 4 parameter binding site (4 parameter logarithmic) model. Infra -assay 
%CV values were <15% in the working range of the assay and values were 
judged to be acceptable within these limits. Fig 2.2 (right panel) shows a 
representative corticosterone RIA standard curve. 
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2.2.5.4 Cyclic AMP 
Production of cyclic AMP could be determined either by measuring its 
appearance in the extracellular medium overlying the cells, or by measuring 
its intracellular accumulation from ethanol extracts of the cells. 
Cyclic AMP was measured by RIA, essentially according to the method 
of Harper & Brooker (1975). This required the samples and standards to be 
acetylated to give maximum assay sensitivity. Samples (or standards), tracer 
and cyclic AMP antibody were incubated together overnight and bound cyclic 
AMP was separated from free by a second antibody preprecipitate the 
following day. 
The assay buffer used was 50mM acetate buffer, pH 5.0, stored at 
4 °C. Standards were prepared in this buffer from a stock solution of 32uM 
of the TRIS salt of cyclic AMP (stored frozen, Sigma). This stock solution was 
diluted to give a 320nM standard to determine non -specific binding, and a 
series of concentrations in the range 0.0625 - 32 nmol /1, for the standard 
curve. These stock standards were stored at 40C for up to 1 month. 
Acetylation of standards was carried out as described previously for 
sample preparation (section 2.2.4). Acetylated standards were used 
immediately, or stored at 4°C for up to one week. 
0.1% BSA (Sigma) was added to the 50mM acetate buffer 
immediately before use. Rabbit antibody to cyclic AMP was supplied by Dr 
B.C. Williams of the Western General Hospital, Edinburgh, and was used at 
a dilution of 1/20,000, judged to give highest sensitivity from its antibody 
dilution curve. Tracer was obtained from Amersham as adenosine 3',5'- cyclic 
phosphoric acid 2'- O- succinyl- 3- [125lliodo- tyrosine, approx 2000Cí /mmol, 
0.01uCi /ul. 
' The second antibody preprecipitate used to separate bound from free 
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cyclic AMP was made as follows - 20m1 donkey anti- rabbit antibody and 
1.5ml normal rabbit serum (both Scottish Antibody Production Unit) were 
mixed and left at 4 °C overnight. Next day the mixture was centrifuged for 
15 minutes at 230g and the loose pellet resuspended in 50m1 of 50mM 
phosphate buffer, pH 7.4. Its ability to precipitate first antibody was 
estimated by using increasing dilutions of preprecipitate and a 
concentration used that gave no loss in binding. In general this was of the 
order of 1:4 to 1:8 relative to undiluted preprecipitate. 
The assay was set up with a Clinicon Dilutrend automatic diluter 
(Boehringer Corporation), using standard 90 tube RIA racks (V.A.Howe), and 
12 x 75 mm polystyrene tubes (LIP). 200u1 of 50mM acetate buffer, pH 5.0, 
containing 0.1% BSA, 1/20,000 dilution of cyclic AMP antibody and approx 
5,000 cpm of tracer was added to each tube, along with 50u1 of either 
standard or unknown solution. Standards and samples were set up in 
duplicate, placing the standard curve at the beginning, followed by unknown 
samples. Repeat analysis controls (RAC's) were placed within the assay to 
check for inter -assay drift. In general no more than 180 tubes were set up 
per assay. Tubes were incubated at 4 °C overnight. 
Next day, 100u1 of second antibody preprecipitate was added to each 
tube, the tubes mixed on a multivortex, and left at room temperature for at 
least 1 hour. A solution of lml of Brij and 500mg micro- crystalline cellulose 
(both BDH) in 1 litre of water was then prepared and allowed to stir for 15 
minutes. 1.5ml of this solution was added to each tube to assist 
precipitation and act as a wash, and the racks of tubes were centrifuged at 
1800g for 30 minutes in an Heraeus Christ Cryofuge 6 -4S (V.A. Howe). 
Supernatant was decanted and radioactivity in the pellet counted for at least 
200 seconds in an LKB /Pharmacia 1261 multigamma counter linked to an 
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IBM computer. Calculations were performed by LKB /Pharmacia RiaCalc 
package and the standard curve fitted by a smoothed spline. Intra -assay 
%CV values were <15% for concentrations within the working range of the 
assay, and values were judged to be acceptable within these limits. Fig 2.3 
(left panel) shows a representative cyclic AMP RIA standard curve. 
2.2.6 Protein Assay 
After cell stimulation, 3 wells of cultured cells or 3 tubes from a 
freshly isolated cell incubation were kept for protein assay. Culture wells 
were washed with (2x) lml of protein free EBS and 500u1 of 1% (v /v) Triton 
X -100 (BDH) added to solubilise the cells. After 5 minutes, wells were 
scraped with the rubber end on the plunger from a lml syringe barrel and 
the liquid transferred to a plastic tube. In the case of freshly isolated cells, 
approx 250,000 cells in a given volume EBS /BSA (in triplicate) were 
centrifuged for 15 minutes at 250g in an Heraeus Sepatech Minifuge T. 
These were resuspended in lml of protein -free EBS and the procedure 
repeated, the final pellet being resuspended in 500u1 of 1% (v /v) Triton X- 
100. Finally, for both freshly isolated and cultured cells, the Triton X -100 
containing solutions were centrifuged for 15 minutes at 4200g to remove 
any (non -protein) precipitate and supernatant collected. 
Protein was assayed by an automated Bradford assay (Bradford, 
1976) adapted for a Cobas Fara centrifugal analyser. Standards (0- 
100ug /m1) were prepared from a lmg /ml stock BSA solution in distilled 
water. These were diluted using 0.1% Triton X -100 to give final standard 
concentrations in 0.1% Triton X -100. 
Samples were diluted 1:10 with distilled water to give a final Triton 








































































































































































































































































































variability and protein was calculated as ug protein /well. Fig 2.3 (right 
panel) shows a representative standardisation profile. 
2.2.7. Total Inositol Phosphate Head -group Assay 
Activation of poly- phosphoinositide- specific phospholipase C by an 
agonist, produces cleavage of phosphatidylinositol 4,5 -bis- phosphate, 
yielding Inositol (1,4,5)tris- phosphate and di- acyl -glycerol (Fig 1.5). In turn, 
Inositol (1,4,5)tris- phosphate can be further metabolised to other inositol 
phosphate isomers of general formula, IPN (N = 1, 2, 3, 4, 5 or 6), which are 
all water soluble. The ability of agonists to stimulate turnover of 
phosphatidyl Inositol lipids can be assessed by measuring the production of 
water soluble Inositol phosphates from cells pre -labelled with [3H]myo- 
inositol. Where total 3H- phosphoinositol production is measured, without 
recourse to HPLC separation of individual isomers, there will also be a small 
contribution of labelled glycero-phosphoinositols (from phospholipase A2- 
mediated deacylation) to the headgroup response. Where agonist- dependent 
stimulation of phospholipase C occurs, the small glycerophosphoinositol 
contribution would not be expected to alter, even with substantial increases 
in labelled phosphoinositol species. 
As discussed in the introduction, the activation of phospholipase C by 
an agonist is often referred to as the PI response (see definition in section 
1.3.3.1). In this thesis, the term PI assay will be used to refer to the total 
inositol phosphate head -group assay. 
2.2.7.1 Cell Labelling with 13H1- Inositol 
[3H]- myo -inositol was added to the cells (prepared in the normal 
manner) by addition at the time of the medium change on day 2. Fresh - 
medium was prepared containing 1OuCi /m1 of [311- myo - Inositol (Amersham) 
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and 0.5ml added to each well for labelling. Previous work had established 
that isotopic steady state was reached after 42 hours exposure to the label 
(Bird et al. 1989), so measurement of the headgroup response was carried 
out on day 4 cells (40 -48 hours later). 
2.2.7.2 Measurement of Total Headgroup Response to Agonist Stimulation 
Agonist stimulation experiments on pre -labelled cells were carried out 
in parallel with unlabelled cells in which cortisol and cyclic AMP could be 
measured as required, to allow comparison within the same cell preparation. 
On day 4 the medium from labelled cells was removed and replaced 
with 0.5ml of bicarbonate buffered EBS /BSA /Glc (37°C) to wash away any 
extracellular inositol. After incubation at 37 °C for 15 minutes, medium was 
replaced by 0.45m1 of EBS /BSA /Glc (37°C) containing 10mM (unlabelled) 
myo- inositol (Sigma) and 10mM LiC1 (Sigma), and a further 15 minute 
incubation carried out. At the end of this period additions of agonists or 
antagonists in 50u1 EBS /BSA /Glc made. After a further 15 minutes 
incubation at 37 °C, the stimulation was terminated by the addition of 250u1 
ice -cold 15% perchloric acid (BDH). 
2.2.7.3 Extraction of Lipid Headproups 
After the addition of perchloric acid, wells were scraped with the 
rubber end on a plunger from a lml syringe and the contents removed to 
1.5ml Eppendorf tubes (Lab M). Each well was rinsed with 0.5ml of distilled 
water and the washings combined. Tubes were then centrifuged in an 
Heraeus Christ Biofuge B microfuge (V.A.Howe) at 6500rpm for 3 minutes. 
Supernatants were removed to glass tubes for deacidißcation by 
freon:octylamine extraction and neutralisation of perchloric acid. The 
following method was used: 
75 
A fresh solution of 1 :1 (v /v) 1,1,2- trichloro- trifluoro -ethane ( "freon ") 
and tri- n- octylamine (both Aldrich) was prepared and 1.5m1 added to each 
sample. Samples were mixed thoroughly and tubes centrifuged at 1500g for 
3 minutes in a Labofuge 3000 bench top centrifuge (V.A.Howe). 
Approximately lml of the lower phase was removed to waste. A further 1m1 
of the original extraction mixture was added and the process repeated. 
Finally 0.9ml of the upper aqueous phase was removed and stored at -20 °C. 
2.2.7.4 Assay of Total Headaroup !noslto! Phosphates 
Plastic micro -columns (8x6Omm, 70um frit size, lab M) were set up to 
contain 0.5ml of Bio Rad AG 1X8 (200 -400 mesh) anion exchange resin 
(formate form), and the resin washed with 4m1 of distilled water. 
Samples were thawed, 100u1 of 10mM EDTA added to each, and the 
sample added to one of the columns, followed by lml of distilled water to 
wash the sample container. Each column was washed with a further 2x4m1 
of distilled water, which was allowed to run to waste (free [311- inositol fails 
to bind under these conditions and is thereby also lost to waste). 
Finally, each column was placed over a scintillation vial insert and 
2m1 of 1M ammonium formate / 0.1M formic acid (both BDH) added to elute 
the bound phosphoinositols which were collected into the vials. Columns 
were placed over fresh vials, and the process repeated to ensure complete 
collection of labelled headgroups. 3m1 of Hydroluma scintillation fluid (May 
& Baker) was added to each vial, and after vigorous shaking, 3H activity was 
measured in a Packard Tri-carb 300 or 1900CA Scintillation Counter 
(Canberra Packard). The effects of background 3H- counts and quenching 
were corrected for automatically. 
Total headgroup inositol phosphate production was calculated by 
combining disintegration per minute values for each pair of scintillation vials 
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and correcting for volume used in the assay. The measurement of total 
headgroup production was used as a measure of phospholipase C activity 
within the cells. 
2.2.8 Statistical Methods 
2.2.8.1 Calculation of Standard Deviation and the Students 't' Test 
In general, all experiments were carried out using triplicate 
determinations for each agonist and /or antagonist concentration. Figures 
show mean values obtained (of triplicates, unless stated) and error bars are 
standard deviations. Where no error bar is shown, the value is too small to 
be visualised on the graph scale. Experiments were repeated several times 
(as indicated in figure legends) and figures are representative results or a 
combination of several experiments (again, as indicated in the figure 
legends). 
The Students 't' test was used to assess significant differences 
between triplicates within individual experiments. A value of p <0.05 was 
considered to be significant. Figure legends indicate the results obtained, as 
appropriate. 
inappropriate 
Care was taken to avoid- over-use of the students 't' test, particularly 
as triplicates (n =3) were being compared. When 'n' values are small the 
assumptions used to derive the equations used for statistical testing break 
down, and results obtained from them are only of limited value. Additionally, 
when comparing basal steroid or cyclic AMP output of cells, %CV values for 
the particular RIAs are high (10 -15 %) and again statistical tests are of 
limited value. The students 't' test is used only where appropriate, and 
generally comparison of results is carried out over a series of similar 
experiments. 
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22.8.2 Linear Regression Analysis 
Where fitting of a straight line to a set of points was required a Casio 
fx -180P programmable calculator was used. A standard "least squares" 
equation was used and, where calculation of confidence limits was 
necessary, the relevant statistical equations and tables were obtained from 
Bowman & Rand (1984) or Geigy Scientific Tables (8th Edition). 
2.2.8.3 Test of Parallelism of Straight Lines 
Parallelism of straight lines was tested by analysis of covariance using 
the SPSS -X statistical package produced by Edinburgh University 
Computing Service. A value of p <0.05 was considered to be significant. 
3 Characterisation of Cell Culture I 
3.1 Introduction 
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As discussed in sections 1.2 & 1.3, bovine adrenocortical cells are 
Down to respond to the classical hormonal stimuli of ACTH and AII. This 
chapter deals with the initial characterisation of the primary cultures of 
bovine adrenal ZFR cells used throughout this thesis, and their 
steroidogenic response to ACTH, All and adrenergic & cholinergic agonists. 
3.2 Day by Day Responses of Cells to Aoonist Stimulation 
Cells prepared as in section 2.2.1 were maintained in primary culture 
in growth medium prepared using fetal calf serum (FCS). Stimulation of 
cultured (day 2 - day 5) cells was carried out over a period of 1 hour using 
ACTH1_24 (Synacthen) and All (section 2.2.3). Freshly isolated, day 1, cells 
were stimulated in suspension as described in section 2.2.2. Cortisol was 
measured in the medium (section 2.2.5.1). Fig 3.1 shows representative 
experimental results of cortisol production over a 1 hour stimulation of day 
1 - day 5 cells. 
It has also been reported that primary cultures of bovine ZFR cells 
respond to stimulation with adrenergic and cholinergic agonists (Kawamura 
et al, 1984 & 1985). Experiments were conducted according to the method 
described above, but using adrenaline and carbachol as agonists. Fig 3.1 
also shows representative results of these experiments. 
In addition, basal cortisol production was measured over a 1 hour 
period in unstimulated cells and was shown to be <10 pmol /well on each 



























































































































































































































































experiments (section 2.2.6) and the combined results are also shown in Fig 
3.1. 
3.3 Effect of Different Sera on Cultured Cells 
FCS was used to prepare growth medium for most of the preliminary 
experiments. In addition, several commonly available sera were also studied 
to assess their potential for use in experiments. These were: 
FCS - various batches (NBL) 
Controlled process serum replacements: CPSR 1, 4, 5 (Sigma) 
Flow defined media (Flow) 
Gibco defined media ( Gibco) 
The following sections describe the results obtained from studying the 
differences in agonist responsiveness of cells grown in growth media 
containing these sera. 
3.3.1 ACTH1- 2 4 Response 
Cortisol secretion from the cells in response to ACTH1 -24 
(Synacthen) was measured on each of day 1 - day 5. Cells were maintained 
in growth media prepared using different sera, and cortisol production 
measured over a 1 hour period. Fig 3.2 shows the results of these 
experiments. 
Different sera were studied in 7 separate cell preparations, a common 
FCS (FCS1) being used each time for comparative purposes and as a control 
response. As cell preparations were variable, experimental results were 
normalised. The maximum cortisol production of cultured cells in FCS1 (day 
3 value), in each experiment, was set to 100 %. All other values were 
adjusted accordingly. As FCS i was used a control in all experiments, this 
allowed comparison of ACTH]. _24 responsiveness in different media. Basal 



































































































































































































































































































































































































































































































































































































































































































































































































































































values were not used to normalise results as, with cortisol levels less than 
10 pmol /well (at which point the %CV values for the cortisol RIA precision 
profiles were high), there were considerable percentage, though not 
absolute, differences between the basal values for each experiment. Three 
separate batches of FCS (NBL), three control process sera (CPSR1, CPSR4, 
CPSR5 ;all Sigma) and defined sera from Flow and Gibco were studied. In 
individual experiments, the following growth sera were studied: (HCS = Heat 




(3) FCS1, FCS2, FCS3, CPSR1 
(4) FCS1, CPSR4, CPSR5 
(5) FCS1, Flow, Gibco 
(6) FCS1, CPSR5, HCS 
(7) FCS1, CPSR5, HCS 
These results showed that, for all sera (except CPSR4, day 3), cortisol 
production of cells on day 3 -day 5 was greater than that of freshly isolated 
(day 1) cells. Peak responsiveness varied between day 3 and day 5. A 
reduction in responsiveness was observed on day 2 of culture with respect to 
that on day 1 (in .7 out of 14 triplicate determinations). Peak Cortisol output 
of cells grown in controlled process sera was also greater than for the other 
sera studied. 
Basal values of cortisol production for any medium, on any day, and 
from all experiments was less than 14% on the scale shown. 
3.3.2 All Response 
All stimulation of cortisol production was studied in exactly the same 
* using a maximal dose of All (10"6 M) 
manner as for ACTH' _24, and data presented in the same format. Fig 3.3 
shows the results of these experiments. 
It can be seen that, as for ACTH 1 _ 2 4 , in almost all cases, cultured 
cell responsiveness was greater than that measured in freshly isolated cells. 
Maximum responsiveness of cultured cells was again observed to be between 
day 3 and day 5. The reduction in responsiveness on day 2 was common to 
all sera, and was observed in all cell preparations (17 out of 17 triplicate 
determin -ations). 
Basal values of cortisol production for any medium, on any day, and 
from all experiments was less than 14% on the scale shown. 
3.3.3 Adreneralc Response 
Adrenergic stimulation of cortisol production - using adrenaline - was 
studied as for ACTH 1 _ 2 4 above, and data presented in the same manner. 
Fig 3.4 shows the results of these experiments. 
In the case of adrenaline, cortisol production was not significantly 
greater than basal in freshly isolated cells. Maximum cellular stimulation 
was again seen between day 3 and 5. 
Basal values of cortisol production for any medium, on any day, and 
from all experiments was less than 19% on the scale shown. 
3.3.4 Cholineralc Response 
*y 
Cholinergic stimulation of cortisol production - using carbachol - was 
studied as for ACTH]. _24 above. Results are presented as amount of cortisol 
produced in each experiment, and not normalised as for the other agonists 
because, as will be discussed, the control FCS itself inhibited this response. 
Fig 3.5 shows the results of these experiments. 
The cholinergic response in FCS was found to be very variable. In 
*, using a maximal dose of adrenaline (10 "6 M) 




some cases cortisol production was only slightly greater in cultured 
compared to day 1 cells (eg. FCS1), whereas in other cases cortisol 
production could reach approximately 5 times day 1 values (eg. FCS3). This 
variability was seen between different batches of FCS and within the same 
batch. In all experiments freshly isolated cells produced cortisol in response 
to carbachol (From 1.1 to 34.5 N -fold relative to basal values, 4 
experiments). Maximum responsiveness again occurred between day 3 and 
5, with a reduction in stimulated cortisol production on day 2 compared to 
day 1 for all the sera tested (16 out of 16 triplicate determinations). 
Basal values of cortisol production for any medium, on any day, and 
from all experiments was less than 9 pmol /well. 
It should be noted that the response of cells to carbachol and 
produced the same maximum cortisol secretion 
acetylcholine 
A 
in all experiments, and these agonists are used 
interchangeably. 
3.3.5 Responsiveness of Cells Grown In Heat Treated Fetal Calf Serum 
Consideration was given to the possibility that FCS may contain heat - 
labile factors detrimental to normal cell agonist responses, and in particular 
might explain the variable effect of carbachol on the cells. 
Heat treated FCS (HCS) was prepared by heating a small volume of 
serum at 560C for 1 hour and allowing to cool before being used to prepare 
growth medium in the normal manner. 
Cells were grown in medium containing control fetal calf serum 
(FCS1), CPSR5 and HCS. Stimulation of the cells was carried out for 1 hour 
on each of days 1 to 5 using the agonists described above and cortisol 
measured. Fig 3.6 shows the results of these experiments - presented as 
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Fig 3.6 Cortisol roduced by a 1 hour stimulation of cells with the 
agonists state on each of the first 5 days of culture. 
Representative experiment (Expt (7); see text). 
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In this experiment, basal cortisol production of cells over days 1 to 5 
was always <20 pmol /well showing a peak on days 3 to 5 as for agonist 
stimulated cells. 
As before, maximum agonist -stimulated cortisol output of the cells 
occurred between day 3 and 5. For each of days 3, 4 and 5, and for each 
agonist, cortisol production was greater in cells grown in CPSR5 compared 
to FCS1. For each of days 3, 4 and 5 and for all agonists, except CCh, 
cortisol production was greater in cells grown in HCS compared to FCS1. 
Basal cortisol production of cells grown in CPSR5, compared to those 
grown in FCS1, was significantly greater on days 3 and 4 (p <0.01), in two 
experiments, and was significantly greater on day 5 (p <0.05) in one of two 
experiments. Basal cortisol production of cells grown in HCS, compared to 
those grown in FCS1, was significantly greater on days 3, 4 and 5 (p <0.05), 
in two experiments. 
From this, it can be concluded that there is a heat -labile factor 
present in FCS which is detrimental to cortisol production of the cells. 
3.4 Discussion 
Using the primary cell culture system described, there were 
significant quantitative differences in the amount of cortisol produced, 
under identical conditions, between each primary cell isolation. The results 
were, however, qualitatively very reproducible. As can be seen from figures, 
within single experiments, standard deviations for triplicate determinations 
were low. Though care was taken to keep cell preparations identical, 
variability was experienced in cell yield and in the magnitude of 
responsiveness of the cells. Variables that may have influenced the cell 
preparations include factors over which there was no control - eg. the breed 
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of cattle from which the adrenal tissue was obtained, the age of the cattle, 
and the effect of any hormones or drugs given to these animals. Other 
factors, over which a certain amount of control was possible, include: 
variability of collagenase preparations (for most of the experiments a single 
stock batch was used) and variability between batches of sera used in 
culture. 
Differences in batches of FCS clearly influenced responsiveness of the 
cells (eg. Fig 3.2 / ACTH]. _24 Response). Even using the same control FCS 
there was variability in responsiveness between different cell preparations 
which produced quite large statistical error when combining experiments 
compared to the small errors seen within each experiment. In general, 
internal controls were used in individual experiments, experiments were 
repeated at least three times and representative experiments quoted in the 
results section - a recognised means of presenting data (Su et al, 1980). 
Occasionally, as in the case of the preceding results section, 
experiments had to be combined. Results for the agonists ACTH1 _24, AII 
and adrenaline were combined by normalising the data: setting the 
maximum stimulated cultured cell cortisol production of the control FCS 
(FCS1) in each experiment equal to 100 %. This proved to be the best method 
of presenting results as it allowed comparison of the cultured cell agonist 
responsiveness between sera. This, however, does not allow true comparison 
of different agonists in the same serum, and therefore a representative 
experiment of all the agonists in FCS1 or CPSR5 is given in Fig 3.6. 
Results for cholinergic stimulation of cortisol production are not 
normalised because the results of agonist -stimulated cortisol production in 
control FCS1 show a high degree of variability. As discussed in section 3.3.5, 
it may be that heat - labile factors present in FCS are detrimental to normal 
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cell agonist responses, in particular the cholinergic response. Results for 
cholinergic stimulation are thus presented as raw data and consequently do 
not give as fair a comparison between experiments. 
It was often observed that there was a drop in cell responsiveness to 
agonists on day 2 as compared to day 1. This was consistently seen with All 
and carbachol but was only seen in 50% of experiments with ACTH1 -2 4 (As 
the day 1 adrenaline response was not significantly above basal in all 
experiments, day 2 values were always equal or greater than day 1 values). 
Observation of cells in culture showed that cell attachment had 
started to occur by the beginning of day 2: 12 -18 hours after initial plating. 
Observation of cells showed that those grown in sera other than FCS 
appeared to attach to culture plates more slowly, although this did not 
appear to significantly affect the peak of cell responsiveness (except possibly 
in the case of Gibco defined medium which gave a peak for all 4 agonists on 
day 5). These observations were not measured quantitatively. 
As already mentioned, peak responsiveness occurred between day 3 
and 5, and, except in case of the Gibco defined medium where this occurred 
on day 5, cortisol production declined thereafter. Several factors may have 
affected the timing of the peak response: 
(a) Cell plating density: although every effort was made to keep cell 
density constant, even slight fluctuations may have resulted in 
differences in the timing of cell attachment to the culture plate. 
(b) Availability of lipid: electron microscopic examination of the cells 
(section 4.1) showed that lipid reserves increased in cultured 
cells. 
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(c) Loss of enzyme activity: it is known that activity of certain steroid 
synthesizing enzymes decreases after several days in culture 
(Hornsby et a1, 1979). 
(d) Changes in second messenger systems: for ACTH]. _24 the amount 
of cyclic AMP produced was greater on day 3 of culture compared 
to day 1 cells (See chapter 4). 
A careful balance between the timing of all these factors probably 
determines overall daily cellular responsiveness. 
In initial experiments FCS was used in the growth medium of 
cultured cells - most of this work concerned the effect of ACTH1 _ 2 4 , All and 
adrenaline on the cells. Later investigation of the effect of carbachol showed 
that the response of the cells in FCS was very variable. From the results 
presented it was decided to choose a serum that gave a similar profile 
of cellular responsiveness for ACT111_24, All and adrenaline as for 
FCS, but an increased responsiveness to carbachol and 
acetylcholine. 
Gibco medium was discounted as a choice because peak 
responsiveness occurred on day 5. Flow medium was not used because 
carbachol stimulation was very low on the first 3 days. CPSR4 also gave 
poor carbachol stimulation on days 2 and 3. This left CPSR1 and CPSR5 as 
possible choices. Both gave similar profiles, with CPSR1 possibly giving 
higher levels of agonist stimulated cortisol production. However, CPSR5 was 
chosen because of its higher lipid content (CPSR1 was designed to have a 
reduced lipid content) so that the bovine adrenocortical cells, specialised 
with steroid synthesis, had an ample supply of lipid. 
Further studies of CPSR5 against control FCS1 (Fig 3.6) showed that 
HCS gave a much improved cortisol response to all agonists, more like that 
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obtained with CPSR5 than for FCS 1. In particular, the carbachol response 
was greater, suggesting that heat treatment was destroying one or more 
inhibitory factors. The basal values of cortisol production in HCS and CPSR5 
were also higher, supporting the theory that an inhibitory factor is present 
in untreated FCS. From the results of agonist effects in the other sera, there 
appeared to be a general trend that responsiveness of cells in untreated FCS 
was lower than in the other sera. Heat treatment of sera is carried out to 
remove factors such as complement proteins which could result in 
premature cell death through lysis. Though HCS produced good results, 
because of batch variability in FCS, it was decided to use CPSR5 as a more 
carefully defined replacement. 
To summarise, most of the earlier experiments on steroidogenesis 
produced by ACTH 1 _2 4, All and adrenergic agonists were carried out in 
FCS, allowing comparison with similar conditions used in published 
literature. Later experiments, and all those involving cholinergic agonists, 
were carried out in CPSR5. Appendix I contains details of the serum used in 
individual experiments presented in figures. 
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4 Characterisation of Cell Culture Il 
4.1 Introduction 
The previous chapter defined the optimum serum requirements for 
studying the agonist responses of bovine ZFR cells, and the daily 
responsiveness of the cells. This chapter deals with experiments designed to 
compare, in more detail, the effects of agonists on uncultured (day 1) cells 
and on cultured (days 3 & 4) cells and to look at the time- courses of steroid 
and second messenger production. 
4.2 Morphological Analysis of Cells 
Light microscopy of freshly isolated (day 1) cells and those on day 3 of 
culture confirmed that the cultured cells had attached to the surface of the 
culture plate, adopting a flattened, elongated appearance relative to the 
rounded appearance of day 1 cells. 
For electron microscopy, cell pellets from day 1 and day 3 cells were 
fixed in 2.5% (v /v) glutaraldehyde in cacodylate buffer (0.1M, pH 7.3). 
Osmium tetroxide (1% in cacodylate buffer) was used as a secondary 
fixative. The fixed samples were dehydrated through graded alcohols into 
propylene oxide and finally embedded in Araldite resin. Ultrathin sections 
(50 -60um) were stained with uranyl acetate and lead citrate in preparation 
for photomicrography using a Philips EM300 electron microscope. 
Approximately 100 cells were studied in at least 3 different ultrathin 
sections from each cell preparation. 
Electron microscopy of the cells showed that cultured (day 3) cells 
had good integrity of ultrastructure and a well - defined plasma membrane 
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Plate 4.1 Ultrastructural comparison of day 1 and day 3 cells: electron 
micrographs. N = nucleus, M = mitochondria, L = lipid, ER = endoplasmic 
reticulum. Scale bars shown in um. 
(á) Typical day 1 cell. 
(b) Damaged day 1 cell, showing indistinct plasma membrane. 
(c) Typical day 3 cell, showing numerous lipid droplets (L). 
(d) Portion of cell shown in (c), showing good integrity of plasma membrane 
and abundant enoplasmic reticulum (ER). 
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(Plate 4.lc,d). In contrast, freshly isolated cells had a more ragged 
appearance, of which a small percentage (10 -15 %) were damaged (Plate 
4.1a,b). Lipid droplets (L) could be seen in all 4 electron micrographs (Plate 
4. la, b, c, d). 
To evaluate the extent of the difference in lipid content between 
freshly isolated cells and cultured (day 3) cells, the number of lipid droplets 
per cell section were counted by light microscopy in thick sections (2 -3um) 
stained with toluidine blue. In freshly isolated cells, 4 lipid droplets per cell 
section (n =100 cell sections, SD =1) were counted, compared with 25 droplets 
per cell section (n =100 cell sections, SD =2) for the cells on day 3 of culture. 
4.3 Comparison of Cultured and Freshly Isolated Cells 
4.3.1 Cortisol Production 
Dose -response experiments to ACTT-11_24, All and noradrenaline 
were set up with freshly isolated (day 1) cells and cultured (day 3) cells from 
the same cell preparation. Cells were stimulated for 1 hour as described in 
sections 2.2.2 & 2.2.3 and cortisol measured (Fig 4.1). 
In 6 out of 7 experiments basal cortisol production was greater on day 
3 than day 1 (p <0.05). ACTHl _2 4 at 10-9 M gave a maximum stimulation, 
and in 6 out of 6 experiments this was greater on day 3 compared to day 1 
(p <0.01). Likewise, a maximum stimulatory dose of All at 10 -8 M gave a 
greater response in day 3 cells than with day 1 cells in 5 out of 5 
experiments (p <0.01). In the case of noradrenaline, there was no significant 
stimulation of cortisol secretion at any dose used in the freshly isolated 
cells, whereas a highly significant stimulation was observed in cells on day 3 

















































































































































































































































































4.3.2 Cyclic AMP Production 
Differences in steroidogenesis between cultured and freshly isolated 
cells may simply reflect differences in the availability of substrate. It may 
also be reflected in differences in the second messenger responsiveness of 
the cells. To test for this latter possibility, cyclic AMP was measured in day 
1 and day 3 cells after stimulation with different agonists (Fig 4.2). All 
showed no significant stimulation of cyclic AMP production on either day 1 
or day 3. In contrast, ACTH]. _24 and noradrenaline produced clear 
differences in cyclic AMP production on days 1 and 3, as illustrated. Again, 
in this experiment, basal cyclic AMP was greater on day 3 compared to day 1 
(p <0.001). As with cortisol production, the cells on day 1 showed no 
significant cyclic AMP production in response to noradrenaline, but 
produced a dose -dependant rise in day 3 cells. For 10- 9 M ACTH1 -24, total 
cyclic AMP output was higher on day 3 than on day 1 (p <0.05). 
4.4 Time- Course of Cellular Response 
4.4.1 Cortisol Production 
Cortisol production was measured in day 4 cells, over a 1 hour period 
of stimulation with ACTH _24 (10 -10 M), All (10 -7 M), adrenaline (10 -6 
M) and carbachol (10 -3 M) (Fig 4.3). Over this period basal cortisol output 
rose linearly. Both ACTH1_24 and All showed linear cortisol production 
with time over 1 hour, the first detectable cortisol measured between 5 and 
10 minutes. Adrenaline and carbachol showed increased cortisol production 
within the first 5 minutes, which continued over the 1 hour period with both 










































































































































































































































































































































































































4.4.2 Cyclic AMP Production 
Cyclic AMP production was measured in ethanol extracts of the cells 
and in the medium after stimulation of day 3 cells with ACTH]. _24 (10- 9 M) 
and adrenaline (10-6 M) (Fig 4.4). The radioimmunoassay for cyclic AMP 
was technically more difficult than that for cortisol. %CV values for this 
assay were generally higher overall than those for the cortisol assay, and 
standard deviations for cyclic AMP triplicate results tended to be greater 
than for cortisol results. Cellular cyclic AMP showed peak values between 1 
and 4 minutes for both agonists, declining slowly thereafter to give values 
still significantly above basal after 64 minutes. Cyclic AMP measured in the 
medium from the same cells showed a steady rise over a 64 minute period, 
and was observed in the medium shortly after the peak of cellular cyclic 
AMP. 
4.4.3 PI response 
Total headgroup inositol phosphates were measured over a 30 minute 
period in prelabelled, day 4, cells stimulated with All (10 -8 M) and 
acetylcholine (10 -4 M) (Fig 4.5). 
Cultured cells were labelled with [311- myo- inositol for a period of 42 
et a,. 
hours, the time required to reach isotopic equilibrium (Bird, 1989). [3H)- 
myo-inositol was added to fresh growth medium on day 2 (24 -30 hours), and 
cell stimulations were carried out on day 4 (66 -72 hours). As agonist- 
stimulated cortisol production was still close to, or at, its maximum value on 
day 4, this was considered to be a reasonable time to carry out experiments. 
Both All and acetylcholine produced a linear increase in total head 
group inositol phosphates with time for at least the first 15 minutes of 
stimulation. The results also showed that acetylcholine produced the first 









































































































































































































































































All 10 8M 
103 
ACh 10 4 M 
Time (mins ) 
Fig 4.5 Time- course of [3,-I)- inositol headgroup response, in day 4 cells, after 
stimulation with All (10- M) and ACh (10 -4 M). Open circles show basal 
response, closed circles show stimulated response. 'N' -fold response shown, 
where basal response = 1 at time = 0 minutes, Representative experiment (1 
of 2 experiments). 
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measurable response by at least 2 minutes and All by at least 5 minutes. 
More detailed analysis (Bird et a1, 1989) showed that for All, significant 
accumulation of the earliest product of phospholipase C action on 
phosphoinositide 4, 5- bisphosphate (namely inositol (1, 4,5) tris- phosphate) 
was seen by 15 seconds. This was seen within 5 seconds for acetylcholine 
(Walker, Strachan, Lightly, Williams & Bird, 1990). 
4.5 Discussion 
Freshly isolated and cultured cells exhibited qualitatively similar 
cortisol dose response curves to ACTH1_24 and All (Fig 4.1). 
Correspondingly greater increases in response to identical agonist 
concentrations was seen in the cultured cells compared to freshly isolated 
cells. The appearance of an adrenergic response in culture, absent in freshly 
isolated cells, was also confirmed. 
All agonists showed a greater ability to stimulate cortisol production 
in cultured (day 3) cells compared to freshly isolated (day 1) cells. Basal 
cortisol output was also higher after culture. Analysis by light and electron 
microscopy provided some information capable of explaining the changes in 
responsiveness of the cells. 
Morphological analysis of the cells showed that the number of lipid 
droplets in cultured compared to freshly isolated cells (Plate 4.1) was 
significantly greater. This may be reflected in a greater availability of 
steroidogenic substrate, providing one possible reason for an increased 
cortisol response. Cells in culture also showed more clearly defined plasma 
membranes, with improved ultrastructural integrity, which might also 
contribute to the difference. These ultrastructural differences might also 
underlie the improved second messenger responses, as evidenced by greater 
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agonist - stimulated cyclic AMP production of the cultured cells (Fig 4.2). 
Recovery from both the stress -induced hormone changes in newly 
killed cattle and from collagenase digestion may also be contributory factors. 
During the preliminary process of the characterisation of a primary 
culture system for bovine ZFR cells, it was shown that ACTH 1 -24 failed to 
stimulate aldosterone production from these cells, confirming the absence of 
significant ZG cell contamination (Williams, Lightly, Ross, Bird & Walker, 
1989). 
Both ACTH]. _24 and All maintained a constant rate of cortisol 
production over a 1 hour period (Fig 4.3), implying that steroidogenic 
substrate must be readily available within the cultured cells. The time - 
course of adrenaline- stimulated cortisol production was not linear. This is 
discussed later (section 5.5). The time- course of carbachol was also non- 
linear. 
Cortisol appeared in the medium bathing the cells between 5 and 10 
minutes after ACTH 1 _2 4 and AII addition, and within the first 5 minutes of 
the addition of adrenergic and cholinergic agonists (Fig 4.3). It is possible 
that, if the adrenergic and cholinergic mechanisms are present in vivo, 
they could stimulate cortisol production from the adrenal faster than the 
hypothalimic- pituitary- adrenal axis. Using a system similar to the cell 
superfusion apparatus for freshly isolated cells, but In this case adapted for 
cultured cells, it should be possible to measure the time- course of cortisol 
production with the different agonists more accurately. 
The time- course of intracellular cyclic AMP production upon 
stimulation with ACM-11_2 4 and adrenaline (Fig 4.4) established that cyclic 
AMP levels had started to rise within the first minute of stimulation, 
reaching a peak between 1 and 4 minutes. In the case of cyclic AMP, on 
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the time scale measured, there was no difference in the timing of the 
responses to ACM-11_24 and adrenaline. The cell superfusion system 
mentioned above would not be of any use in determining more accurately 
the timing of the cyclic AMP response, as it is the rise in intracellular cyclic 
AMP that is important. If supply of agonist to the cells could be adequately 
controlled, and the reaction could be terminated by some chemical or 
physical means (eg. liquid nitrogen) it may be possible to determine the 
time- course more accurately. 
There appeared to be a mechanism for extrusion of cyclic AMP into 
the extracellular medium where cyclic AMP was observed after at least 4 
imter 
minutes. In vivo, this may be a form of intracellular communication, 
possibly acting via gap. junctions. 
The time- courses of total inositol phosphate production in response to 
All (10-8 M) or acetylcholine (10-4 M) were linear for at least the first 15 
minutes (Fig 4.5). Bird et a1 (1989) have shown that in these cells, a rise 
in inositol (1,4)bis- phosphate can be detected within the first 15 seconds 
upon stimulation with 10 -7 M AII. They also concluded that inositol 
(1,4)bis- phosphate was formed by dephosphorylation of inositol (1,4,5)tris- 
phosphate, the most likely initial product of AII- stimulated phospholipase C 
activation. Walker, Strachan, Lightly, Williams & Bird (1990) have shown 
that, in these cells the formation of inositol(I,4,5)tris- phosphate occurs 
within 5 seconds of stimulation with acetylcholine (10 -4 M) and precedes 
the production of all other inositol phosphates. Thus, AII and acetylcholine 
produce steroidogenesis in primary cultures of bovine adrenocortical zona 
fasciculata / reticularis via activation of phospholipase C. 
Further study of the adrenergic and cholinergic responses within 
these cells required identification of suitable experimental conditions for the 
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measurement of steroid products and second messengers. Experiments 
involving purely cortisol measurement were carried out on day 3 or 4 cells 
after a 1 hour agonist stimulation. Where both cyclic AMP and cortisol 
measurements were required this was carried out on medium from agonist 
stimulated cells after 1 hour. Where a more accurate measurement of 
intracellular cyclic AMP was required, ethanol extraction of cells after 5 
minutes agonist stimulation was used. For experiments involving phospho- 
inositide turnover, agonist stimulation was terminated after 15 minutes by 
the addition of perchloric acid (section 2.2.7.2), at which point the time - 
course of total inositol phosphates was still linear. In these experiments cells 
stimulated in parallel were used to assess cortisol output and combined 
(medium + cellular) cyclic AMP after a 15 minute period. 
Hence, the results presented in this chapter (most of which have been 
published as: Williams, Lightly, Ross, Bird & Walker, 1988) show that day 3 
cells gave qualitatively similar cortisol production in response to ACTH1 -2 4 
& All compared to day 1 cells, but show the appearance of a response to 
adrenergic agonists. Ultrastructural comparison of day 1 and 3 cells show 
improved integrity of day 3 cells, also reflected in increased cortisol output 
and cyclic AMP production of cells In culture. Studies of the second 
messengers produced upon agonist stimulation of cultured cells also gave 
information serving as a base for further studies of agonist responses. 
5 The Adrenergic Response 
5.1 Introduction 
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Results of stimulating cells with adrenergic and cholinergic agonists 
over 5 days (Fig 3.5), and of comparison between adrenergic dose responses 
of cells on day 1 and day 3 (Fig 4.1) showed that, though the cells failed to 
respond to catecholamines after initial isolation, after 12 -18 hours (day 2 
cells) of culture adrenergic stimulation produced steroidogensis. 
This chapter presents results of further study of the adrenergic 
response, concentrating on the nature of the second messengers involved, 
initial classification into alpha or beta response, and a study of 
desensitisation of the cells to adrenergic agonists. 
5.2 Dose Responses to Catecholamines 
Day 3 cells were stimulated with increasing doses of the 
catecholamines adrenaline (Adr), noradrenaline (NAdr) and isoprenaline 
(Isop). Cortisol was measured in the medium after 2 hours as already 
described, and results are shown in Fig 5.1. All 3 agonists showed similar 
dose response profiles. The threshold dose for each was 10-8 M (p <0.05) 
relative to basal and all agonists produced maximum cortisol output 
between 10 -6 and 10 -5 M. 
Fig 5.2 shows corticosterone measured in the medium from the same 
experiment. Corticosterone levels were 15 -30% of cortisol levels in the 
medium. Again dose responses were similar, though not identical for all 
three catecholamines. In this case the threshold dose was 10 -7 M (p <0.01) 





















































































































































































































































































































































































































































































Maximum cortisol output was achieved by 10-6 M for all agonists, but the 
maximum value decreased in the order adrenaline > noradrenaline > 
isoprenaline in this experiment 
ED50 values for cortisol output are summarised in table 5.1 over a 
series of experiments. From this table it is clear that isoprenaline is the most 
potent agonist achieving 50% of maximum cortisol output (ED50) at a lower 
dose than either adrenaline or noradrenaline. The order of potency was 
therefore isoprenaline > noradrenaline > adrenaline. 
Fig 5.3 shows combined (medium + cellular) cyclic AMP levels after a 
1 hour stimulation of day 3 cells using adrenaline, noradrenaline and 
isoprenaline. This is a separate experiment from that illustrated in Figs 5.1 
& 5.2. All 3 agonists produced a dose -dependant increase in cyclic AMP, 
having threshold concentrations of 104 M. It is not clear whether maximum 
cyclic AMP output had been obtained by the highest doses of agonists used. 
Cyclic AMP production over such a long time period was not necessarily a 
valid measure of the generation of this second messenger because all cells 
contain phosphodiesterases capable of breaking down this second 
messenger, and thus levels of cyclic AMP at any one instant are a subtle 
balance of breakdown and synthetic processes. 
5.3 Comparison of Second Messenger Responses 
Day 4 cells were stimulated with increasing concentrations of All, 
adrenaline and carbachol for 15 minutes and cortisol measured. Cyclic AMP 
was measured both in the medium after stimulation of these cells and in 
cellular extracts. In parallel cell incubations, total inositol phosphate 
headgroup production was measured according to the method described in 
section 2.2.7. Results are presented in Figs 5.4, 5.5 & 5.6. 
* Over the series of experiments presented in table 5.1, observation indicated that adrenaline, 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































All 3 agonists produced dose - dependant increases in cortisol 
production, though the relative magnitude of these responses varied. In the 
case of All (Fig 5.4), no significant increase of cyclic AMP relative to basal 
values was observed for any concentration studied. All did not inhibit cyclic 
AMP production relative to basal values. In contrast, All produced a dose - 
dependant increase in phosphoinositols which paralleled the cortisol dose 
response. 
Adrenaline produced no significant increase in phosphoinositols 
relative to basal at any concentration used, but showed a dose- dependant 
increase in cyclic AMP which paralleled cortisol production (Fig 5.5). 
The results for carbachol stimulation were qualitatively similar to 
those for AII (Fig 5.6). Carbachol stimulation produced a dose - dependant 
rise in phosphoinositols and in cortisol output. No significant increase in 
cyclic AMP relative to basal was seen for any concentration studied. 
Absolute phosphoinositol production was lower than that for All as was 
cortisol output. 
5.4 The Effects of Alpha and Beta Blockade on Cortisol Production 
Day 3 cells were stimulated for 1 hour with isoprenaline, 
noradrenaline and adrenaline in the presence or absence of the alpha - 
adrenergic antagonist phentolamine or the beta - adrenergic antagonist 
propranolol. Antagonists were present at 10 -fold greater concentration than 
the agonists. Cortisol was measured to assess the effects of the alpha or 
beta -blockade (Fig 5.7 & 5.8). 
Phentolamine at 10-6 M had no effect on cortisol secretion produced 
by any of the catecholamines at 10 -7 M (Fig 5.5). Propranolol at 10 -6 M 
produced a 97% inhibition (stimulated relative to basal value) in cortisol 
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Fig 5.7 Cortisol produced by a 1 hour stimulation of da 3 cells with 10 -7 M 
catecholamine in the presence ( +) or absence ( -) of 10- M phentolamine. 
B = basal. Representative experiment (1 of 3 experiments). 
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Fig 5.8 Cortisol produced by a 1 hour stimulation of daa 3 cells with 10 -7 M 
catecholamine in the presence ( +) or absence ( -) of 10- M propranolol. 
B = basal. Representative experiment (1 of 3 experiments). 
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production by 10 -7 M adrenaline, and a 96% inhibition in cortisol 
production by 10 -7 M noradrenaline. Propranolol inhibited cortisol 
produced by 10 -7 M isoprenaline by 75 %. Propranolol and phentolamine 
had no effect on basal cortisol production. 
5.5 The Effect of Alpha and Beta Blockade on Cellular Second 
Messengers 
Day 4 cells were stimulated with adrenaline (10'6 M) and the effects of 
phentolamine and propranolol on cyclic AMP production observed. 
Antagonists were present at 10 -fold greater concentration than the agonist. 
Cells were stimulated for 15 minutes, and cyclic AMP was measured in both 
the medium and in extracted cells. Results are presented as combined 
(medium + cellular) cyclic AMP (Fig 5.9). 
In a parallel experiment, using the same batch of cells and identical 
conditions, phosphoinositol production was measured. These results are 
also shown in Fig 5.9. 
Phentolamine produced a 35% reduction in cyclic AMP compared to 
that seen with adrenaline alone (not significant, p >0.05), while propranolol 
almost completely abolished the cyclic AMP response, achieving a reduction 
of 98 %. 
Adrenaline (10 -6 M) produced no . increase in phosphoinositols 
relative to basal, and neither the basal nor the stimulated cell 
phosphoinositol production were affected by phentolamine or propranolol. 
5.6 Effect of Growing Cells in Catecholamine Supplemented 
Medium 
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Fig 5.9 Combined (medium + cellular) cyclic AMP (top) and phosphoinositols 
(bottom) production over a 15 minute period in day 4 cells stimulated wi 
adrenaline (10 -6 M) in the presence or absence of phentolamine (Ph, 10- M) 
or propranolol (PL, 10-5 M). Abbreviation: NS, not significant. B = basal. 
Representative experiment (1 of 2 experiments). 
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medium containing 10 -7 M adrenaline or 10 -6 M adrenaline. On day 2, at 
the time of normal medium change, fresh adrenaline containing medium 
was used. On day 3, cells were stimulated as previously described (Section 
2.2.3), and incubations with adrenaline set up for 1 hour. Cortisol was 
measured in the medium after this time (flg 5.10). Cells from the same cell 
preparation, grown in control medium (not supplemented with adrenaline), 
were used as controls. 
Cells grown in 10-6 M adrenaline failed to respond to stimulation 
with adrenaline on day 3. These results are identical to those obtained by 
stimulating freshly isolated (day 1) cells with adrenaline (Fig 4.1 - in this 
case noradrenaline) Cells grown in 10 -7 M adrenaline responded in a dose - 
dependent manner to adrenaline, but gave much lower absolute values of 
cortisol production compared to the control cells (21% of the amount of 
cortisol produced by 10-6 M adrenaline). 
5.7 Desensitisation of the Adrenergic Response 
Day 3 cells were preincubated for between O to 4 hours with growth 
medium containing 10 -6 M adrenaline. All preincubations within each 
experiment were timed to end at the same point. After washing the cells with 
(3x) lml EBS /BSA /Glc, they were stimulated in the normal manner (section 
2.2.3) with 10 -6 M or 10 -7 M adrenaline for a 1 hour period and cortisol 
measured (Fig 5.11). 
Preincubation of the cells in adrenaline- containing medium produced 
StchKLatcón 
-an-homologous- desensitisation of the cells to4adrenalinertThe time required 
to fall to 50% of the maximum response, produced by control cells with the 














































































































































































































































































































































































































Previous workers in the field of adrenal research have reported the 
effects of catecholamines on aldosterone production in both rat and bovine 
species (De Lean et a1, 1984; Sequeira & McKenna, 1985). There is much 
less information on the effects of catecholamines on fasciculata cells. De 
Lean et a/ (1984) showed that there was no effect of catecholamines on 
freshly isolated bovine ZFR cells. Kawamura et al (1984) also showed that 
there was no effect of catecholamines on a mixed bovine adrenocortical cell 
preparation, but that, after 48 hours in culture, catecholamines could 
stimulate steroid secretion. These experiments did not use a clearly defined 
zonal cell preparation and steroid was measured fluorometrically, giving 
total steroid and not a measure of the individual types present. 
The results presented in this chapter show that in cultured day 3 or 4 
(48 -60 hour) bovine ZFR cells responded to stimulation with catecholamines. 
They produced cortisol and corticosterone in a dose -dependent manner, the 
latter steroid being made at only 15 -30% of the levels of the former (Figs 5.1 
& 5.2). The ED50 values for catecholamine- stimulated cortisol production 
showed that the order of potency, isoprenaline > noradrenaline > adrenaline, 
was the same as would be expected for a response mediated by beta1 
adrenergic receptors (Furchgott, 1972). 
All 3 catecholamines also stimulated cyclic AMP production from the 
cells in a dose - dependant manner (Fig 5.3). An increase in cyclic AMP 
production is consistent with a response mediated by beta - adrenergic 
receptors, because none of the known alpha- adrenergic receptors are linked 
to an increase in cyclic AMP (Section 1.2.2). It should be noted that alpha - 
adrenoceptors could also be present, but not involved in steroidogenesis. 
The evidence from studies of the second messengers in the cells (Figs 
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5.4. 5.5 & 5.6) also confirmed the involvement of cyclic AMP in stimulation 
of cortisol production by adrenergic agonists. This also showed that 
adrenergic agonists failed to stimulate phosphoinositol production in the 
cells. This was in contrast to the effects of All which did not produce an 
increase in cellular cyclic AMP, relative to basal values. but gave a dose - 
dependant rise in phosphoinositols. Carbachol acted in a similar manner to 
All in that it too appeared to mediate its steroidogenic effects via the 
phoshphoinositde- derived second messenger system. Thus it appears that 
the catecholamines produce steroidogenesis in cultured bovine ZFR cells via 
a cyclic AMP dependant mechanism and that All and cholinergic agonists 
produce there effects via phosphoinositide breakdown. 
Experiments with the specific alpha-antagonist phentolamine, and 
the specific beta - adrenergic antagonist propranolol (Fig 5.7 5.8), 
confirmed that beta -adrenoceptors were responsible for mediating the 
steroidogenic effect of these agonists on the cells A 10 -fold excess of 
propranolol relative to adrenaline, noradrenaline or isoprenaline almost 
completely blocked cortisol production stimulated i , each of these 
catecholamines. In identical experiments, phentolamine had no effect on 
catecholamine -stimulated cortisol production. Additionally. propranolol 
completely blocked adrenaline stimulated cyclic AMP production, while 
phentolamine appeared to reduce cyclic AMP production. but not to a 
significant degree. Phosphoinositol production was unaffected by either of 
the antagonists. 
One of the arguments for the absence of an adrenergic response in 
freshly isolated (day 1) cells is that high levels of catecholamines in the 
adrenal caused by stress before the death of the animal may lead to a 
desensitisation of this response (Section 1.4.2). Growing cells in medium 
* control exepriments showed that phentolamine and propranolol had no effect on cortisol 
secretion produced by ACTH1_24 or All. 
supplemented with adrenaline (Fig 5.10) .. all 
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ticalily reduced the 
adrenergic response. Cells grown in medium containing 10-6 M adrenaline 
failed to produce cortisol in response to stimulation with adrenaline on day 
3. (It should be noted that no account was taken of breakdown of 
catecholamine, as the medium was only changed every 24 hours, yet the 
cells were still subject to desensitisation of the adrenergic response). The 
absence of a dose- response to adrenaline is a sárnilar situation to that seen 
with adrenergic stimulation of freshly isolated cells (see Fig 4.1). Growing the 
cells in catecholamine- supplemented medium may be simulating the local 
environment that the adrenocortical cells are present in shortly after the 
death of the animal 
The adrenal cells are unlikely to be subject to significant levels of 
catecholamines in vivo, unless there is an, as yet unproven, retrograde 
flow of blood between medulla and cortex. However, desensitisation of the 
adrenergic response of the adrenal cortex in vivo could also occur by 
prolonged stimulation via adrenergic innervation. 
If the adrenergic response of the adrenocortical cells had been 
desensitised in this way, or by exposure to high levels of catecholamine after 
the death of the animal, recovery of the adrenergic response after isolation 
may occur. The earliest time at which catecholamine stimulation of the cells 
was carried out was 16 hours after initial isolation, at which point 
adrenaline was shown to stimulate cortisol production (Fig 3.4). Also, cells 
kept at 40C overnight (16 -20 hours) failed to respond to catecholamines, but 
produced cortisol in response to ACTH]. _24, All and carbachol. Beta - 
adrenergic receptors have variable half -lives, and reappearance after 
homologous desensitisation can take several days (Mahan et al, 1987). The 
argument that beta -adrenergic receptors are destroyed by the isolation 
* Treatment of animals prior to death with adrenergic antagonists may theoretically stop this 
effect and may show the presence of an adrenergic response in freshly isolated cells. A single 
experiment showed that propranolol could cause desensitisation of the adrenergic response in 
day 3 cultured cells, so this approach may still be ineffective. 
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procedure also fits into this model as resynthesis of new receptors would 
follow the same time course as resensitisation if both involved protein 
synthesis. 
Homologous desensitisation of catecholamine- stimulated 
steroidogenesis was also seen in cultured (day 3) cells (Fig 5.11). 
Desensitisation of responses mediated by beta- adrenergic receptors are 
common (Mahan, 1987) and are often associated with a short term 
conformational change in the receptor, reducing its ability to bind ligand. 
followed by a longer term degradation of receptor. Recovery of the cells from 
short term desensitisation would be expected to happen within minutes or 
hours; whereas resensitisation of the adrenergic response after receptor 
degradation would take a longer period. It is not known if the bovine ZFR 
cells studied followed this model. 
The results presented in this chapter (most of which have been 
published as: Walker, Lightly, Milner & Williams, 1988) clearly show the 
presence of a steroid -producing beta- adrenergic response in cultured bovine 
ZFR cells. They also establish that this response is mediated by cyclic AMP 
and does not involve phosphoinositide- derived second messenger systems. 
Additionally, the response is subject to homologous desensitisation of 
unknown mechanism. 
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6 Further Study of the Beta Adrenergic Response 
6.1 Introduction 
The results in the previous chapter demonstrated that beta - 
adrenoceptors are responsible for mediating the effect of catecholamine 
stimulated steroidogenesis. Beta -adrenoceptors can be further classified into 
betas and beta2- receptors (Furchgott, 1972) and a recently characterised 
beta3- subclass (Arch et a1, I984; Kaumann, 1989). 
As discussed in section 1.6.2, there is some evidence for adrenergic 
innervation in certain species (Mikhail & Amin, 1969; Kleitman & Holzwarth, 
1985), and this has been suggested as an alternative means of controlling 
adrenal steroidogenesis. In the bovine system there is no published data on 
this type of innervation. It is not absolutely clear yet whether there is 
actually adrenergic control in vivo in any species. 
Ungar (1979) and O'Donnell (1987) have suggested that, in general, 
betas- adrenoceptors tend to be innervated by adrenergic neurons, whereas 
beta2- adrenoceptors respond mainly to circulating catecholamines. Beta 1- 
adrenoceptors also have a lower affinity for catecholamines than beta2- 
adrenoceptors, which is to be expected for receptors that are subject to 
much higher local concentrations of catecholamines in the synapse. Hence, 
determination of the subclass of beta -adrenoceptors on bovine ZFR cells 
should provide circumstantial evidence as to whether the adrenergic control 
of the adrenal cortex is by direct innervation or via circulating 
catecholamines. 
Schild (Schild 1947a,b, 1949) first suggested the method of using pA2 
values, where: 
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pA2 = -1og10[dissociation constant of antagonist] 
Initially, pA2 values were used as a means for classifying antagonists 
and later this was extended to a method for differentiating between receptor 
subclasses (Kenakin, 1982). Previously, agonist potency ratios had been 
used (Lands et a1, 1967a, b). However, this method is complicated by 
differing intrinsic efficacies of the agonists themselves. Schild analysis, as it 
is now called, eliminates this problem, relying only on the differing affinities 
of the antagonists used. 
Subclassification of beta -adrenoceptors has been successfully 
reported using the selective betas- antagonist practolol (Dunlop & Shanks, 
1968) and the selective beta2- antagonist ICI118,551 (Bilski et a1, 1983). 
These antagonists were used to determine the subclass of beta - 
adrenoceptors on the primary cultures of bovine adrenocortical ZFR cells 
used throughout this thesis. The effects of the selective beta -agonists; 
noradrenaline ( beta1), salbutamol ( beta2), dobutamine ( beta1), isoprenaline 
(beta1/2), and BRL37344A (beta3) were also compared. 
6.2 Traditional Methods of Receptor Classification - An 
Introduction 
Most of the detailed theory of drug- receptor pharmacology applicable 
to this chapter is contained in Kenakin (1987). 
Several models have been derived to describe drug- receptor 
interactions in biological systems, one of the most important being the 
occupation theory which relies on equilibrium considerations for the 
derivation of the equations. 
The action of an agonist on a cell or tissue depends on its ability to 
bind (affinity) and its capacity to elicit a response when bound (efficacy). The 
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total responsiveness is a combination of both of these factors. Study 
of agonist potency ratios was used originally to determine differences 
between agonist -receptor interactions - this being only a relative and not an 
absolute measure. However, though a single receptor subtype will produce 
the same potency ratios for a set of agonists in different tissues, the 
converse is not necessarily true ie. a set order of potency ratios does not 
imply a single receptor subtype. Further, differing efficacies of the agonists 
will produce false potency ratios: only full agonists - those that will produce 
the same maximum tissue response - can be used to classify receptors in 
this way. Partial agonists, producing only a fraction of the maximum 
response are less useful. 
Ways exist to separate the affinity and efficacy contributions of the 
agonists. For example, using an irreversible antagonist in increasing 
concentration, progressively more of the receptors are immobilised, and 
extrapolation to 100% inactivation will give a measure of the agonist efficacy. 
These methods are, however, complex and a further step away from the in 
vi vo situation. 
A much more useful means of receptor classification is by 
determination of the affinity with which a competitive antagonist binds to a 
receptor. Antagonists have, of course, no efficacy contribution. 
Schild (1947a,b, 1949) first proposed the use of PAX values to classify 
antagonist -receptor interactions. pAX is defined as the negative (base 10) 
logarithm of the molar concentration of antagonist that produces an equtactive 
dose ratio of magnitude x ie. pAX represents a concentration of antagonist 
that produces an 'x' fold shift to the right of the agonist dose response. 
A single antagonist will, in theory, have the same pAX value when it 
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acts on a single receptor subtype in different tissues. Hence, determination 
of the pAx value for a specific antagonist on the tissue in question, and 
comparison with previously published data for this antagonist, will give an 
indication as to whether that particular receptor is present on the tissue. 
Derivation of the effects of a pure competitive antagonist on an 
agonist dose response using occupation theory yields the equation :- 
log10(dr - 1) = 1og10[Antag] - log10 (KAntag) 
(Kenakin, 1987, p213) 
where dr is the dose ratio, or the degree to which the antagonist shifts the 
agonist dose response to the right. [Antag] is the concentration of 
antagonist and KAntag is the dissociation constant of the antagonist. 
Schild regression analysis involves measuring the dose ratio for a 
series of antagonist concentrations and plotting logl o (dr - 1) versus 
log10 [ Antag] . This should give a straight line, gradient = 1, and x- 
intercept = -log10 (KAntag) for a pure competitive antagonist. A pA2 
value implies dr = 2 and hence KAntag = [ Antag] , thus pA2 = 
PKAntag = -log10 (KAntag) Hence, it is possible to obtain a measure of 
the affinity of an antagonist for a receptor irrespective of the agonist used to 
get this result. Regressions with a gradient not equal to one, suggest that 
the antagonist is deviating from pure competitive behaviour. Reasons for 
this are discussed in Kenakin (1987). 
Experimental determination of the pA2 values of selective antagonists 
on a tissue or in a cell system gives a means of classifying receptor subtypes 
and also shows existence of non - equilibrium states. Study of agonist 
potency is a useful means of confirming or refuting the receptor 
classification using Schild analysis. 
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6.3 Statistical Analysis 
For the estimation of antagonist pA2 values, dose response curves 
were tested for parallelism by analysis of covariance using the SPSS -X 
statistical package produced by Edinburgh University Computing Service. 
Schild regression lines were fitted with a least squares fit using a Casio fx- 
180P programmable calculator and confidence limits calculated from the 
relevant statistical equations (Bowman & Rand, 1984) using tables of 2- 
tailed t statistics (Geigy Scientific Tables). 
6.4 Results - The Effect of Various Selective Beta -Agonists on 
Cortisol Secretion 
The effect of increasing concentrations of isoprenaline, noradrenaline, 
dobutamine, salbutamol and BRL37344A was tested on day 3 cells (Fig 6.1). 
The agonists had relative potency of: 
isoprenaline > noradrenaline > dobutamine > salbutamol > BRL37344A. 
Isoprenaline, noradrenaline and dobutamine all produced the same 
maximum response, salbutamol gave approximately 70% and BRL37344A 
gave approximately 10% of the maximum response. 
Neither practolol nor ICI118,551 produced cortisol secretion by the 
cells, and therefore have no intrinsic agonist effects in these cells (Fig 6.2). 
6.5 Schild Analysis - Determination of the pA2 Values for 2 
Selective Beta -Antagonists 
Dose response curves (central portion shown is linearto isoprenaline 
were set up, in the presence of increasing doses of practolol or ICI118,551. 
Representative experiments for each antagonist are shown in Fig 6.3 & 6.4 
(left -hand graphs). The dose response lines were judged to be parallel by 
* curvature added by artist 
B -10 -9 -8 -7 -6 -5 -4 
Log 10 [ AGONIST] 
3 
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Fig 6.1 Dose -response curves for the secretion of cortisol produced upon 
stimulation of day 3 cells with isoprenaline (o), noradrenaline (.), 
dobutamine (o), salbutamol (A) and BRL37344A (o). B = basal. 





. , . . . . . 
B B 3 6 5 4 
-Log [Antagonist ] 
Fig 6.2 Cortisol production upon stimulation of day 3 
cells with increasing concentrations of practolol 
(open circles) and ICI118,551 (closed circles). 
B = basal. Single experiment. 
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analysis of covariance. Experiments were repeated on cells from 4 separate 
cell preparations for practolol and 3 separate cell preparations for 
ICI118,551. 
The dose ratio for each concentration of antagonist was obtained 
and Schild plots of log10 (dr - 1) versus antagonist concentration plotted (Fig 
6.3 & 6.4, right -hand graphs) and used to calculate pA2 values for each 
antagonist and to obtain 95% confidence limits. Similarly, the slope of the 
regression line and 95% confidence limits were also estimated. Results for 
both antagonists are shown in Table I. 
6.6 Discussion 
The results presented in this chapter (and published as. Lightly, 
Walker, Bird & Williams, 1990) establish the existence of beta1- 
adrenoceptors on cultured bovine ZFR cells. 
Study of the effects of several selective beta -adrenergic agonists 
showed that isoprenaline, noradrenaline and dobutarnine were all full 
agonists, whereas salbutamol acted as a partial agonist and was less potent 
than the full agonists. Salbutamol is known to act as a full agonist at beta2- 
adrenoceptors, but only as a partial agonist at betal- adrenoceptors (Farmer 
et al, 1970). This in itself suggests that beta 1-adrenoceptors are present 
on the cells. 
Although BRL37344 produced stimulation of the cells at 10 -5 M, it 
was the least potent of all the agonists studied only producing 14% of the 
maximum response seen with isoprenaline. Previous studies have shown 
that, in systems known to contain beta3- adrenoceptors, BRL37344 was a 
more potent agonist than isoprenaline (Arch et al, 1984; Bond & Clarke, 
Weak 
1988). Hence, it is likely that BRL37344 is producing a -nen-speefe- 
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(possibly via beta, -adrenoceptors) 
stimulation/ and that beta3- adrenoceptors are not present on cultured 
bovine ZFR cells. 
Determination of the pA2 values for the betas- antagonist practolol 
and the beta2- antagonist ICI118,551 provided definitive evidence for the 
presence of betas- adrenoceptors (Table I). The pA2 value for practolol of 6.85 
(6.67 - 7.06) (Lower & upper 95% confidence limits) agreed satisfactorily 
with published values shown in the table. The gradient of the Schild 
regression was significantly less than 1. slope = 0.90 (0.84 - 0.96). 
suggesting deviation from an ideal competitive antagonist. Though practolol 
and ICI118,551 showed no partial agonist activity (Fig 6.2), practolol is 
known to be a partial agonist in other systems (Kenakin & Black. 1978). It is 
possible that isoprenaline may potentiate the partial agonist properties of 
practolol leading to production of more cortisol than expected and hence 
giving a Schild regression < 1. 
The pA2 value for the action of ICI118,551 at beta2- adrenoceptors is 
9.26 and at betas- adrenoceptors is 7.17 (Bilski et al, 1983). Hence, the 
experimental value of 7.14 (7.03 - 7.28) agrees with the value for beta1- 
adrenoceptors. In this case the gradient of the regression line of 0.99 (0.97 - 
1.01) suggests that ICI118,551 is acting as a pure competitive antagonist. 
Thus, Schild analysis provided strong evidence that beta 1- 
adrenoceptors were present on the cells, and the results of the selective 
agonist stimulations confirmed this. 
As mentioned in the introduction to this chapter betas- adrenoceptors 
are commonly found at adrenergic synapses. Thus it seems possible that 
there may be adrenergic innervation of the bovine adrenal cortex in vivo. 
Shims et al (1984) has already shown, using binding of [3H)dihydro- 
aiprenol.ol, that membranes prepared from both the capsulated (ZFR) and 
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decapsulated (ZG) regions of the rat adrenal cortex contain beta1- 
adrenoceptors, only the latter being coupled to adenylate cyclase in 
vitro. 
Hence this evidence from the rat in which there is thought to be 
adrenergic innervation (Kleitman & Holzwarth. 1985). and the results 
presented in this chapter suggests that, at least in some species. adrenergic 
innervation may play a part in controlling steroidogenesis in the adrenal 
cortex. 
7 The Cholinergic Response 
7.1 Introduction 
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As discussed in section 3.3.4, during characterisation of the cell 
culture system, it was found that bovine ZFR cells secrete cortisol in 
response to stimulation with the cholinergic agonists, acetylcholine and 
carbachol. This was shown in both freshly isolated cells, and in cells 
between 2 - 5 days of primary culture. 
Further analysis of the cholinergic response was carried out. An 
attempt was made to characterise the receptor subtype, and the second 
messenger system, responsible for mediating this response. 
7.2 Initial Characterisation 
As shown in Fig 3.6 (part of which is duplicated here as Fig 7.1 for 
convenience), the day -by -day responsiveness of the cells to ACh stimulation 
depended on the serum used in preparing the growth medium. In this 
representative experiment, the peak cortisol response (day 4) was seen in 
cells grown in CPSR5. 
Earlier, (section 5.3) the measurement of cortisol, cyclic AMP and 
phosphoinositol levels in day 4 cells, stimulated with increasing 
concentrations of CCh, was described (Fig 5.6 is duplicated here as fig 7.2 
for convenience). No significant increase in cyclic AMP was seen at any dose 
of CCh, while phosphoinositol production paralleled that of cortisol. 
In section 4.4.1, the time- course of cortisol production in day 3 cells 
stimulated with 10 -3 M CCh was studied (Fig 4.5). The time- course of 



























































































































































































































































































































































































































also measured (section 4.4.3, Fig 4.7). 
Day 4 cells were stimulated with increasing concentrations of 10- 
4 M ACh and cortisol production measured. In parallel incubations, in the 
same batch of cells, but labelled with [3H]- Inositol, phosphoinositol 
production was measured. Fig 7.3 shows the results obtained. 
Basal cortisol output was almost linear. Significant levels of cortisol 
were not produced in stimulated cells until after 5 minutes (p <0.001 at 15 
minutes). Stimulated cortisol output was non -linear, the output at 60 
minutes being only slightly greater than that seen at 30 minutes. No further 
work on the possibility of desensitisation of the cholinergic response was 
carried out. 
Phosphoinositol production of stimulated cells was linear for at least 
15 minutes and subsequently declined. Phosphoinositol production in 
stimulated cells was statistically significant at 2 minutes (p <0.005). 
7.3 The Effect of Selective Cholinergic Agonists and Antagonists 
on Cortisol Production 
Day 3 cells were stimulated with increasing concentrations of the 
cholinergic agonists: ACh (M /N), nicotine (N) and McN -A -343 (M1) (where 
M = muscarinic and N = nicotinic, see section 1.5 for details of known 
subtypes). Cortisol production was measured and results are shown in Fig 
7.4. 
ACh produced a dose - dependent rise in cortisol output, achieving 
maximum output by 10 -4 M (in some experiments 10-5 M). The threshold 
response was between 10 -7 and 10 -6 M (in 4 experiments). The ED50 for 
ACh stimulated cortisol production was 1.2 x 10 -6 M (Range: 3.7 x 10 -7 to 













































































































































































































































































































































































Although nicotine stimulated cortisol production this was not seen 
until 10 -5 M, and was then only 25% of the maximum seen with ACh. 
Stimulation with nicotine was also inconsistent, being seen in only 2 out of 5 
experiments. Concentrations of nicotine > 10 -5 M were less potent and cells 
showed evidence of morphological damage. 
The specific M1- agonist, McN -A -343, produced no significant increase 
in cortisol production at any of the doses used. 
Also in day 3 cells, the effect of increasing concentrations of the 
cholinergic antagonists atropine (M), tubocurarine (N) and hexa- hydro -sila- 
difenidol (M3) on the cortisol response of cells stimulated with ACh 10 -4 M 
was studied (Fig 7.5). A dose -dependant inhibition of cortisol production was 
seen with atropine. This was significant at 10 -8 M and was greater than 60% 
by 10 -7 M. The nicotinic antagonist tubocurarine had no effect at these 
doses, and even at 10 -4 M produced only 47% inhibition, at which point a 
similar dose of atropine had reduced cortisol output to basal levels. The M3- 
antagonist, hexa- hydro- sila- difenidol, produced significant inhibition of 
cortisol secretion by 10 -7 M, inhibiting to basal levels by 10 -5 M. 
It has been shown in chapter 3 that bovine ZFR cells produce cortisol 
in response to catecholamines. Thus, it is possible, though unlikely, that 
contaminating medullary cells present in the culture could produce 
catecholamines in response to the cholinergic agonists, thus indirectly 
stimulating cortisol production. Fig 7.5 shows that the beta -adrenergic 
antagonist, propranolol, had no effect on cortisol production by ACh, thus 



























































































































































































































































































































7.4 The Effect of Selective Cholinergie Aqonists and Antagonists 
on Phosphoinositol Production 
Day 4 cells, prelabelled with 3H- Inositol, were stimulated with the 
cholinergie agonists: ACh (M /N, 10 -4 M), nicotine (N, 10 -4 M) and McN -A- 
343 (M1, 10 -4 M), and the total inositol phosphate headgroup production 
measured. The effect of the cholir ergic antagonists: atropine (M, 10 -6 M), 
tubocurarine (N, 10 -6 M), hexa- hydro - sila -difenidol (M3, 10 -6 M) and 
glycopyrrolate (M, 10 -6 M) on the total inositol phosphate headgroup 
response produced by ACh 10 -4 M was also studied. Both sets of results are 
shown in fig 7.6. 
The agonists nicotine and McN -A -343 did not produce a significant 
increase in phosphoinositols, compared to basal levels, while ACh 10 -4 M 
produced a 2.7 -fold increase over basal. 
The non - selective muscarinic antagonist atropine completely blocked 
ACh - stimulated phosphoinositol production, while the non -selective 
nicotinic antagonist tubocurarine did not produce a significant inhibition of 
the response. The muscarinic antagonists, hexa - hydro -sila- difenidol and 
glycopyrrolate, significantly reduced ACh - stimulated phosphoinositol 
production (p <0.001). In this experiment, with hexa - hydro -sila -difenidol a 
75% reduction in response (relative to basal values) was seen, while with 
glycopyrrolate an 89% reduction was seen. 
7.5 Discussion 
Initial characterisation (Fig 7.1) showed that the cholinergic response 
was more pronounced in cells grown in medium prepared with CPSRS. As 
suggested in chapter 3, FCS appeared to inhibit the appearance of a 










































































































































































































































































































































































































































normally removed by heat treatment of serum. In all experiments, freshly 
isolated (day 1). bovine ZFR cells produced cortisol in response to ACh or 
CCh. This had also been shown previously by Blair -West et al (1962) and 
Hadjian et at (1981, 1982). As with AII, cells on day 2 of culture showed a 
dramatically reduced response to cholinergic agonists (Fig 7.1). 
The cholinergic response of the cells is mediated by a process 
involving increased turnover of inositol- containing phospholipids and not 
involving changes in cyclic AMP concentration (Fig 7.2). Increased 
incorporation of 32P into inositol- containing phospholipids was also 
reported by Hadjian et al (1984) in freshly isolated bovine ZFR cells. In 
bovine ZG cells, Kojima et al (1986) has also shown that cholinergic 
stimulation of aldosterone secretion was mediated by a process involving 
increased turnover of inositol containing phospholipids, and that inositol 
trisphosphate (isomers not characterised) was the first phosphoinositol 
species to be produced. All these pieces of evidence suggest that the 
cholinergic response of bovine ZFR (and ZG) cells utilises phosphoinositide 
breakdown as the second messenger system. 
Walker, Strachan, Lightly, Williams & Bird (1990) have also shown, 
using detailed HPLC analysis of the inositol phosphate products of 
cholinergic stimulation (ACh 10 -4 M) of cultured (day 4) bovine ZFR cells, 
that the initial product was inositol (1,4,5)trisphosphate, appearing within 5 
seconds of stimulation. 
It was also demonstrated that, in EBS containing the equivalent of 
120nM free Ca2 +, the total head group phosphoinositol production was 
statistically significant (p <0.05) at 5 minutes. The response was 19.25% of 
that seen in normal EBS. Basal labelling at 120nM Ca2+ was unaffected. 
This reduction in response is similar to that seen with All in the same cells 
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(Bird et al, 1989). 
Both the appearance of inositol(1,4,5)tris phosphate as the initial 
product of ACh stimulation, and the presence of a response in low Ca2+ 
buffer are consistent with the activation of phospholipase C by cholinergic 
agonists. 
Walker, Strachan, Lightly, Williams & Bird (1990) found that, in 
bovine ZFR cells kept in suspension until day 4 and pre -loaded with the 
calcium indicator Fura -2, ACh (10 -4 M) produced a 1.6 -fold increase in 
intracellular [Ca2 +]. Under similar conditions, AII produced a 1.8 -fold 
increase in intracellular [Ca2 +]. Atropine completely blocked the rise in 
intracellular [Ca2 +] produced by Ach, but had no effect on the increase 
caused by AII. Again, in buffer containing 120nM Ca2 +, the increase in 
intracellular [Ca2 +], though reduced, was still present for both agonists. 
These observations confirm that release of intracellular Ca2+ is involved in 
mediating the response of bovine ZFR cells to cholinergic agonists. This is 
consistent with phospholipase C activation as the primary response. 
The results presented in this chapter provide evidence that M3- 
cholinergic receptors are responsible for mediating steroidogenesis 
stimulated by cholinergic agonists in primary cultures of bovine ZFR cells. 
Thus, Fig 7.4 shows that ACh was a potent stimulant of steroidogenesis in 
the bovine ZFR cells,. and that the M1- selective agonist, McN -A -343, had no 
effect. While nicotine stimulated steroidogenesis in 2 out of 5 experiments, 
this was only to 20% of the levels of ACh. This suggests that nicotine may be 
acting non -specifically to stimulate steroidogenesis. Nicotine was also shown 
to be cytotoxic at doses above 10 -5 M. These results confirm those of 
Hadjian et al (1981, 1982), that muscarinic receptors are present on bovine 
adrenocortical ZFR cells. Benjamina et al (1987) has shown that muscarinic 
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receptors are responsible for mediating the steroidogenic response to 
cholinergic agonists in the frog, although Rubin & Warner (1975) have 
shown that nicotine stimulates steroidogenesis in a mixed adrenocortical 
preparation from the cat. 
It was also shown that the muscarinic antagonist, atropine, caused a 
dose -dependent blockade of steroidogenesis stimulated by 10 -4 ACh. The 
nicotinic antagonist, tubocurarine, produced antagonism at doses above 10- 
6 M. The M3- antagonist, hexa- hydro -sila- difenidol, also showed a dose - 
dependent blockade of steroidogenesis. It is not possible to say conclusively 
from these results whether tubocurarine is simply acting non -specifically on 
muscarinic receptors, but as it is much less potent (in the order of 100 
times) than either of the muscarinic antagonists, it would seem likely that 
only muscarinic receptors are present. To determine the subtype of receptor 
conclusively requires the use of Schild analysis as described for the beta - 
adrenergic receptor in chapter 6 and possibly additional evidence from 
radio - ligand binding studies. 
The effect of these agonists and antagonists on the phosphoinositol 
response was also studied (Fig 7.6), showing that nicotine and McN -A -343 
had no effect, while ACh produced a 2.7 -fold increase relative to basal. All of 
the antagonists studied had no intrinsic effect on phosphoinositol turnover. 
Again it was shown that tubocurarine had no significant effect on 
phosphoinositol turnover, while the M3- selective antagonist, hexa- hydro- 
sila- difenidol produced considerable inhibition of the phosphoinositol 
response. Glycopyrolate, which is more selective antagonist for M3 
receptors, but is also effective as an M1- antagonist, also caused 
considerable inhibition of the phosphoinositol response produced by Ach. 
I. O S . II 
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8 Conclusions 
In addition to a detailed description of the characterisation of a 
primary culture system for bovine adrenocortical zona fasciculata / 
reticularis cells, this thesis aimed to address the two questions stated in the 
introduction: - 
(1) What relevance do adrenergic and cholinergic stimulation of cortisol 
production have to the overall, currently accepted, picture of 
regulation of cortisol production in the adrenal zona fasciculata / 
reticularis cells? 
(2) What molecular mechanisms are involved in adrenergic and 
cholinergic stimulated cortisol production in bovine zona 
fasciculata / reticularis cells, and how do these relate to the mode 
of action of other adrenocortical secretagogues? 
8.1 Characterisation of a Cell Culture System 
The need to use a purified adrenocortical cell preparation has been 
emphasised in the reviews of Tait et al (1980) and Brown et al (1982). 
Even minor contamination by cells from other zones may influence 
experimental results. Many other workers who have used enzymically 
dispersed adrenocortical cells have either worked with a mixed 
adrenocortical cell preparation (Kawamura et al, 1984, 1985) or have used 
cells prepared from dissected tissue (Gospodarowicz et al, 1977). The 
preparation employed to isolate the cells used in the experiments contained 
in this thesis relied on an initial primary separation of the zones by slicing of 
the gland using a Staddie -Riggs microtome and selection of tissue slices 
containing only zona fasciculata cells. Additionally the purification method 
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of McDougall, Williams et a/ (1979) was employed. This yielded cells 
essentially free from red blood cells and debris. Cells were also free from 
glomerulosa cell contamination, as All- stimulation failed to show 
aldosterone production (Williams, Lightly, Ross, Bird & Walker, 1988). The 
cells responded steroidogenically to ACTH1.24 and All both before and after 
several days in culture. Thus, a viable cell isolation and culture system for 
bovine zona fasciculata / reticularis cells was used to obtain the results 
contained in this thesis. 
8.2 Question (1) - Relevance of Adrenergic and Cholinergic Mechanisms 
There is already evidence for innervation of the adrenal cortex in 
several species (Section 1.4.1), but no clear knowledge of any effect of 
adrenergic agonists in vivo. The results in chapter 3 show that freshly 
isolated, enzymically dispersed, cells do not respond steroidogenically to 
adrenergic agonists. This finding is in agreement with the findings of Sequira 
& McKenna (1985), Kawamura et a/ (1984) and DeLean et al (1985). In 
addition, cells respond steroidogenically to adrenergic agonists after 
approximately 12 -18 hours of primary culture. This was also seen by 
Kawamura et al (1984) in a mixed bovine adrenocortical preparation, and 
by DeLean et al (1985) in, cultured rat subcapsullar cells. 
Shima et al (1984) showed, using binding of[311- dihydro- alprenolol, 
that rat adrenal cortex possessed betas- adrenoceptors. In chapter 5, it was 
shown that catecholamine stimulation of steroidogenesis in cultured bovine 
ZFR cells was mediated by beta -adrenoceptors, and further in chapter 6 that 
these receptors were of the betas- subtype. As discussed in chapter 6, betal- 
adrenoceptors tend to be associated with innervated tissue with the 
implication that adrenergic innervation of the adrenal cortex may be linked 
158 
to steroid secretion in vivo. 
Physiologically, one potential advantage to mammals of using 
adrenergic innervation to stimulate steroidogenesis, would be that the 
response would be almost instantaneous. Although stimulation of 
*, 
adrenocortical steroidogenesis by ACTH is central to the mammalian stress 
response, it is possible that the initial stimulus is via adrenergic innervation.1 
In chapter 7 the cholinergic response of bovine adrenal ZFR cells was 
discussed. It was shown that freshly isolated, enzyrnically dispersed, cells 
responded steroidogenically to cholinergic agonists, supporting the evidence 
of Blair -West et al (1962) in freshly isolated sheep adrenocortical cells, 
Rubin & Warner (1975) in cat cells, and Hadjian et a1 (1981, 1982, 1984) 
in bovine adrenocortical cells. The steroidogenic response was also seen in 
cultured cells, in agreement with the results of Kawamura et al (1985) 
who showed that primary cultures of a mixed preparation of bovine 
adrenocortical cells responded steroidogenically to acetylcholine. 
Additionally it was shown (chapter 7) that cholinergic- stimulated 
steroidogenesis in bovine zona fasciculata / reticularis cells was mediated by 
M3- cholinoceptors. 
An important observation is the occurrence of cholinergir_ stimulation 
of steroid production in freshly isolated cells, which suggests that the cells 
have the potential to respond in vivo. This finding makes it difficult to argue 
that the cholinergic response is an artefact of culture. As there is evidence 
for cholinergic innervation of the adrenal cortex (Coupland, 1961; Robinson 
et al, 1977), this is yet further evidence for the presence of a cholinergic 
response of adrenocortical cells in vivo. 
*, From stimulation of CRH release from the hypothalmus, to the direct action of ACTH on the 
adrenal cortex would be expected to take several minutes, whereas innervative control could 
theoretically act in less than a second. 
*2 by direct innervation of the adrenocortical cells, in addition to innervation of blood vessels, 
and control of adrenal blood supply. 
159 
f Arralc utd Cholinercilc A9onists 
i iregftilltS presented in chapter 5, showed clearly that adrenergic 
milmaglation \11 iAV:WrtIng to the cells was mediated solely by 
ey 'a-I% " " product its consistent with the presence of betai- 
adrenoceptors on the provides a useful method for further 
investigating the effects p.ii íLycllie AMP on ssteroidogenesís. h ACTH receptors are linked to adenylate 
cydase via a G ne.. 1f$' this is the case, it is possible that the beta1- 
.,A116 Mi114111*A11)1 0. :. 
fl11ÍlÍÌÍ:64i ï+4111 
protein varrits.. 
,;0111116 1. tt rr 
ÌIL¡wÍ11114w111 to 
i+11111 am the IA,.,Í41<z 
or link to 





link to e same adenylate cyclase units 
Ít1 th the same adenylate cyclase and G 
tthe adenylate cyclase / G protein units may be 
test ,t,; additivity of ACTH and adrenaline may 
II tlr:il1111M 
Ford:Der studies, Í1I111 identifying the various G proteins in the 
G !in,, which it is now possible to produce, 
would zase le a useful means II Í sY111t ä "r,itr any link between the ACTH and 
It should be possible to study the properties of 
the ademilate oydase units which are present in the cells by isolating bovine 
// retioollaris cal membranes from cultured cells, 
"711.1:üß11tÌ1( 





wItth ACM ar aeúren 
lltmettk and dher 
the s Ie,I. IRflifq'I I 




agonists and assaying for adenylate 
y procedures. Using this assay, the 
the adrenergic and ACTH- linked adenylate 
(j)rl),IÍlilli)i: l 
mill r., ergie agenists stimulate steroidogenesis in a 
Winhlag. WiNDMOr tm xlma // cyt brc Amp -stìanulated steroidogenesis. In 
Mktg-44,t, OinIEW r to stimulate a phospholipase C, 
n l 11,4,,5=triis phosphate (and other inositol 
160 
phosphates), and thereby to cause raised intracellular [Ca2 +]. Cholinergic 
agonists do not appear to produce any increase in cellular cyclic AMP levels. 
This process shares much in common with AII- stimulated steroidogenesis, 
though the magnitude of the PI response, and the amount of steroid 
produced, is much less (Bird et al., 1989). 
Thus, cholinergic agonists and All appear to stimulate steroidogenesis 
in a similar manner. They both cause activation of phospholipase C and an 
increase in intracellular [Ca2 +]. This is likely to lead to the stimulation of a 
calmodulin- dependant protein kinase and possible activation, by 
phosphorylation, of several steroidogenic enzymes. Again further work is 
needed to clarify this, for example by analysis of the particular protein 
kinases present in the cells by the use of phosphorylation assays. The 
proteins that these kinases act on could also be identified. 
Thus the second messenger systems activated by ACTH and 
adrenergic agonists, and AII and cholinergic agonists are similar. 
8.4 Summary of Alms 
The questions posed at the beginning of this thesis, though not fully 
answered, have been given full consideration. A primary culture system for 
bovine ' adrenocortical zona fasciculata / reticularis cells has been 
established, the relevance of the adrenergic and cholinérgic response of 
adrenocortical cells has been discussed, and the mechanisms of action of 
these effectors has been elucidated. 
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Appendix I 
Serum used in Experiments Presented in Figures 
FCS 
3.1; 4.1; 4.2; 4.3; 5.1; 5.2; 5.3; 5.7; 5.8; 5.10; 5.11. 
CPSR5 
4.4; 4.5; 4.6; 4.7; 5.4; 5.6; 5.9; 6.1; 6.2; 6.3; 6.4; 7.2; 7.3; 7.4; 7.5; 7.6. 
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ABSTRACT 
Analysis by electron microscopy indicated that after 3 
days of primary culture, purified bovine adrenal zonal 
fasciculata /reticularis (ZF /ZR) cells showed improved 
integrity of their ultrastructure, with an increased 
density of lipid droplets and smooth endoplasmic 
reticulum. The basal cortisol output was significantly 
(P <0.05) greater on day 3 of culture than for the 
freshly isolated cells in six out of seven experiments. 
Similarly, in six experiments with ACTH (1 nmol /1) 
and five experiments with angiotensin II (10 nmol /1), 
the stimulated cortisol secretion was significantly 
(P <0.01 for all 11 experiments) higher on day 3 of 
culture than in freshly isolated cells. 
No significant increase in cortisol secretion above 
basal was observed with noradrenaline at any concen- 
tration in the freshly isolated cells, whereas a dose - 
dependent increase in cortisol secretion was observed 
on day 3 of culture in all of four experiments. These 
findings were supported by cyclic (c) AMP output 
measured in one such experiment. Thus the basal 
cAMP output and that stimulated by ACTH (1 nmol /1) 
were significantly higher after culture (P <0.001, 
n= five wells for basal comparison; P < 0.05, n= three 
wells for ACTH at 1 nmol /1). In agreement with the 
cortisol results, cAMP production was unaffected by 
any concentration of noradrenaline in the freshly iso- 
lated cells, whereas a dose -dependent rise was found 
after culture. Angiotensin II at all concentrations had 
no effect on cAMP production in freshly isolated or 
cultured cells. 
These studies demonstrate that the primary culture 
of purified bovine ZF /ZR cells increases basal ster- 
oidogenesis and leads to an enhanced responsiveness to 
the physiological stimuli, ACTH and angiotensin II. 
In addition, primary culture of purified bovine ZF /ZR 
cells revealed a noradrenaline response which was not 
readily observed in freshly isolated, purified ZF /ZR 
cells. 
Journal of Endocrinology (1989) 121, 317 -324 
INTRODUCTION 
Since the enzymic digestion procedure was first 
employed to obtain dispersed adrenocortical cells 
(Kloppenborg, Island, Liddle et al. 1968; Swallow & 
Sayers, 1969), the use of isolated zona glomerulosa 
(ZG), zona fasciculata (ZF) and zona reticularis (ZR) 
cells has considerably advanced our understanding of 
the control mechanisms which regulate the secretion 
of adrenal steroids. The need to use purified cell prep- 
arations for these studies has been stressed in two 
major reviews (Tait, Tait & Bell, 1980; Brown, 1982), 
and several methods are now available for the purifi- 
cation of rat ZG, ZF and ZR cells (Tait, Tait, Gould 
& Mee, 1974; Bell, Gould, Hyatt et al.1978; McDougall, 
Williams, Hyatt et al. 1979; Tait et al. 1980; Chu & 
Hyatt, 1986). 
Bovine adrenocortical cells from the inner zones have 
not been rigorously purified, unlike cells from the rat. 
Workers have employed either unpurified freshly iso- 
lated cells prepared from adrenocortical slices (Hepp, 
Grillet, Peytremann & Vallotton, 1977) or unpurified 
cultured cells prepared from crudely dissected inner - 
zone adrenal cortical tissue (Gospodarowicz, Ill, 
Hornsby & Gill, 1977). In order to obtain a reproduc- 
ible isolated ZF /ZR cell system to study the intra- 
cellular mechanisms which are involved in cortisol 
secretion, we have recently employed the column 
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filtration method (McDougall et al. 1979) for the 
purification of ZF /ZR cells from the bovine adrenal 
cortex. The steroidogenic capacity of these purified 
ZF /ZR cells has been compared with the same cells 
after 3 days in primary culture using adrenocortico- 
trophic hormone (ACTH), angiotensin II (AII) and 
noradrenaline as stimulants. 
MATERIALS AND METHODS 
Bovine adrenal glands were obtained from steers (age 
range 18 months to 2 years) within 20 min of slaughter 
at the Gorgie Abattoir, Edinburgh and transported 
within 20 min to the laboratory on ice. After trimming 
away the fatty tissue under sterile conditions, the 
glands were rinsed with Earle's balanced salt solution 
(EBSS; Gibco Biocult Ltd, Paisley, Strathclyde, U.K.) 
and placed in a Staddie -Riggs microtome. 
Slices of tissue of approximately 100 gm thickness 
were cut using a skin graft blade. The first slice, which 
consisted of the adrenal capsule and adhering zona 
glomerulosa, was discarded and the second and third 
slices which contained the ZF /ZR (with no visible 
contamination by the adrenal medulla) were finely 
chopped into 1 -2 mm portions and digested by incu- 
bation with collagenase (Worthington Biochemical 
Corporation, Lome Diagnostics Ltd, Bury St 
Edmonds, Suffolk, U.K.) dissolved in EBSS (1.5- 
2.0 mg /ml) containing 2% (w /v) bovine serum albu- 
min (BSA, fraction V; ICN Biomedical Ltd, High 
Wycombe, Bucks, U.K.). Routinely, 3 g adrenal ZF/ 
ZR tissue were digested for 90 min in 30 ml collage - 
nase solution in a shaking water bath at 37 °C; at 
30 -min intervals the tissue was dispersed mechanically 
(Haning, Tait & Tait, 1970) by repeated pipetting (30 
strokes, 5 ml pipette). 
Dispersed cells were separated from undigested 
tissue- by filtration through a 250 µm mesh nylon 
gauze (Henry Simon, Stockport, Cheshire, U.K.). The 
cells were then harvested by centrifugation at 300 g for 
15 min at 4 °C, washed three times in EBSS containing 
0.2% BSA and filtered through 100 pm mesh nylon 
gauze followed by 30 p.m mesh nylon gauze; this 
removed any aggregates present. The cell suspension 
(10 ml) was then applied to a Sephadex column 
(McDougal et al. 1979) which consisted of 5 ml G -50 
Sephadex (Pharmacia, Milton Keynes, Bucks, U.K.) 
supported on 5 ml G -10 Sephadex; this had previously 
been equilibrated with EBSS containing 0.2% BSA at 
room temperature. 
A further 20 ml EBSS containing 0.2% BSA was 
passed through the column to remove red blood cells, 
cell debris and small damaged cells. The ZF /ZR cells 
were then harvested from the column by resuspending 
the Sephadex and filtering through a 30 gm nylon 
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gauze; this allowed the adrenal cells to pass through, 
but not the Sephadex beads (McDougall et al. 1979). 
From the original unpurified cell population, approxi- 
mately 70% of the ZF /ZR cells were retained by the 
Sephadex as judged by light microscopy, and more 
than 90% of these cells were considered viable by the 
trypan blue exclusion test. Routinely 3 g ZF /ZR tissue 
gave a yield of approximately 15 x 106 purified ZF /ZR 
cells, essentially free from cell debris and red blood 
cells. 
After counting the cells in an improved Neubauer 
haemocytometer, they were either used directly to 
study steroid secretion or were plated out in 12 -well 
plates in Ham's F12 medium containing 10% (v /v) 
fetal calf serum (NBL, Cramlington, Northumberland, 
U.K.) with added penicillin (50 IU/ml), streptomycin 
(50 gg /ml) and amphotericin B (2.5 gg /ml) (Flow 
Laboratories, Rickmansworth, Herts, U.K.) using 
2 x 105 cells per well. The cells were cultured at 37 °C 
in an atmosphere of 5% CO2, and the medium was 
changed on the second day. Steroid secretion from the 
cultured cells was studied on the third day, except for 
the first series of experiments which evaluated the 
steroid output of the cells daily from days 1 to 5 of 
culture. 
Incubation of dispersed cells 
Freshly isolated purified ZF /ZR cells were incubated 
for 1 h at 37 °C in 1 ml EBSS containing 0.2% BSA in 
the presence of increasing concentrations of ACTH(1- 
24) (Synacthen; CIBA Laboratories, Horsham, Sussex, 
U.K.; 10 fmol -10 nmol /1), [Asp I,Val5]- angiotensin II 
(MRC Research Standard A; NIBSC, Hampstead, 
London; 0.01 -10 nmol /1) or noradrenaline (Winthrop 
Laboratories, Horsham, Sussex, U.K.; 1 nmol- 
1 gmol /l). All incubations were carried out in triplicate 
for each agonist concentration and a basal secretion 
(no agonist) measured for each experiment; at least 
three experiments were performed with each agonist. 
At the end of the incubation period the cell suspen- 
sions were centrifuged at 300 g for 15 min at 4 °C and 
the cyclic AMP (cAMP), cortisol and aldosterone (in 
some experiments) outputs measured in the medium 
by radioimmunoassay procedures. In addition, cAMP 
was also measured in an ethanol extract of the cell 
pellets. 
Cultured purified ZF /ZR cells were initially washed 
once with EBSS containing 0.2% BSA, after remov- 
ing the tissue culture medium. However, the relatively 
long period of basal cortisol secretion during culture 
led to significant carry -over of cortisol into the incu- 
bation medium when only one wash was used. Conse- 
quently, with the exception of the earlier experiments 
analysing the day -by -day response, all later exper- 
iments used two washes with EBSS plus 0.2% (w /v) 
BSA. Incubations were then carried out exactly as 
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This difference is, therefore, unlikely to be due solely 
to limited availability of substrate for steroidogenesis 
in freshly isolated cells. Instead, the greater respon- 
siveness may be due to an increase in the number of 
viable receptors for ACTH in the cultured cells, with 
activation of more adenylate cyclase units within the 
plasma membrane. Alternatively, there may be an 
increase in the number of adenylate cyclase units 
capable of coupling to the receptors, since only a small 
proportion of ACTH receptors need to be activated in 
order to obtain maximal steroidogenesis (Mcllhinney 
& Schulster, 1975). It should be possible to determine 
which of these explanations is correct by performing 
binding studies using biologically active 125I- labelled 
derivatives for ACTH and AII. 
Ultrastructural studies using electron and light 
microscopy indicated that the cellular content of lipid 
droplets within the ZF /ZR cells increased following 3 
days of culture. This may mean that cultured ZF /ZR 
cells contain higher levels of steroid precursors, able 
to contribute to the increase in basal steroidogenesis 
observed in the cultured cells. Crivello, Hornsby & 
Gill (1982) demonstrated a progressive deterioration 
of steroidogenesis with time in bovine ZG cell cul- 
tures; after several days of culture, aldosterone output 
was practically undetectable. To overcome this prob- 
lem, they introduced metyrapone and the antioxidant 
dimethyl sulphoxide into the tissue culture medium. 
In contrast to the bovine ZG cell culture system, we 
observed an increase in cortisol secretion suggesting 
that, after primary culture, the metabolic state of the 
ZF /ZR cells has improved. It would appear that the 
enzymes responsible for cortisol synthesis are less 
susceptible to oxidation than those required for 
aldosterone biosynthesis. 
No significant effect of noradrenaline was observed 
in freshly isolated purified ZF /ZR cells on cAMP or 
cortisol production over the concentration range 
0.1 nmol -1 gmol noradrenaline /1. However, after 
culturing the ZF /ZR cells for 3 days, we observed a 
stimulatory effect of noradrenaline on cAMP and 
cortisol production, at a threshold concentration of 
10 nmol /1 for cortisol (Walker, Lightly, Milner & 
Williams, 1988). We have suggested that the lack of a 
significant effect of noradrenaline on steroidogenesis 
in freshly isolated ZF /ZR cells may be due to an in- 
vivo effect, such as stress, leading to desensitization of 
the f3-receptors that slowly regain their sensitivity in 
culture as the in -vivo effect wears off. 
In conclusion, comparison of the freshly isolated 
and cultured ZF /ZR cells from bovine adrenal cortex 
demonstrates clear differences in ultrastructural 
integrity and agonist responsiveness. The cultured 
cells display a significantly greater secretion of corti- 
sol, both basal and in response to stimulation by 
ACTH and AII. They also respond steroidogenically 
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to ß- agonists, whereas the freshly isolated cells are 
completely unresponsive. In addition, the basal 
cAMP output .and that in response to ACTH and 
ß- agonists is also significantly greater after culture. 
These functional differences are reflected in better 
ultrastructural preservation of the cultured cells, 
which contain an increased density of lipid droplets 
and smooth endoplasmic reticulum. 
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FIGURE 3. Output of (a) cortisol and (b) cAMP by bovine zona fasciculata /zona reticularis cells in 
response to noradrenaline. Cells were uncultured (solid bars) or cultured for 3 days (hatched bars), 
and results are expressed as a stimulation ratio relative to the basal (unstimulated) value on day 1 
(uncultured) or day 3, as appropriate. Values are means ± S.E.M. for three wells. 
(2 -3 µm) stained with toluidine blue. In the freshly 
isolated cells, 4± 1 lipid droplets per cell section 
(n=100 cell sections) were counted, compared with 
25 ± 2 droplets per cell section (n =100 cell sections) 
for the cells on day 3 of culture. 
DISCUSSION 
Characterization of the steroidogenic responsiveness 
and intracellular control mechanisms of cells isolated 
from the inner zones of the bovine adrenal cortex 
requires initial purification to remove cellular debris 
and red blood cells, and to minimize contamination 
by cells of the ZG. This is particularly important for 
studies involving ACTH and AII, since they act on 
both the ZG and ZF /ZR in the bovine species. Earlier 
studies on steroid secretion from bovine ZF /ZR cells 
did not include any purification step, and Hepp et al. 
(1977) reported that aldosterone, measured by a 
protein- binding assay, was still present in the final cell 
suspension. 
In the present study, we employed the column fil- 
tration method originally devised for rat adrenal cell 
purification (McDougall et al. 1979) in order to isolate 
the ZF /ZR cells of the bovine adrenal cortex. Con- 
tamination by cells from the ZG was monitored using 
a sensitive and specific radioimmunoassay for aldo- 
sterone (Campbell et al. 1981). The aldosterone out- 
put from cells purified by column filtration was lower 
than the detection limit of the radioimmunoassay, 
suggesting that contamination by cells from the ZG is 
insignificant. No red blood cells or cellular debris 
could be seen under phase- contrast microscopy in the 
purified ZF /ZR cell preparation. 
The comparisons between freshly isolated cells (day 
1) and cultured cells on day 3 of culture was based on 
experiments that showed that the response to ACTH 
(0.1 nmol /1) was greatest on day 3. A similar result has 
been reported on an unpurified preparation of bovine 
adrenocortical cells (Kawamura, Nakamichi, 
Imagawa et al. 1984) and also in a partially purified 
preparation of bovine ZF /ZR cells (Duperray & 
Chambaz, 1980). Monolayer cultures of bovine ZF/ 
ZR cells were also found by Goodyer, Torday, Smith 
& Giroud (1976) to show peak cortisol secretion 
within the first week of culture, thereafter declining. 
These findings contrast with those of O'Hare & 
Munro Neville (1973) using monolayer cultures of rat 
adrenocortical cells, where total steroid production 
(largely corticosterone) in response to ACTH 
remained high and relatively constant for 40 days or 
more in culture. In none of these studies has the agonist 
responsiveness of the freshly isolated (uncultured) 
cells been compared with the cultured cells, and the 
comparative effects of AII and catecholamines have 
never been examined. Neither is there any infor- 
mation on the effect of culture on the cAMP response 
to ACTH and catecholamines. 
It could be argued that the differences between the 
response on day 3 of culture and the freshly isolated 
cells might be due to selective plating out of a respon- 
sive cell population, possibly cells least damaged by 
collagenase treatment. However, when dispersed into 
wells at 250 000 cells /ml, 80-90% of cells have 
attached to the plate after 24 h. Hence the cultured 
ZF /ZR population is representative of the freshly 
isolated ZF /ZR population. 
Cyclic AMP production, both basal and in response 
to ACTH, was significantly increased after culture. 
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described for the freshly isolated purified ZF /ZR cells. 
At the end of the incubation period, the medium was 
carefully removed from the wells and assayed for 
cAMP, cortisol and, in some experiments, aldosterone 
by radioimmunoassay procedures. Following ethanol 
extraction, the cellular contents of cAMP were also 
measured. 
Radioimmunoassay procedures 
Cyclic AMP levels in the medium were determined by 
adding 0.5 ml of the medium to 2 ml absolute alcohol 
in a glass tube to precipitate protein. After centrifuga- 
tion, the supernatant was dried and the extract recon- 
stituted in 0.5 ml sodium acetate buffer (0.05 mol /1; 
pH 4.8) containing 0.1% BSA. Cellular levels of 
cAMP were measured by extracting the cells twice 
with 0.5 ml ethanol and reconstituting the dried -down 
extract in 0.5 ml sodium acetate buffer in the same 
way. Total cAMP was the sum of medium and cellular 
contents. Acetylation of the samples and the assay of 
cAMP were carried out according to the method of 
Harper & Brooker (1975). The interassay precision 
was less than 10% in the working range 0.30 -3 nmol /1 
and less than 20% of the working range 0.1 -20 nmol /1. 
Cortisol output was measured in 100 gl of sample 
by direct radioimmunoassay (Gray, Seth & Beckett, 
1983). The antibody for cortisol was kindly provided 
by the Scottish Antibody Production Unit, Carluke, 
Lanarkshire, U.K. The interassay precision was less 
than 10% over the working range 12 -1000 nmol /1 and 
less than 20% over the working range 5 -12 nmol /1. 
In the experiments where aldosterone outputs were 
measured, the antibody employed (402 L) was kindly 
provided by Dr F. A. O. Mendelsohn (Department of 
Medicine, The Austin Hospital, Melbourne, Australia). 
The characteristics of this antibody have been 
described (Campbell, Mendelsohn, Adam & Funder, 
1981). The assay employed 50 gl of sample; it had an 
interassay coefficient of variation of less than 12% 
over the working range 0.2 -20 nmol /1. 
The standards used for the measurement of cAMP, 
cortisol and aldosterone were purchased from Sigma 
Chemical Co., Poole, Dorset, U.K. 
Cellular protein content 
This was measured on a minimum of three wells for 
each experiment, by adding 0.5 ml 1% (v /v) Triton X- 
100 (BDH, Glasgow, Strathclyde, U.K.) to each well. 
After diluting the sample 1 : 10 with water, protein 
content was determined by the method of Bradford 
(1976), automated for use on the Cobas Fara (Roche) 
centrifugal analyser. The assay standard was BSA 
made up in 0.1% Triton X -100. 
Morphological analysis of cells 
Cell pellets from days 1 and 3 of primary culture were 
fixed in 2.5% (v /v) glutaraldehyde in cacodylate 
buffer (0.1 mol /1, pH 7.3). Osmium tetroxide (1% in 
cacodylate buffer) was used as a secondary fixative. 
The fixed samples were dehydrated through graded al- 
cohols into propylene oxide and finally embedded in 
Araldite resin. Thick sections (1 gm) were stained with 
toluidine blue for light microscopy. Ultrathin sections 
(50-60 nm) were stained with uranyl acetate and lead 
citrate for examination and photomicrography using 
a Philips EM300 electron microscope. Approximately 
100 cells were viewed in at least three different 
ultrathin sections for each sample preparation. 
Statistical analyses 
Comparison of basal cortisol and cAMP values, and in 
response to agonist stimulation, employed Student's 
t -test for the freshly isolated purified ZF /ZR cells 
versus the same cells after primary culture. The com- 
parison was carried out after normalizing the cortisol 
secretion rate with respect to cellular protein. When 
comparing the stimulated cortisol responses on days 1 
(uncultured) and 3 (cultured), the basal value was first 
substracted. 
RESULTS 
The secretion of cortisol under basal conditions and in 
response to ACTH (1 nmol /1), All (10 nmol /1) and 
adrenaline (1 gmol /1) was measured for the purified 
ZF /ZR cells on day 1 (uncultured) and days 2, 3, 4 
and 5 (in culture). The basal and stimulated secretion 
of cortisol increased progressively to reach a peak 
on day 3, thereafter declining. The basal cortisol 
secretion and that in response to ACTH (1 nmol /1) on 
day 1 were 27 ±0.5 (s.E.M.) and 441 ±4.8 pmol /h per 
mg protein respectively. By day 3, the corresponding 
values had risen to 100 ±4.5 and 1542± 17.6 pmol /h 
per mg protein respectively. By day 5, the basal 
secretion had declined to 80 +3.8 and the secretion 
stimulated by ACTH (1 nmol /1) had fallen to 
195 ±28.9 pmol /h per mg protein. All these values are 
for n= three wells. Detailed comparisons of cortisol 
production on the freshly isolated cells on day 1, and 
the same cell isolates on day 3 of primary culture were 
therefore carried out. In these experiments, the use of 
two steps in the wash -out procedure (see Materials 
and Methods) was found to lower basal values and 
lead to significant differences in n -fold stimulation as 
well as absolute cortisol secretion rates. 
When the basal cortisol output was compared in 
this way, the normalized secretion rate was signifi- 
cantly (P <0.05) greater on day 3 than day 1 in six out 
of seven experiments. The stimulated cortisol output 
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FIGURE 1. Output of (a) cortisol and b) cyclic (c)AMP by bovine zona fasciculata /zona reticularis cells in 
response to ACTH. Cells were uncultured (solid bars) or cultured for 3 days (hatched bars), and results 
are expressed as a stimulation ratio relative to the basal (unstimulated) value on day 1 (uncultured) or 
day 3, as appropriate. Values are means ± E.E.M. for three wells. 
(normalized) was also significantly greater on day 3 
for ACTH, AII and noradrenaline. Thus ACTH at 
1 nmol /1 achieved a greater cortisol output on day 3 in 
all six experiments where this comparison was made 
(P < 0.01 for six experiments). Likewise, All at 
10 nmol /l showed a very similar pattern, with cortisol 
secretion greater on day 3 in all experiments where 
this was examined (P<0.01 for five experiments). In 
the case of noradrenaline, there was no significant 
stimulation of cortisol secretion at any dose used in 
the freshly isolated cells, whereas a highly significant 
stimulation was observed in culture on day 3 
(P <0.001 for all four experiments). The comparison 
for days 1 and 3 for a full dose -response of the agon- 
ists is illustrated in Figs. 1 (ACTH), 2 (AII) and 3 
(noradrenaline). The results are expressed as stimu- 
lation ratios (stimulated output /basal output) to 
enable the steroidogenic responsiveness of the cells to 
the three agonists to be more readily compared. No 
aldosterone was detectable in response to ACTH or 
AII using the column -purified ZF /ZR cells, either 
freshly isolated or in culture. 
These differences might simply reflect deficient 
availability of substrate for steroidogenesis in the 
freshly isolated cells. To exclude this possibility, 
cAMP was measured in the experiment illustrated in 
Figs 1 and 3. The basal cAMP output was 
1.89 ± 0.17 pmol /h per mg protein (n = five wells) on 
day 1, rising to 4.52 ±0.19 pmol /h per mg protein by 
day 3 (n = six wells). The higher output on day 3 is 
statistically significant (P <0.001). As with the corti- 
sol response, the cells on day 1 showed no increase in 
cAMP production in response to any concentration 
of noradrenaline, whereas a dose -dependent rise 
occurred on day 3 of culture. For ACTH at 1 nmol /1, 
the total cAMP output was also higher on day 3 
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FIGURE 2. Cortisol response to angiotensin II (AII) for bov- 
ine zona fasciculata /reticularis cells on day 1 (uncultured) 
(solid bars) and on day 3 (cultured) (hatched bars), 
expressed as a stimulation ratio relative to the basal 
(unstimulated) value on day 1 (uncultured) or day 3, as 
appropriate. Values are means ± S.E.M. for three wells. 
-s 
(P <0.05; n =three wells). No stimulation of cAMP 
production by AII was observed on either day. 
An ultrastructural comparison of the cells on days 1 
and 3 was also carried out. For all intact cells from 
these preparations, clear morphological differences 
were observed. The cultured cells consistently showed 
a higher density of smooth endoplasmic reticulum and 
lipid droplets (Plate). 
To evaluate the extent of the difference in lipid con- 
tent between freshly isolated cells and cultured cells 
(day 3), the number of lipid droplets per cell section 
was counted by light microscopy in thick sections 
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DESCRIPTION OF PLATE 
An ultrastructural comparison of freshly isolated bovine 
zona fasciculata /zona reticularis (ZF /ZR) preparations on 
day 1 (uncultured) and day 3 (cultured). Scale bars are 
shown in µm. 
FIGURE 1. A typical cell found in the freshly isolated bovine 
ZF /ZR preparation on day 1 (uncultured). N, nucleus; M, 
mitochondrion. 85 -90% of the cells showed these features. 
FIGURE 2. A cell found in the freshly isolated bovine ZF /ZR 
preparation on day 1 (uncultured). This cell shows poor in- 
tegrity of the ultrastructure and an indistinct plasma mem- 
brane. A small percentage (10 -15 %) of the freshly isolated 
cells showed this appearance, but were not evident in the day 
3 (cultured) preparation. 
FIGURE 3. A representative cell found on day 3 of culture of 
the bovine ZF /ZR preparation. Numerous lipid droplets (L) 
are present, and the cell shows good integrity of ultrastruc- 
ture. 
FIGURE 4. A portion of the cell shown in fig. 3 showing good 
integrity of the plasma membrane and an abundance of 
smooth endoplasmic reticulum (ER). 
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Catecholamine stimulation of cortisol secretion by 3 -day primary cultures 
of purified zona fasciculata /reticularis cells 
isolated from bovine adrenal cortex 
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Summary 
Primary cultures of zona fasciculata /reticularis cells derived from bovine adrenal cortex secreted 
cortisol and corticosterone in response to isoprenaline, noradrenaline and adrenaline on the third day of 
culture. The potency order was isoprenaline > noradrenaline, adrenaline with an ED50 for all three 
agonists within the range 1 -5 x 10 -8 M. A dose -dependent increase in medium content of cyclic AMP 
was also observed. Secretion of cortisol in response to these catecholamines was specifically blocked by 
propranolol but unaffected by phentolamine. The ß- agonist effect on cortisol secretion was specifically 
and progressively reduced, in a time- and dose -dependent manner, by pre -incubation of the cells with 
adrenaline. 
Introduction 
ACTH is recognised as the major determinant 
of glucocorticoid secretion from the adrenal cortex, 
but other agonists such as angiotension II also 
stimulate glucocorticoid secretion in some species 
(Gill et al., 1977). An effect of catecholamines on 
adrenocortical function was suggested by Vogt 
(1944), who found that intravenous infusion of 
adrenaline or splanchnic nerve stimulation in dogs 
led to secretion of a factor(s) which prolonged the 
median survival of adrenalectomised rats. Subse- 
quent work on hypophysectomised animals sup- 
ported an effect of catecholamines on ACTH 
secretion rather than a direct effect on the adrenal 
Address for correspondence: S.W. Walker, Department of 
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cortex (Pickford and Vogt, 1951), but Inaba et al. 
(1975) reported a significant increase in plasma 
[corticosterone] following administration of adren- 
aline to hypophysectomised rats. 
Stimulation of membrane adenylate cyclase ac- 
tivity by catecholamines was reported in the 
corticosterone - secreting tumour 494 from the rat 
(Schor et al., 1971; Brush et al., 1974). In humans, 
ß- adrenergic receptors linked to adenylate cyclase 
were described in four out of six adrenocortical 
carcinomas, but not in three preparations derived 
from normal adrenal cortex (Katz et al., 1985). 
Specific binding of the radioligand [ 3 H]dihy- 
droalprenolol, a ß- receptor antagonist, was dem- 
onstrated in two out of three cortisol- secreting 
adenomas of human origin (Hirata et al., 1981). 
Significant stimulation of aldosterone and corti- 
costerone secretion by isoprenaline from the cap- 
sular fraction obtained from normal rat adrenal 
0303 -7207/88/$03.50 0 1988 Elsevier Scientific Publishers Ireland, Ltd. 
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cortex was obtained by Shima et al. (1984); al- 
though the subcapsular fraction was apparently 
unresponsive, specific binding sites for [3H]dihy- 
droalprenolol were identified. 
Using capsular explants of rat adrenal cortex in 
a perifusion system, Pratt et al. (1985) observed a 
stimulation of aldosterone secretion by ß- agonists. 
De Lean et al. (1984) showed that ß- agonists 
would stimulate aldosterone secretion from 3 -day 
primary cultures of bovine adrenocortical cells. 
Kawamura et al. (1984) also examined the effect 
of catecholamines on steroidogenesis from primary 
bovine adrenal cultures on the second day of 
culture and found a dose -dependent increase in 
steroid output accompanied by a rise in cyclic 
AMP; however, no attempt was made in this 
study to separate the zona fasciculata / reticularis 
cells from the zona glomerulosa cells and steroid 
secretion was quantitated by a non -specific fluo- 
rimetric method. 
We have recently established and optimised a 
primary culture system for purified bovine zona 
fasciculata / reticularis cells. This system is highly 
responsive to ACTH, and has been used to clarify 
the possible effect of catecholamines on gluco- 
corticoid secretion from zona fasciculata cells. In 
addition to eliminating zona glomerulosa cells 
from the cell preparation by column purification, 
we have also employed specific radioimmunoassay 
methods for determining the secretory responses 
of the two major glucocorticoids, cortisol and 
corticosterone. 
Materials and methods 
Materials 
Bovine adrenal glands were obtained from 
freshly slaughtered cattle at the Edinburgh Dis- 
trict Council slaughterhouse. Ham's F12 growth 
medium, fetal calf serum, Earle's balanced salt 
solution, glutamine and cell culture plastics were 
obtained from NBL, Cramlington, U.K. Penicillin, 
streptomycin and fungizone were from Flow 
Laboratories, Rickmansworth, U.K. Collagenase 
was from Lorne Diagnostics, Bury St. Edmunds, 
U.K. and bovine serum albumin (fraction V) from 
ICN Biomedical, High Wycombe, U.K. Sephadex 
G -10 and G -50 were from Pharmacia, Milton 
Keynes, U.K. The sources of the agonists and 
antagonists were as follows: isoprenaline (0.1 
mg /ml) from McCarthay's, Romford, U.K.; 
adrenaline (1 mg /ml) from Phoenix Pharmaceuti- 
cals, Gloucester, U.K.; noradrenaline (1 mg /ml) 
from Winthrop Laboratories, Horsham, U.K.; 
propranolol from Imperial Chemical Industries, 
Macclesfield, U.K.; Synacthen from CIBA 
Laboratories, Horsham, U.K. 
Cortisol, corticosterone and adenosine 3',5'- 
cyclic monophosphate (cyclic AMP) standards 
were obtained from Sigma Chemical Company, 
Poole, U.K. Radioisotopes for the cyclic AMP 
and corticosterone assays were synthesised by the 
methods of Harper and Brooker (1975) and Al- 
Dujaili et al. (1981), respectively. The cortisol 
label, cortisol -3 -(O- carboxymethyl) oximino -(2- 
[125I]iodohistamine), and [125I]NaI were from 
Amersham International, Aylesbury, U.K. 
The cortisol antiserum was obtained from the 
Scottish Antibody Production Unit, Carluke, U.K. 
Methods 
Cell culture. Primary cultures of bovine adre- 
nocortical cells were established as follows. 
Adrenal glands from freshly slaughtered animals 
were collected on ice into phosphate- buffered 
saline and transported within 20 min to the 
laboratory. After the surrounding fat was carefully 
removed, the cortex was sectioned into 100 µM 
slices with a Stadie -Riggs microtome; the first 
slice, which (by light microscopy) can be shown to 
consist of the capsule and underlying zona 
glomerulosa, was discarded. The second slice, con- 
sisting of zona fasciculata /reticularis tissue, was 
collected into Earle's balanced salt solution con- 
taining 0.2% (w /v) bovine serum albumin (BSA) 
(EBS /0.2% BSA). 
After mincing the zona fasciculata /reticularis 
with scissors, the tissue was digested for 1.5 h in 
EBS containing 2% (w /v) BSA with collagenase 
added to a final concentration of 1.5 -2 mg /ml. 
The tissue was mechanically disrupted by repeated 
pipetting at 30 min, 60 min and 90 min during the 
incubation. At the end of the collagenase di- 
gestion, undigested tissue was removed through 
250 µM nylon gauze and the cells harvested by 
centrifugation at 300 X g (4° C). After resuspen- 
sion in EBS /0.2% BSA, the cells were filtered 
through 100 µM and then 30 µM gauze and 
finally applied to a column containing 5 ml of 
Sephadex G -10 in order to trap the intact cells 
amongst the Sephadex beads. The Sephadex G -10 
was overlaid by 5 ml of Sephadex G -50 (coarse) to 
act as a pre -filter. 
The column was washed with EBS /0.2% BSA, 
and the cells then harvested by passing the resus- 
pended gel through 30 µM gauze; this traps the 
Sephadex beads but allows the cells through. Cells 
prepared in this way were substantially free from 
debris, red blood cells and clumps of cells. 
The cells were counted and then plated out in 
12 -well plates in Ham's F12 medium containing 
10% (v /v) fetal calf serum with added penicillin 
(50 IU /ml), streptomycin (50 µg /ml) and 
amphotericin B (2.5 µg /ml), with 2.5 X 105 cells 
per well. Culture was carried out at 37 ° C in an 
atmosphere of 5% CO2. The medium was changed 
on the second day and the agonist experiments set 
up on the third day. 
Cultured cells are characterised by a threshold 
response to ACTH of 10 -12 M and a peak re- 
sponse to 10 -10 M ACTH, with a 20- to 30 -fold 
stimulation (relative to basal) at the peak ACTH 
concentration (third day). 
Agonist / antagonist experiments. All experi- 
ments were carried out on the third day of culture 
unless otherwise stated. The medium was removed 
and the cells washed once with EBS /0.2% BSA. 
Agonists and antagonists were made up freshly 
in EBS /0.2% BSA with 0.1% (w /v) added glucose 
(EBS /0.2% BSA /0.1% glucose) to the concentra- 
tion shown in the Results section; they were add- 
ed (as 1 ml) to three wells for each concentration. 
In all experiments, the basal cortisol output was 
determined in 1 ml of EBS /0.2% BSA /0.1% glu- 
cose alone. 
Incubations were for 1 -2 h in 5% CO2 at 37° C 
and were terminated by transferring the overlying 
solution to tubes cooled on ice. After centrifuga- 
tion for 10 min at 300 X g (4°C), 250 Al of 
cell-free supernatant was added to 1 ml of ice -cold 
ethanol, for the cyclic AMP assay; the remaining 
750 Al was transferred to a fresh tube, for the 
corticosterone and cortisol assays. Samples were 
stored prior to assay at -20° C; the thawed sam- 
ples were centrifuged immediately before assay to 
remove protein precipitated on storage. All experi- 
ments were repeated at least three times. 
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In some experiments, adrenaline or ACTH was 
present in the growth medium either throughout 
the whole period of culture or for shorter, defined 
time -periods before setting -up the agonist experi- 
ments on the third day. In these experiments, the 
wells were washed twice with EBS /0.2% BSA/ 
0.1% glucose before exposure to the agonist. 
To standardise the cortisol, corticosterone and 
cyclic AMP secretion rates, results were expressed 
as pmol per h per 105 cells, with cells counted in 
all three wells. In later experiments, it was found 
more convenient to standardise secretion rates 
relative to the protein content in the well. Protein 
was measured after digesting the cells in 1% Tri- 
ton-X, using the method of Bradford (1976), 
adapted for use on the Cobas Fara (Roche) 
centrifugal analyser. Samples were diluted 1 : 10 
with water before the Bradford assay and bovine 
serum albumin standards made up in 0.1% Triton - 
X. Higher concentrations of Triton -X were found 
to increase the absorbance at the monitoring 
wavelength of 595 nm. 
Assays for cortisol, corticosterone and cyclic 
AMP. Cyclic AMP, cortisol and corticosterone 
were measured by in -house radioimmunoassays. 
The cyclic AMP assay was carried out essen- 
tially as described by Harper et al. (1975). Ethanol 
extracts were dried down at room temperature 
under a stream of nitrogen and reconstituted in 
EBS prior to acetylation. Standards were also 
prepared and acetylated in EBS. The first anti- 
body incubation was overnight at 4°C, with a 
charcoal separation for the second stage. 
The corticosterone assay used an overnight in- 
cubation with first antibody at 4° C and a char- 
coal separation for the second stage (Al- Dujaili et 
al., 1981). 
The cortisol assay used a single incubation for 
70 min with an antibody pre -precipitate as de- 
scribed by Gray et al. (1983). 
The between -assay CV was 10% or less over the 
working range for the cortisol and corticosterone 
assays and 13% or less over the working range for 
the cyclic AMP assay. 
Results 
The effect of catecholamines on cortisol and corti- 
costerone secretion 
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Fig. 1. An illustrative experiment showing the effect of isopren- 
aline, noradrenaline and adrenaline on the secretion of cortisol 
from 3 -day primary cultures of zona fasciculata /reticularis 
cells. Each bar represents the mean cortisol secretion rate 
± SD (n = 3 wells) for the concentration of agonist used. The 
threshold concentration of agonist producing a significant re- 
sponse (P < 0.05) relative to basal secretion (0; no agonist) is 










T T T 





2a 50 - 
¿40.: 








io-9 io -8 10 -7 io-6 io-e 
Noradrenaline (molli) 
0 10 -9 10 -8 10-7 10 -6 10 -5 
Adrenaline (mo1/1) 
Fig. 2. An illustrative experiment showing the effect of isopren- 
aline, noradrenaline and adrenaline on the secretion of corti- 
costerone from 3 -day primary cultures of zona fasciculata /reti- 
cularis cells. Each bar represents the mean corticosterone secre- 
tion rate ± SD (n = 3 wells) for the agonist concentration used. 
The threshold concentration of agonist producing a significant 
response (P < 0.05) relative to the basal secretion (0; no 
agonist) is shown (* ). 
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Isoprenaline 3 1.3 X 10-8 0.3-5.0 x10-8 
Noradrenaline 5 3.2 x10-8 1.3-7.9 x 10-8 
Adrenaline 3 5.0x10-8 2.0-12.6x10-8 
adrenaline on the output of cortisol and corti- 
costerone from cultured zona fasciculata /reti- 
cularis cells on the third day of primary culture 
are shown in Figs. 1 and 2, respectively. All three 
agonists produced a dose -dependent increase in 
cortisol and corticosterone secretion compared 
with basal secretion over the same period. The 
potency order was isoprenaline > noradrenaline, 
adrenaline. A summary of the effects of the three 
agonists on cortisol secretions is shown in Table 1. 
The cyclic AMP response to catecholamines 
The threshold catecholamine concentration 
producing a significant increase in cyclic AMP 
production occurred at 10 -8 M for isoprenaline 
and 10 -7 M for noradrenaline and adrenaline. A 
dose -dependent increase in cyclic AMP was ob- 
served with all three ß- agonists (Fig. 3). 
The effects of a- and ß- blockade 
To establish the nature of the catecholamine 
receptor responsible for the stimulation of cortisol 
secretion, the effects of a- blockade (with phen- 
tolamine) and ß- blockade (with propranolol) were 
examined. Phentolamine (10 -6 M) had no effect 
on the cortisol secretory response achieved by 
10 -7 M isoprenaline, noradrenaline or adrenaline 
(Fig. 4), whereas 10 -6 M propranolol abolished 
Fig. 3. An illustrative experiment showing the effect of isopren- 
aline, noradrenaline and adrenaline on cyclic AMP production 
from 3 -day primary cultures of zona fasciculata /reticularis 
cells. Significant stimulation relative to basal cyclic AMP pro- 
duction (0; no agonist) at a level P < 0.01 is shown (* * ). Each 
bar represents the mean cyclic AMP production ± SD (n = 3 
wells) for the agonist concentration used, showing the SD only 
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(in the case of noradrenaline and adrenaline) or 
severely reduced (in the case of isoprenaline) the 
secretory response to 10 -7 M concentrations of 
these three agonists. Propranolol and phentol- 
amine alone, at 10 -6 M, had no effect on cortisol 
secretion compared with basal (not shown). 
The effect of adrenaline pre- incubation on the corti- 
sol secretory response 
The results of an experiment in which cells 
were cultured in the presence of zero, 10-7 M or 
10 -6 M adrenaline over the whole period from 
initial plating to immediately before the agonist 
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with 10 -7 M adrenaline significantly reduced, and 
pre -incubation with 10 -6 M adrenaline com- 
pletely abolished, the cortisol response to re -chal- 
lenge with adrenaline. 
Parallel experiments, in which cells were pre -in- 
cubated with 10-11 M ACTH over the same period, 
showed that ACTH and adrenaline responses on 
the third day were not significantly different from 
the control response. 
The time -course for the decrease in cortisol 
secretory response produced by pre -incubation 
with adrenaline (10 -7 M) shows that the cortisol 
response is significantly impaired after 2 h and 
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Fig. 4. The effect (Fig. 4A) of 10 -7 M concentrations of isoprenaline, noradrenaline and adrenaline, with and without the addition of 
10 -6 M phentolamine, on cortisol secretion from primary cultures (third day) of zone fasciculata /reticularis cells. The basal 
secretion is shown at B. Each bar represents the mean cortisol secretion rate ± SD (n = 3 wells). No significant effect of 10 -6 M 
phentolanune on the cortisol response was observed. Fig. 4B shows the same experiment, except that 10 -6 M propranolol was used 
in place of 10 -6 M phentolamine. Inhibition of the cortisol response to 10 -7 M agonist by propranalol was observed. 
E 
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Fig. 5. The effects of pre- incubating cultured zona 
fasciculata /reticularis cells with adrenaline on the subsequent 
cortisol dose -response to adrenaline on day 3 of culture. An 
illustrative experiment is shown. Cells were plated out at 
2.5 x 105 cells power well with zero, 10 -7 M or 10 -6 M 
adrenaline; this was replenished on the second day and washed 
out before carrying out the full dose -response experiments with 
adrenaline on the third day. Each bar represents the mean 
cortisol response ± SD (n = 3 wells), showing the SD only 
where this is sufficiently large to appear on the scale used. The 
highly significant decline in cortisol response achieved by 
pre -incubation with 10 -7 M adrenaline, and the abolition of 
response by 10 -6 M adrenaline are evident. Adrenaline pre -in- 
cubation had no significant effect on the protein content of the 
wells as compared to the control (no adrenaline) pre- incuba- 
tion. 
output was also measured in some experiments. 
There was a similar decline (not shown) in the 
responsiveness to adrenaline re- challenge follow- 
ing pre -incubation with adrenaline. 
Discussion 
Several previous studies examined the effects of 
catecholamines on aldosterone production in both 
rat and bovine species (De Lean et al., 1984; Pratt 
et al., 1985; Sequeira and McKenna, 1985). How- 
ever, there is much less information on the effect 
of catecholamines on zona fasciculata function. 
De Lean et al. (1984) reported that ß- agonists had 
no effect on cortisol secretion from bovine zona 
fasciculata cells, but did not state whether freshly 
isolated cells or cultured cells were used in these 
experiments. Although Kawamura et al. (1984) 
reported secretion of steroids from 2 -day primary 
Adrenaline (MI 
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Fig. 6. An experiment illustrating the time- course for 
desensitisation of the response to adrenaline when the cultured 
cells (day 3) are pre -incubated with 10 -7 M adrenaline. Cells 
were initially plated out at 2.5 x 105 cells per well. At each 
time -point, the adrenaline was washed out and the cortisol 
response to zero (i.e. basal), 10 -8 M and 10 -7 M adrenaline 
measured. Results show the mean cortisol secretion rate ± SD 
(n = 3 wells) for each bar, the SD only being indicated where 
this is sufficiently large to appear on the scale used. A progres- 
sive decline in cortisol secretion is observed over the 4 h period 
of the experiment. There was no significant effect of adrenaline 
on the protein content of each well. 
cultures of bovine adrenocortical cells, their study 
was limited in a number of ways. Total steroid 
output was measured by a non -specific fluori- 
metric method, without specific measurement of 
individual hormones, and no attempt was made to 
separate the zona glomerulosa from the zona 
fasciculata to define a specific ß- agonist effect on 
the zona fasciculata. The marked differences in 
ß- agonist responsiveness between freshly isolated 
and cultured cells were not studied. 
Our results support and extend the findings of 
previous work on cultured bovine adrenocortical 
cells. They demonstrate that catecholamines are 
potent stimulators of steroidogenesis. The cortisol 
and corticosterone responses to isoprenaline, 
noradrenaline and adrenaline have been con- 
sistently observed in experiments on the cultured 
bovine zona fasciculata /reticularis cells. The most 
potent catecholamine was isoprenaline which 
showed a threshold response between 10 -10 M 
and 10 -9 M; this hierarchy of potency is con- 
sistent with the specific inhibition of the 
catecholamine effect by the ß- blocker, proprano- 
lol. The a- blocker, phentolamine had no effect. 
The dose -dependent secretion of cortisol and 
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corticosterone is accompanied by an increase in 
the cyclic AMP content in the medium that mir- 
rors the steroid response (Figs. 1 -3). A similar 
increase in cyclic AMP in response to ß- agonists 
was reported by Kawamura et al. (1984). Studies 
on the effect of catecholamines on aldosterone 
secretion have not measured the cyclic AMP re- 
sponse. 
An important question is whether these in vitro 
studies have relevance in vivo. The doses of 
catecholamines that elicit the responses described 
in the cultured cells are encountered in the circula- 
tion during the stress response in man ( Barrand 
and Callingham, 1983). Furthermore, there is in- 
creasing evidence for an adrenergic innervation of 
the adrenal cortex in some mammalian species 
(Kleitman and Holzwarth, 1985; Edwards and 
Jones, 1987). In the hypophysectomised rat, infu- 
sion of isoprenaline produces a significant eleva- 
tion in plasma [corticosterone] (Inaba and Kamata, 
1975), and adenylate cyclase activity linked to 
ß- agonist stimulation has been reported in adre- 
nocortical tissue, both normal and neoplastic 
(Schor et al., 1971; Brush et al., 1974; Hirata et 
al., 1981; Shima et al., 1984; Katz et al., 1985). 
In our experience, and also that of Kawamura 
et al. (1984), cells freshly isolated from the adrenal 
cortex show no response to catecholamines. 
Sequeira and McKenna (1985) also reported that 
adrenaline and noradrenaline were without effect 
on aldosterone production from freshly isolated 
suspensions of bovine zona glomerulosa cells. 
These findings suggest that the ß- receptor is ab- 
sent in vivo and is acquired in culture, as has been 
described for cultured hepatocytes (Nakamura et 
al., 1983). However, several other explanations are 
possible: the ß- receptor may be damaged during 
the cell isolation procedure, or the ß- receptor is 
present but shows a high ß- agonist occupancy, or 
the ß- receptor is down -regulated in vivo as a result 
of high circulating catecholamine levels, ß- adren- 
ergic nerve activity or a combination of both. 
We have found that the cultured zona fasci- 
culata cells are far more responsive to agonists 
such as ACTH compared with freshly isolated 
cells. Loss by degradation of the ß- receptor during 
the cell isolation period, with recovery during cul- 
ture, cannot be ruled out. Against this possibility, 
however, experiments on capsular explants from 
rat adrenals in a perifusion system, where col - 
lagenase digestion was not used, showed stimula- 
tion of aldosterone production by ß- agonists (Pratt 
et al., 1985). Similarly, we found that incubation 
of the zona fasciculata /reticularis cultured cells 
with concentrations of collagenase used in the 
isolation procedure failed to impair significantly 
the subsequent steroidogenic response to /3- 
agonists. 
The experiments in which the cultured cells 
were pre -incubated with adrenaline support the 
hypothesis that the ß- receptor may be down -regu- 
lated in vivo, so that freshly isolated cells are 
unresponsive to ß- agonists. Thus, the catechol- 
amine response falls off over a few hours if adren- 
aline is present in the growth medium, falling to 
less than 200 of the response seen normally with 
10 -7 M adrenaline after as little as 4 h pre -in- 
cubation. The phenomenon is not related to sub- 
strate exhaustion since the ACTH response is 
unaffected. This observation resembles the loss in 
aldosterone secretion in response to ß- agonist 
stimulation observed in co- cultures of bovine 
adrenocortical and adrenomedullary cells (De 
Lean and Racz, 1985). 
It is possible that the ß- receptor is important in 
the cortisol response to acute stress, whereas in 
situations of more chronic stress the predominant 
stimulator of cortisol secretion is ACTH. With a 
stress response lasting more than a few hours, 
down -regulation of the ß- receptor would occur, 
but ACTH levels would remain elevated to main- 
tain the steroid response. In view of the stressful 
circumstances that obtain for some hours before 
removal of adrenal glands from animals at a 
slaughterhouse, this hypothesis could account for 
the absent ß- response in the freshly isolated cells. 
Our results support the possibility that 
catecholamines may regulate steroidogenesis in 
vivo. They provide another example of the im- 
portant interactions which exist between the 
adrenal cortex and medulla (Weinkove and 
Anderson, 1986). 
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Subclassification of ß- adrenoceptors responsible for 
steroidogenesis in primary cultures of bovine adrenocortical 
zona fasciculata /reticularis cells 
'E.R.T. Lightly, S.W. Walker, I.M. Bird & *B.C. Williams 
Department of Clinical Chemistry, University of Edinburgh, The Royal Infirmary, Edinburgh, EH3 9YW and *Department of 
Medicine, University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU 
1 Forty eight hour primary cultures of purified bovine adrenocortical zona fasciculata /reticularis cells 
secreted hydrocortisone in response to stimulation with ß- adrenoceptor agonists. The observed order of 
potency was isoprenaline > noradrenaline > dobutamine > salbutamol > BRL37344. 
2 Salbutamol acted as a partial agonist on these cells hence suggesting the presence of a 
ß1- adrenoceptor. 
3 Schild analysis of the hydrocortisone response to isoprenaline showed that the selective ß1- antagonist 
practolol and the selective ß2- antagonist ICI118,551 gave pA2 values of 6.85 and 7.17, respectively. These 
values were in close agreement with corresponding pA2 values previously obtained for the 
ß1- adrenoceptor. 
4 We conclude that ß1- adrenoceptors are responsible for mediating catecholamine- stimulated hydrocor- 
tisone secretion from primary cultures of bovine zona fasciculata /reticularis cells. 
Introduction 
Adrenocorticotrophic hormone (ACTH) and, in some species, 
angiotensin II are known regulators of steroidogenesis in the 
adrenal cortex (Gill et al., 1977; Tait et al., 1980). However, 
there is also evidence for innervation of the adrenal cortex in 
man (Mikhail & Amin, 1969), the rat (Kleitman & Holz - 
warth, 1985) and the mouse (Migally, 1979), and this has been 
suggested as another means of controlling adrenocortical 
steroidogenesis and possibly adrenal cell growth. 
We have previously shown that primary cultures of bovine 
zona fasciculata /reticularis (ZFR) cells produce hydrocor- 
tisone in response to stimulation with catecholamines, and 
that this adrenergic stimulation of steroidogenesis is mediated 
by ß- adrenoceptors (Walker et al., 1988). The subclass of ß- 
adrenoceptors which is involved in this response -either ß1 or 
ß2 as classified by Furchgott (1972), or the more recently char- 
acterised ß3 subclass (Arch et al., 1984; Kaumann, 1989 )-is 
unknown. 
It is not yet clear in bovine or other species whether adren- 
ergic control of hydrocortisone secretion at the level of the 
adrenal cortex occurs in vivo and, if so, whether this depends 
on adrenergic innervation, on the effects of circulating cate- 
cholamines, or even on catecholamines locally derived from 
the adrenal medulla. Ungar (1979) suggested that, in general, 
ß1- adrenoceptors tend to be innervated by adrenergic neu- 
rones, whereas ß2- adrenoceptors respond mainly to blood - 
borne catecholamines. On this basis, determination of the 
subclass of ß- adrenoceptor should provide valuable evidence 
as to whether adrenergic control of the adrenal cortex is by 
direct innervation or via circulating catecholamines. 
Traditional receptor classification is based on determi- 
nation of antagonist pA2 values (Schild, 1947; Kenakin, 1982), 
and comparison of a range of selective agonists (Lands et al., 
1967). Subclassification of ß- adrenoceptors has been suc- 
cessfully demonstrated with the selective ß1- antagonist prac- 
tolol (Dunlop & Shanks, 1968) and the selective ß2- antagonist 
ICI118,551 (Bilski et al., 1983). These antagonists have been 
used in this present study. The effects of the selective /3- 
agonists noradrenaline (ß1), salbutamol (ß2), dobutamine (ß1), 
isoprenaline (ß1 /ß2), and BRL37344 (ß3) were also compared. 
`Author for correspondence 
Methods 
Cell culture and stimulation 
Bovine adrenal ZFR cells were prepared as described by 
Walker et al. (1988) using collgenase digestion, and purified 
by the column -filtration method developed by McDougall et 
al. (1979). This procedure gives a preparation essentially free 
from zona glomerulosa cell and medullary cell contamination 
(Williams et al., 1989). The ZFR cells were dispersed into 
12 -well culture dishes (1.5 cm wells) at 250,000 cells per well in 
Ham's F10 medium containing 10% (v /v) CPSR5, penicillin 
(50 iu ml - 1), streptomycin (50 pg m1-1) and amphotericin B 
(2.5 pg ml -1), and cultured at 37 °C under 5% CO2 . After 24 h 
(day 2), the medium was replaced with 1 ml of identical fresh 
medium. 
Experiments were carried out 48 h after initial plating (day 
3). Medium was removed and cells were washed twice with 
1 ml of Earl's balanced salt (EBS) solution containing 0.2% 
bovine serum albumin (BSA) and 0.1% added glucose (EBS/ 
BSA /glucose). Agonists and antagonists were made up in 
EBS/BSA /glucose and added to the cells, giving a final volume 
of 1 ml per well. Antagonists were added 1 min before the 
addition of any agonists. Stimulation was carried out for 1 h 
under the same incubation conditions as those used to culture 
the cells and, at the end of this period, the medium overlying 
the cells was removed and stored at -20 °C before assay for 
hydrocortisone. 
Hydrocortisone was measured by radioimmunoassay as 
described by Gray et al. (1983). The inter -assay CV was 10% 
or less over the working range of the assay. 
Statistical analysis 
Experiments were carried out on cells from at least 3 separate 
cell preparations for determination of agonist potencies and 
for Schild analysis of each antagonist. Within each experi- 
ment, triplicate determinations were carried out for each com- 
bination of agonist and antagonist. 
For the estimation of antagonist pA2 values, dose -response 
curves were tested for parallelism by analysis of covariance 
710 E.R.T. LIGHTLY et al. 
using the SPSS -X statistical package produced by Edinburgh 
University Computing Service. Schild regression lines were 
fitted with a least- squares fit by a Casio fx -180P programm- 
able calculator and confidence limits calculated. 
Materials 
The source of all cell culture and radioimmunoassay materials 
is described in Walker et al. (1988). The controlled process 
serum replacement No. 5 (CPSRS) was obtained from Sigma 
Chemical Company, Poole, Dorset, U.K. 
Noradrenaline was obtained from Winthrop, Guildford, 
Surrey, U.K.; salbutamol' from Allen & Hanburys Ltd., 
London, U.K.; dobutamine from Eli Lilly & Co. Ltd., Basing- 
stoke, U.K. and isoprenaline from Macarthy Medical, 
Romford, U.K. BRL37344 ((R*R*)-(±)-4-[2-[2- hydroxy -2 -(3- 
chlorophenyl)-ethylamino]propyl]phenoxyacetic acid. Na 
salt) was a generous gift from Beecham Pharmaceuticals, 
Epsom, Surrey, U.K. Practolol was obtained from ICI plc, 
Macclesfield, Cheshire, U.K. and ICI 118,551 (erythro- ( ±) -1- 
(7- methylindan -4- yloxy ) -3- isopropylaminobutan -2 -ol) was a 
generous gift from the same company. 
Results 
The effects of various selective ß- agonists on 
hydrocortisone secretion 
The effects of increasing concentrations of isoprenaline, nor- 
adrenaline, salbutamol, dobutamine and BRL37344 were 
tested on cells on day 3 of culture (Figure 1). The agonists had 
B -10 -9 -8 -7 -6 -5 -4 -3 
Logic, [Agonist] (M) 
Figure 1 Dose -response curves for the secretion of hydrocortisone 
produced upon stimulation of purified bovine adrenocortical zona 
fasciculata /reticularis cells with isoprenaline (0), noradrenaline (6), 
dobutamine (0), salbutamol (A) and BRL37344A (D) B = basal corti- 
sol production. 
relative potencies as follows : isoprenaline > noradrenaline > 
dobutamine > salbutamol > BRL37344. Isoprenaline, nor- 
adrenaline and dobutamine all produced the same maximum 
response. Salbutamol and BRL37344 gave approximately 
70% and 19% of the maximum response, respectively. 
The effects of the antagonists practolol and ICI118,551 
on the isoprenaline dose -response curve 
A series of dose -response curves for the effect of isoprenaline 
on hydrocortisone secretion were set up in the presence of 
increasing doses of either practolol or ICI118,551. Representa- 
tive experiments for practolol and ICI118,551 are shown in 
Figures 2 and 3, respectively. The dose -response lines for each 
concentration of antagonist were judged to be parallel by 
analysis of covariance. Experiments were repeated on cells 
from 4 separate cell preparations for practolol and 3 separate 
cell preparations for ICI118,551. 
The dose -ratio (DR) for each concentration of antagonist 
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Figure 2 Representative experiment showing dose -response curves 
for the secretion of hydrocortisone produced on stimulation with iso- 
prenaline, alone (Q) and in the presence of increasing concentrations 
of practolol 10 -6.5M (o), 10 -6M (A), 10 -5.5M (A). Inset: Schild 
regression -least squares fit of logo (DR - 1) versus logo 
[practolol] where DR = dose -ratio. Cumulative data from 4 separate 
cell preparations. 
Table 1 Comparison of experimental and published data for practolol and ICI118,551 
Experimental 
Antagonist pA2 95% CL 
Practolol 
1C1118,551 




6.85 0.90 6.801 (ß,) 
7.06 0.96 
7.03 1.01 
7.14 0.99 7.172 (ß,) 
7.28 0.97 9.262 (ß2) 








-9 -8 -7 
Logic) Ilsoprenaline] (M) 
-7 -6 -5 
Log10 [ICI 118551] (M) 
Figure 3 Representative experiment showing dose -response curves 
for the secretion of hydrocortisone produced on stimulation with 
isoprenaline, alonr (0) and in the presence of increasing concen- 
trations of ICI118,551 10 -6.5M (S), 10 -6M (A) 10 -5.5M (A). 
Inset: Schild regression -least squares fit of 1og10(DR - 1) versus 
log10[ICI118,551] where DR = dose -ratio. Cumulative data from 3 
separate cell preparations. 
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concentration plotted (lower sections in Figures 2 and 3) and 
used to calculate pA2 values for each antagonist and to obtain 
95% confidence limits. The slope of the regression line and 
95% confidence limits were estimated similarly. Results for 
both antagonists are shown in Table 1. 
Neither practolol nor ICI118,551 caused hydrocortisone 
secretion and therefore had no intrinsic agonist effects on the 
cells. 
Discussion 
The results establish the existence of ß1- adrenoceptors on 
bovine cultured adrenal ZFR cells, for two reasons, as dis- 
cussed below. 
Firstly, the effects of several selective ß- adrenoceptor agon- 
ists on hydrocortisone secretion were consistent with this clas- 
sification. Isoprenaline, noradrenaline and dobutamine were 
all full agonists, whereas salbutamol acted as a partial agonist, 
producing 70% of the maximum response. Salbutamol is 
known to act as a full agonist at ßZ adrenoceptors, but only as 
a partial agonist at ß1- adrenoceptors (Farmer et al., 1970). 
This, in itself, suggests that the adrenergic stimulation of 
hydrocortisone secretion is mediated by ß1- adrenoceptors. 
Although BRL37344 produced stimulation of the cells at 
10 -5M, it was the least potent of all the agonists studied and 
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Acetylcholine stimulates cortisol secretion through the M3 muscarinic 
receptor linked to a polyphosphoinositide -specific phospholipase C 
in bovine adrenal fasciculata/reticularis cells 
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Summary 
Zona fasciculata /reticularis (ZFR) cells, isolated from the bovine adrenal cortex, secreted cortisol in 
response to acetylcholine (AcCh). The response was present in freshly isolated cells and in cells maintained 
in primary culture, reaching a maximum after 48 -72 h and thereafter declining. Cells maintained in 
primary culture for 72 h secreted cortisol with an ED50 at 1.2 X 10 -6 M. 
The potent inhibition of AcCh -stimulated secretion by atropine, and the relative ineffectiveness of 
nicotine or nicotinic antagonists, were consistent with a predominantly muscarinic response to AcCh in 
these cells. A selective Ml- receptor agonist, McN -A -343, had no effect on cortisol secretion whereas the 
M3 antagonist, hexahydro- sila- difenidol, produced a dose -dependent inhibition of AcCh -stimulated corti- 
sol secretion. These findings are consistent with AcCh mediating its effects on cortisol secretion through an 
M3 receptor. 
While AcCh had no effect on cAMP formation, a dose -dependent increase in [3H]phosphoinositols 
(identified using high- performance liquid chromatography (HPLC)) occurred in a manner that was not 
dependent on an influx of extracellular Ca2+. Detailed HPLC analysis of the formation of 3H- labelled 
phosphoinositols and glycerophosphoinositols from pre- labelled cells over the period 0 -15 min showed 
that the earliest significant rise was in Ins(1,4,5)P3 at 5 s, followed by later rises in InsP1, InsP2 and 
Ins(1,3,4)P3. Additional studies using cells loaded with fura -2 indicator revealed a 1.6 -fold increase in 
[Ca2 +]; from a mean resting value of 75 nM in response to 10 -4 M AcCh. Furthermore, the rise in Ca' 
was not abolished by lowering extracellular Ca2+ to resting cytosolic levels, suggesting the mobilisation of 
an intracellular pool. These observations indicate that AcCh promotes rapid activation of a Ca"-indepen- 
dent and polyphosphoinositide -specific phospholipase C, and that the Ins(1,4,5)P3 formed releases Ca' 
from an intracellular pool. The stimulation by AcCh of this signal transduction mechanism is consistent 
with our conclusion, based on the effects of the selective muscarinic agonist and antagonist on cortisol 
secretion, that the AcCh receptor is of the M3 subtype. 
We conclude that AcCh, acting through an M3 receptor coupled to phospholipase C, regulates cortisol 
secretion at the cellular level in bovine adrenal ZFR cells. 
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Introduction 
There is an extensive literature on the ability of 
acetylcholine (AcCh) to stimulate catecholamine 
secretion from adrenomedullary cells, whereas 
there is little available information on the 
cholinergic response of adrenocortical cells. Ro- 
senfeld (1955) provided the first evidence for 
muscarinic cholinergic stimulation of cortisol 
secretion in the isolated perfused calf adrenal 
gland. Although a nicotinic response was later 
described in cat adrenal cortex, the effects of 
AcCh itself or other cholinergic agonists and 
antagonists were not tested (Rubin and Warner, 
1975), so the presence of a muscarinic receptor 
could not be excluded. Muscarinic, cholinergic 
regulation of adrenocortical steroidogenesis is not 
confined to mammals, but has also been observed, 
using a perifusion technique, in frog adrenal (in- 
ter- renal) tissue (Benjamina et al., 1987). 
Crude membrane preparations of bovine adre- 
nocortical tissue have been shown to contain bind- 
ing sites for the muscarinic antagonist, L- quinuc- 
lidinyl benzylate (Kd of 1.2 nM), while trypsin- 
dispersed cells derived from bovine zona fasci- 
culata /reticularis (ZFR) have been shown to 
secrete cortisol in response to AcCh via a 
muscarinic receptor (Hadjian et al., 1981, 1982). A 
muscarinic steroid response has also been reported 
in both cultured bovine adrenocortical cells (whole 
cortex) (Kawamura et al., 1985) and in freshly 
dispersed bovine zona glomerulosa (ZG) cells 
(Kojima et al., 1986). 
The second messenger response to cholinergic 
stimulation of adrenocortical cells has been in- 
vestigated by Hadjian et al. (1984) and by Kojima 
et al. (1986). Using bovine ZFR cell suspensions, 
Hadjian et al. (1984) showed that AcCh induced a 
dose -dependent increase in 32P-labelling of phos- 
phatidylinositol, first detectable at 2 min and 
abolished in the presence of muscarinic antagonists 
but not nicotinic antagonists. The rapid disap- 
pearance of prelabelled phosphoinosites was not 
investigated, however, and definitive evidence of 
activation of a phospholipase C was not provided. 
Using bovine ZG cells prelabelled with [3H]inosi- 
tol, Kojima et al. (1986) demonstrated that 
carbachol induced a rapid increase in formation of 
[3H]inositol trisphosphate (isomer(s) not char- 
acterised), with slower increases in formation of 
labelled inositol bis- and monophosphate species, 
a response characteristic of the activation of a 
polyphosphoinositide -specific phospholipase C. 
Both Hadjian et al. (1982) and Kojima et al. 
(1986) found that AcCh and carbachol, respec- 
tively, failed to elicit any increase in adenosine 
3,5- cyclic monophosphate (cAMp) production at 
maximal steroidogenic concentrations of either 
agonist. The former group also reported no change 
in guanosine 3,5 -cyclic monophosphate above 
basal levels. 
It has recently become clear that the pharmaco- 
logical subdivision of the muscarinic receptor into 
Ml, M2 (cardiac) and M3 (glandular) subtypes 
(Levine and Birdsall, 1989) is reflected in different 
subtypes of muscarinic AcCh receptor mRNA 
species (mAChR). Indeed, four unique mAChR 
subtypes have been identified, designated mAChR 
I -IV. The receptor subtypes corresponding to 
mAChR I and mAChR III appear to act through 
phosphoinositide hydrolysis and to equate with 
the Ml and M3 subtypes, as defined pharmaco- 
logically (Fukuda et al., 1988). The receptor sub- 
type involved in the muscarinic stimulation of 
adrenocortical steroidogenesis is not known. 
In studying the effects of AcCh on ZFR func- 
tion, it is important to use a preparation free from 
ZG cell contamination; AcCh is known to stimu- 
late aldosterone secretion from bovine ZG cells 
(Kojima et al., 1986) and other released steroids 
(e.g. progesterone) could potentially serve as 
steroidogenic precursors for cortisol production 
from the ZFR cells. The extent of glomerulosa cell 
contamination has not been investigated in the 
several reports of the effects of AcCh on cortisol 
production from bovine ZFR cells. 
By employing the column purification method 
described by McDougall et al. (1979), we have 
previously shown that it is possible to obtain ZFR 
cell preparations which have undetectable 
glomerulosa cell contamination (Williams et al., 
1989). Using this highly responsive culture system 
for purified bovine ZFR cells (Williams et al., 
1989) we now show that the cortisol response to 
AcCh is mediated by the M3 receptor. High -per- 
formance liquid chromatography (HPLC) analysis 
of the water -soluble products of phosphoinositide 
hydrolysis confirmed that the M3 receptor is cou- 
pled to a polyphosphoinositide -specific phos- 
pholipase C. Studies on the Cat+ sensitivity of 
this response and the direct effect of AcCh on 
intracellular [Ca2 +] are also reported. 
Materials and methods 
The preparation of bovine adrenocortical ZFR 
cells, and the radioimmunoassay of cortisol and 
cAMP have been described elsewhere (Williams et 
al., 1989). The materials used for the measurement 
of 3H-labelled phosphoinositols and glycerophos- 
phoinositols were as described by Bird et al., 
1989a), and for the small -scale periodate oxidation 
of the putative glycerophosphoinositol peaks from 
the detailed HPLC time -course are also described 
(Bird et al., 1989b). The partisphere SAX -5 col- 
umns were obtained from Jones Chromatography. 
[myo- 3H]Inositol and the [myo-3H]phosphoinosi- 
tol standards were obtained from Amersham In- 
ternational, Aylesbury, U.K. Hydroluma scintilla- 
tion fluid was from May and Baker, Eccles, U.K. 
The fura -2 acetoxymethyl ester (AM) was ob- 
tained from BCL, Lewes, U.K. The AcCh, 
carbachol, pirenzipine, nicotine, atropine, tubo- 
curarine and the CPSR5 (controlled serum re- 
placement) were from the Sigma Chemical Co., 
Poole, U.K. Angiotensin II (Asp' -Vals) (AII) was 
the WHO International Standard from the Na- 
tional Institute for Biological Standards and Con- 
trol. The Ml agonist McN -A -343 and the M3 
antagonist, hexahydro -sila -difenidol hydrochlo- 
ride, were obtained from Drs. G. Lambrecht, E. 
Mutschier and R. Tacke of the Johann- Wolfgang- 
Goethe University, Frankfurt am Main, F.R.G. 
All other chemicals were of Analar grade and 
obtained from BDH, Poole, U.K. and the Aldrich 
Chemical Co., Gillingham, U.K. 
Preparation, purification and culture of bovine 
adrenocortical ZFR cells 
Bovine adrenal glands were obtained from 
freshly slaughtered 1 to 2 year -old steers at the 
local abattoir. The details of the tissue digestion 
(ZFR slices), the column purification step and the 
properties of the cell preparation are described by 
Williams et al. (1989). Purified cells were plated 
out at 250- 300,000 cells /ml in 12 -well plates in 
Ham's F10 medium supplemented with 10% fetal 
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calf serum (or controlled replacement serum), 
penicillin (50 IU /ml), streptomycin (50 µg /m1) 
and amphotericin B (2.5 µg /ml). Addition of 
[3H]inositol label (10 SCi /ml) is most conveni- 
ently carried out at 24 h when the growth medium 
is changed. Previous work with these cells had 
established that steady -state labelling was reached 
42 h after label addition. Therefore the second 
messenger and steroid studies have been regularly 
carried out at 72 h (Bird et al., 1989a). 
Agonists and antagonists were made up and 
diluted in Earle's balanced salt solution (EBS) 
containing 0.1% added glucose and 0.2% added 
bovine serum albumin (BSA) (EBS /BSA/ 
glucose). In the case of agonists and antagonists 
used for the studies of phosphoinositide hydroly- 
sis, LiC1 (10 mM) and inositol (10 mM) were also 
present (note that neither LiC1 nor inositol were 
present when measuring the effects of the differ- 
ent agonists/ antagonists on cortisol secretion). 
The solutions were added in 50 pi to each well to 
achieve a final volume of 500 Al. In experiments 
with both antagonists and agonists, the antagonist 
was added 5 min before the appropriate agonist. 
Experiments investigating the effects of different 
agonists/ antagonists on cortisol production, 
cAMP production and 3H- labelled total head 
groups were carried out on at least three occa- 
sions, unless otherwise stated. 
Cortisol and cAMp production 
The procedure for measuring the cortisol out- 
put from the cultured cells and the details of the 
cortisol assay are described in Walker et al. (1989). 
In some experiments cAMP levels in both 
medium and cells were measured at 15 min as 
described by Williams et al. (1989). For these 
experiments, the dose range of AcCh used to 
investigate the cAMP response was the same as 
the dose range used to investigate the cortisol 
response (i.e. 10-7 to 10-3 M AcCh). In these 
experiments, ACTH at 10-10 M served as a posi- 
tive control stimulus. 
Measurement of phospholipase activation (measured 
as total [3HJhead groups formation) 
The cell labelling with [3H]inositol, the execu- 
tion of the agonist/ antagonist experiments at 72 h 
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in the presence of Li' and the subsequent re- 
covery and measurement of water -soluble 3H- 
labelled total head groups (i.e. total 3H- labelled 
phosphoinositols and glycerophosphoinositols) 
have been described by Bird et al. (1989a). 
HPLC analysis of 3H- labelled phosphoinositols and 
glycerophosphoinositols 
To the neutralisèd aqueous samples (0.9 ml 
each) containing the labelled products (processed 
according to Bird et al., 1989a), 1 mg mannitol 
was added to act as carrier and the samples 
lyophilised. Each dried sample was then dissolved 
in 1.5 ml EDTA (1 mM) and stored at -20°C 
prior to analysis. 
HPLC analysis was carried out using a 25 cm 
partisphere SAX -5 column with a 1 cm SAX -5 
guard column pre- equilibrated with H2O alone. 
Each sample was made up to 2 ml with 0.5 ml of a 
mixture of ATP /ADP /AMP (each at 0.1 mg /ml) 
in 1 mM EDTA. The flow -rate was kept at 1 
ml /min throughout. At 5 min after sample injec- 
tion, gradient elution with 1 M ammonium for- 
mate (pH 3.7 using orthophosphoric acid) (solu- 
tion B) was started, rising to 100% B at 35 min 
and remaining at 100% for the next 5 min. Frac- 
tions (0.5 ml) were collected throughout. 3H counts 
in each fraction were measured after addition of 3 
ml scintillation fluid, counting for 2 min in a 
Packard 1900 scintillation counter with 20 cpm 
background correction and correcting for chem- 
iluminescence. 
The identical procedure was also carried out 
with radiolabelled Ins1P, Ins(1,4)P2 and Ins(1,4, 
5)P3 standards in order to assist peak identifica- 
tion. Where AcCh -stimulated extracts were 
processed to destroy glycerophosphoinositols with 
sodium periodate, unlabelled GroPInsP mix was 
added to 0.5 mM as cold carrier and the proce- 
dure described by Bird et al. (1989b) followed. 
Prior to HPLC analysis of the periodate- oxidized 
samples, dimethylhydrazine derivatives were first 
removed by passing the sample through a C -18 
reverse -phase SepPak cartridge. 
Measurement of water -soluble [3HJhead groups in 
low and normal Ca? +- containing medium 
To investigate the Caz +- dependency of the pro- 
duction of 3H- labelled total aqueous head groups, 
experiments were carried out as above in medium 
with normal extracellular Ca2+ (1.8 mM, present 
in EBS) and modified medium for which the free 
Cat+ concentration had been adjusted to 120 nM 
according to the EGTA /Ca2+ buffer system de- 
scribed by Renard et al. (1987). Pre -labelled cells 
were stimulated for 5 min with 10 -4 M AcCh in 
medium of normal or low Ca2+ content. The 
reaction was stopped and the perchloric acid ex- 
tracts processed as previously described (Bird et 
al., 1989a). 
Measurement of intracellular [Ca? 41 
Cells were prepared as described above, but 
kept in suspension culture, rather than plating out, 
at a concentration of 106 cells /ml in Ham's F10 
(containing 10% CPSR5 serum replacement) over 
72 h. The cells in suspension culture could be 
shown to be viable at 72 h on the basis of their 
responsiveness to a range of agonists which in- 
cluded ACTH, All and AcCh. 
At 72 h, the cells were harvested, centrifuged at 
450 x g, washed in modified Krebs- Ringer buffer 
containing 0.5% BSA and 0.1% added glucose 
(Capponi et al., 1986), and resuspended in the 
same buffer at 5 X 106 cells /ml. Cells were loaded 
at this density with 15 ¡Al fura -2 AM for 30 min 
at 37 °C. 1 ml portions of the fura -2 loaded cells 
were then centrifuged at 450 X g for 2 min in 
Eppendorf tubes and the pellet resuspended in 2 
ml of modified Krebs- Ringer buffer (without BSA) 
to give a final cell density of 2.5 X 106 cells /ml, 
using 2 ml per cuvette. Fluorescence measure- 
ments were carried out at an excitation wave- 
length of 340 nm, recording the fluorescence sig- 
nal at the emission wavelength of 505 nm on a 
Perkin -Elmer model LS -5 fluorimeter with con- 
tinuous stirring at 37 °C. Agonists and antagonists 
were added in a volume of 20 p.l to give the 
appropriate final concentrations. Details of the 
calibration for the determination of intracellular 
Caz+ are as described by Capponi et al. (1986), 
but substituting digitonin for Triton -X. 
Statistics 
Tests of statistical significance employed Stu- 
dent's t -test. 
Results 
Day -by -day cholinergic response of cultured bovine 
adrenal ZFR cells 
Preliminary experiments established that maxi- 
mal cortisol secretion of the bovine ZFR cells was 
achieved by 10 -4 M AcCh. Accordingly, this dose 
of AcCh was used to measure cortisol secretion 
(over 60 min) in the freshly isolated cells (0 h) and 
at 24, 48, 72 and 96 h in culture. The pre -culture 
(0 h) experiments were all carried out in 
EBS /BSA /glucose before cells had been exposed 
to any growth medium. Fig. 1 shows the day -to -day 
changes in both basal and AcCh -stimulated corti- 
sol secretion for cells grown in Ham's F10 supple- 
mented with 10% fetal bovine serum, 10% heat - 
treated (57 °C for 45 min) fetal bovine serum 
(same batch) or 10% CPSR5 serum replacement 
(Sigma). 
Responsiveness was found to be greatest in 
CPSR5 serum substitute, and better in the heat - 
treated serum as compared to unheated serum. All 
subsequent studies of the cholinergic response were 
undertaken in Ham's F10 medium containing 10% 
(v /v) CPSR5. Although maximal responsiveness 
occurred at 48 h, all experiments have been car- 
ried out at 72 h to conform to the relatively long 
period (42 h) necessary to achieve steady -state 
labelling of these cells with [myo- 3H]inositol (Bird 
et al., 1989a). Label was added at 24 h in culture 
at the time of the medium change. 
Characterization of the cholinergic receptor 
Fig. 2 shows the dose -dependent secretion of 
cortisol in response to AcCh, nicotine and McN- 
A -343. No response was observed to the Ml 
agonist, McN -A -343. Although nicotine did elicit 
some cortisol secretion in the experiment il- 
lustrated, this was not achieved until 10-5 M and 
even then the maximum was < 25% of that to 
AcCh. The threshold response to AcCh was be- 
tween 10 -7 M and 10 -6 M (in four experiments) 
rising steeply to reach a maximum by 10 -4 M. 
The ED50 for AcCh -stimulated cortisol secretion 
at 72 h was 1.2 X 10 -6 M (range: 3.7 x 10 -7 M to 
3.7 x 10 -6 M; n = 4 experiments). Stimulation of 
cortisol secretion was also observed in two experi- 
ments with the synthetic muscarinic agonist, be- 
thanechol (data not shown). 
A. 
8 0 - 
6 0 - 
- 
2 0 - 
Fetal Bovine Serum 




Fetal Bovine Serum Iheat-treated) 
40 - 
20- 
0/' o o 
1 2 3 6 5 
C. 
BO- 




1 2 3 6 5 
Days in culture 
Fig. 1. Dependence of the day -by -day cortisol response to 
AcCh on growth conditions. Cells were isolated and plated out 
as described in Materials and Methods. For the freshly isolated 
cells (in suspension) and at 24, 48, 72 and 96 h later (in 
culture), the basal cortisol response (o) and the response to 
10 -4 M AcCh (S) were measured over a 1 h incubation. The 
graphs illustrate the responsiveness of cells grown in the pres- 
ence of 10% fetal bovine serum (A), 10% heat - treated fetal 
bovine serum (B) and 10% serum replacement CPSR5 (Sigma) 
(C), all using Ham's F10 as growth medium. Each point is the 
mean of a triplicate determination. A very similar picture was 
also found in a second experiment in which 10 -4 M carbachol 
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Fig. 2. The cortisol response of cultured zona fasciculata /reti- 
cularis cells to AcCh, nicotine and McN -A -343. The cortisol 
production (1 h incubation) for increasing doses of the three 
different agonists is shown (s = AcCh; = nicotine; _ 
McNeil -A -343). The basal cortisol production is shown as the 
single bar (labelled `Basal'). Each point is the mean ± S.D. for 
triplicate wells in a single experiment. Similar findings were 
obtained in two experiments with nicotine, two with McN -A- 
343 and 4 with AcCh. In three other experiments carried out 
with nicotine, no stimulation of cortisol was observed. From 
the AcCh experiments, threshold response was consistently 
observed between 10 -7 M and 10 -6 M, with an ED50 of 
1.2 x 10 - 6 M acetylcholine. 
The ability of a range of antagonists to inhibit 
the cortisol response to 10 -4 M AcCh is shown in 
Fig. 3. The effect of the ß- adrenergic antagonist, 
propranolol, was tested to eliminate the possibility 
that AcCh might be acting to release adrenaline 
from contaminating adrenomedullary cells, and 
thereby indirectly stimulating cortisol secretion 
(see Walker et al., 1988). Propranolol failed to 
inhibit the AcCh -stimulated response (Fig. 3, panel 
A), confirming that the effect of AcCh is directly 
on the ZFR cells. 
The AcCh response is dose -dependently in- 
hibited by the muscarinic antagonist atropine (Fig. 
3, panel A). Significant inhibition of the response 
is evident at 10-8 M atropine and is > 60% by 
10 -' M atropine, at which concentration the 
nicotinic antagonist, tubocurarine, has no effect 
on AcCh -stimulated cortisol production. Indeed, 
inhibition by tubocurarine is still minimal at 10 -4 
M, while an equal concentration of atropine in- 
hibits stimulated cortisol secretion to basal levels. 
These results are therefore consistent with the 
presence of a predominantly muscarinic, choliner- 
gic receptor in these cells. 
Pirenzipine, an Ml antagonist, produced in- 
hibition of the AcCh -stimulated cortisol response, 
but only at concentrations of 10 -5 M pirenzipine 
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Fig. 3. The effects of different antagonists on AcCh -stimulated 
cortisol secretion. The cortisol response (1 h incubation) was 
measured for each agonist, antagonist or combination, ex- 
pressing the secretion as a percentage of the response achieved 
by 10 -4 M AcCh (100 %). Panel A shows the effect of the 
muscarinic antagonist, atropine (A) (A) and the nicotinic 
antagonist, tubocurarine (T) (). The basal response alone is 
shown as the single bar (`Basal'). The effect of propranolol (P) 
(at 10 -6 M) on the AcCh -stimulated response is shown in the 
last bar of the figure. Similar findings were obtained in three 
such separate experiments. Panel B shows the effect of the M3 
antagonist, hexahydrosila -difenidol (Hex) (S). The basal re- 
sponse alone is shown as the single bar (`Basal'). All values are 
the mean ± SD for triplicate wells in a single experiment. 
Similar results were obtained in a total of two such experi- 
ments. In all cases, no effect of the antagonist alone on basal 
cortisol secretion was found. 
antagonist was much less effective, even when 
compared with concentrations of atropine 10 -fold 
lower at 10 -6 M. Previous studies have shown 
that the antimuscarinic potencies of pirenzipine 
and atropine at Ml receptors are very similar, 
whereas atropine is almost 100 -fold more potent 
at M2 or M3 receptors (Lambrecht et al., 1985). 
Hence, these findings argue strongly that the 
cholinergic response of the ZFR cells is mediated 
via an M2 or M3 receptor. 
Fig. 3 (panel B) shows that the M3 receptor 
antagonist, hexahydro -sila -difenidol, produced a 
dose -dependent decrease in cortisol response con- 
sistent with AcCh acting through the M3 receptor. 
Second messenger responses to AcCh 
No change in cAMP production was observed 
in response to the full dose range of AcCh used to 
study cortisol secretion. Under these conditions, 
the positive control, ACTH1_24' elicited a clear 
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Fig. 4. Comparison of AcCh -stimulated cortisol secretion and 
[myo-3H]inositol- labelled total head group response. At 72 h in 
culture, unlabelled cells were stimulated with increasing con- 
centrations of AcCh and the cortisol output measured (1 h 
incubation), as described (solid line; ). The basal cortisol 
output over this period is also shown as the shaded bar 
(`Basal'). [myo-3H]Inositol- labelled cells were stimulated with 
the same concentration range of AcCh for 15 min and the 
incorporation of label into total water -soluble head groups 
measured (broken line; o). The basal total head group re- 
sponse is shown as the unshaded bar (`Basal'). Each data point 
is the mean ±SD of three wells for a single cell preparation in 
which the cortisol and total head group responses could be 
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Fig. 5. Time -course of cortisol secretion and [myo-3H]inositol- 
labelled total head group response. The time- course of cortisol 
production was measured (72 h in culture) in the absence (o) 
or presence () of 10 -4 M AcCh (graph A). Within the same 
cell preparation, the corresponding time -course of total head 
group production was also measured (72 h in culture) using 
pre -labelled cells in the absence (o) or presence () of 10 -4 M 
AcCh (graph B). Each point is the mean ± SD of three wells in 
a single experiment. Similar results were obtained in a total of 
three such experiments. 
Phospholipase activation (reflected as increased 
total [3H] -head group production in cells pre - 
labelled with [3H]inositol -see Materials and 
Methods) showed a dose -dependent increase in 
response to AcCh. The close similarity of the 
dose- response relationships for cortisol secretion 
and total head group response are evident in Fig. 
4. 
The time -dependent changes in cortisol and 
total head group response to 10 -4 M AcCh and 
the corresponding basal (no AcCh) changes are 
illustrated in Fig. 5. The stimulated cortisol re- 
sponse was linear for at least 30 min, but there- 
after declined. The total head group response re- 
mained linear for at least 15 min and also subse- 
quently declined. The response was statistically 
significant (P < 0.005) when compared to the basal 
response at the earliest time -point measured (2 
min); the stimulated cortisol secretion only 
reached statistical significance by 15 min. 
The total head group response was shown to 
occur in the absence of Cat+ influx in three 
experiments carried out in EBS containing free 
[Ca2 +] buffered to 120 nM (P < 0.05; n = 3) (Re- 
nard et al., 1987). The total head group response 
was, however, diminished to 19.25 ± 0.75% (mean 
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± range) of that in EBS with normal free [Can] 
in the two experiments where this comparison was 
made, a finding similar to that observed previ- 
ously with All stimulation in the same cells (Bird 
et al., 1989a). 
High -resolution analysis of the time -dependent 
changes in 3H- labelled phosphoinositols and 
glycerophosphoinositols 
The formation of 3H- labelled phosphoinositols 
and glycerophosphoinositols from pre -labelled 
cells in response to 10 -4 M AcCh was studied 
over the period 0 -15 min, analyzing each time - 
point by HPLC (Fig. 6). Peak identification was 
assisted by determining the elution positions of 
the three radiolabelled standards Ins1P, Ins(1,4)P2 
and Ins(1,4,5)P3. The three peaks eluting after the 
Ins(1,4,5)P3 standard were assigned to InsP4, InsP5 
and InsP6 (Fig. 6). Provisional assignment of the 
peaks eluting immediately before the Ins1P and 
Ins(1,4)P2 standards as GroPlns and GroPIns4P, 
respectively, was subsequently confirmed by peri- 
odate oxidation. This process selectively removes 
the glycerol backbone of such compounds, con- 
verting them to their corresponding phos- 
phoinositols. After periodate oxidation of a 
stimulated sample (15 min) and subsequent HPLC 
analysis, the putative GroPlns and GroPIns4P 
peaks had disappeared, the products presumably 
now migrating with the InsP and InsP2 peaks. 
Fig. 6 shows that the cells stimulated by 10 -4 
M AcCh show much increased formation of 
[3H]inositol mono -, bis- and trisphosphates, but 
not of the glycerophosphoinositols. Thus AcCh 
must stimulate the activation of a phospholipase C 
and not, for example, a phospholipase A2. 
On the partisphere SAX -5 column, it was not 
possible to resolve the InsP isomers into Ins1P or 
Ins4P; neither could the InsP2 peak be resolved 
into isomers. Accordingly, these peaks are simply 
labelled InsP and InsP2 in Fig. 6. However, the 
same column was able to resolve InsP3 into two 
peaks, one co- eluting with the Ins(1,4,5)P3 stan- 
dard and assigned, therefore, this isomer status 
and the other eluting slightly ahead of the stan- 
dard and presumed to be Ins(1,3,4)P3. Further 
support for the identity of this peak as Ins(1,3,4)P3 
rather than as GroPlns(4,5)P2, which has a reten- 














Fig. 6. HPLC profile of [myo-3H]inositol- labelled phos- 
phoinositols and glycerophosphoinositols at 15 min stimulation 
with 10 -4 M AcCh. The water -soluble extracts containing 
[myo-3H]inositol- labelled phosphoinositols and glycerophos- 
phoinositols were subject to HPLC analysis on a partisphere 
SAX -5 column for cells incubated (15 min) in the presence () 
or absence (o) of 10 -4 M AcCh. The column was eluted with 
a gradient of 0 -1 M ammonium formate (pH 3.7), collecting 
0.5 ml fractions and measuring total 3H counts in each frac- 
tion. The elution positions of 3H- labelled Ins1P, Ins(1,4)P2 and 
Ins(1,4,5)P3 standards on the same column are shown, together 
with the peak assignments for the stimulated (0) and unstimu- 
lated (o) cells. The inset illustrates the partial separation of 
Ins(1,3,4)P3 and Ins(1,4,5)P3 peaks which is observed at the 
earlier time -point of 5 s, before the Ins(1,4,5)P3 peak is masked 
by the larger Ins(1,3,4)P3 peak. Further details concerning the 
peak assignments are discussed in Results. 
Ins(1,4,5)P3, is provided by its observed resistance 
to periodate oxidation. 
At the 15 min time -point, the two InsP3 peaks 
were not clearly resolved; most of the InsP3 peak 
in the stimulated sample is made up of Ins(1,3,4)P3 
at this time and masks the much smaller radio - 
labelled Ins(1,4,5)P3 peak. At the earliest time - 
points, when the Ins(1,3,4)P3 peak was not so 
large, it was possible to resolve the two isomers 
(see Fig. 6, inset) and monitor increased formation 
of Ins(1,4,5)P3 and Ins(1,3,4)P3 separately in the 
stimulated samples (Fig. 7). 
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Fig. 7 shows the full time -course for both the Ins(1,3,4)P3/ Ins(1,4,5)P3, InsP4 and InsP5 for each 
unstimulated and stimulated samples, measuring time -point. The earliest significant change in re- 


























































Fig. 7. Time -course of appearance of 3H- labelled phosphoinositol species in response to AcCh. Pre- labelled cells were exposed (0) or 
not exposed (o) to AcCh (10 -4 M) (72 h in culture), terminating each incubation over the time period 0 to 900 s. The water -soluble 
extracts at each time -point were subject to HPLC analysis on a partisphere SAX -5 column, and the 3H counts in the peaks identified 
(using appropriate standards) as InsP, InsP2, Ins(1,4,5)P3, Ins(1,3,4)P3, InsP4 and InsP5,separately measured. The figure shows the 
time -course of appearance of 3H counts in these different phosphoinositol species. Each point is the mean ± SD of three HPLC 
analyses from three separate wells. The earliest time -point at which the stimulated cells differ significantly from the unstimulated 
cells for each phosphoinositol species is shown. Note that the stimulated InsP2 is significantly different from control at 60 s. In the 
case of Ins(1,4,5)P3, stimulated cells achieve significant difference from control cells at 5 s and 15 s; this is shown in the inset graph 
with the expanded scale. 
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Ins(1,4,5)P3 at 5 s, consistent with a phospholipase 
C- dependent hydrolysis of Ptdlns(4,5)P2 as the 
earliest event in response to AcCh stimulation. 
Significant increase in radiolabelling of InsP was 
subsequently observed at 15 s and at 60 s for both 
InsP2 and Ins(1,3,4)P3. The increased radiolabel- 
ling in all these peaks was sustained for the re- 
mainder of the time -course, suggesting continuous 
phospholipase C action on the polyphosphoinosi - 
tides. Small increases in labelling of InsP4 and 
InsP5 were not statistically significant. 
Measurement of changes in intracellular [Ca 2 +.1 
The basal intracellular Ca2+ was found to be 
75 ± 3 nM (mean ± SE, n = 52). In response to a 
maximally stimulatory dose of AcCh (10 -4 M), 
the mean increase over basal was 1.6 -fold (n = 4 
experiments; P < 0.05). The same cells also re- 
sponded to 10 -8 M All with a mean n -fold in- 
crease in intracellular [Ca2 +] of 1.8 -fold (n = 4 
experiments; P < 0.05). Since the fura -2 signal 
from individual cells oscillates in response to AcCh 
(10 -4 M) (Williams, B.C., unpublished observa- 
tions), peak concentrations of intracellular [Ca2 +] 
in individual cells are likely to be considerably 
higher than is suggested by this n -fold value, mea- 
sured in these experiments as a population aver- 
age. 
Fig. 8 shows a representative recording in re- 
sponse to 10 -4 M AcCh. In three cell suspensions, 
atropine at 10 -6 M was added prior to addition of 
10 -4 M AcCh. Atropine itself had no effect on the 
fura -2 fluorescence, yet completely blocked the 
increase in fluorescence (and, therefore, intracellu- 
lar Ca2 +) in response to AcCh, in agreement with 
the previous experiments in which the water -solu- 
ble head group (and cortisol) responses were also 
completely abolished at this concentration of 
antagonist. The same cell suspensions could be 
shown to be viable by the occurrence of a normal 
response to All (10 -8 M) when added after the 
AcCh, but in the presence of atropine (Fig. 8). 
The fura -2 fluorescence in response to 10 -4 M 
AcCh was also measured in Krebs- Ringer buffer 
in which the Ca2+ concentration was buffered to 
120 nM (Renard et al., 1987). As with the total 
head group response, the increase in fura -2 fluo- 
rescence and, by inference, [Ca2 +]i was still pre- 



















Fig. 8. Changes in intracellular [Ca2+ ] in cells stimulated by 
AcCh. Cells were prepared and cultured in suspension over 72 
h and then loaded with fura -2 AM, as described in Materials 
and Methods. The upper trace illustrates the fluorescence 
signal from a cell suspension successfully loaded with fura -2 
AM, and the increase in fluorescence when the cells are ex- 
posed to AcCh (10 -4 M). In the bottom trace, a different cell 
suspension was first exposed to atropine (10 -6 M) prior to 
addition of AcCh (10 -4 M). The fluorescence response to 
AcCh is completely abolished by atropine, yet the same cell 
suspension was shown to be viable through its subsequent 
response to the Ca2 + -mobilising agonist, All (10 -8 M) (see 
Bird et al., 1989a). Values for the intracellular [Ca2+ ] are given 
in the text. 
with the mobilization of an intracellular Ca2+ 
pool by Ins(1,4,5)P3, the product of phospholipase 
C action on Ptdlns(4,5)P2. 
Discussion 
We have found a consistent steroid (cortisol) 
response to AcCh in our cultured bovine ZFR 
cells. This agrees with results of previous studies 
on purified bovine fasciculata /reticularis cells 
(Hadjian et al., 1982), unpurified adrenocortical 
cells from cat and bovine species (Rubin et al., 
1975); Kawamura et al., 1985) and the perfused 
whole adrenal from calf (Rosenfeld, 1955). 
The cortisol response was present in the freshly 
dispersed cells and was retained for at least 72 h 
in culture. At 24 h in culture, the cells were least 
responsive for any given concentration of AcCh. 
Maximal responsiveness was evident at 48 h, fall- 
ing slightly by 72 h (Fig. 1). The response was 
present under a variety of growth conditions but 
was optimal in the serum replacement which was 
therefore used in subsequent experiments. 
The occurrence of the cholinergic response in 
vivo is evidenced both by the presence of the 
response to AcCh in freshly dispersed cells and 
from studies, such as that described by Robinson 
et al. (1977) in sheep, which have demonstrated 
cholinergic innervation of adrenocortical cells. 
Studies with a range of cholinergic agonists and 
antagonists established that cortisol secretion was 
occurring predominantly through binding to the 
muscarinic receptor. Previous studies have failed 
to clarify the subtype of muscarinic receptor which 
mediates this response in adrenocortical cells. 
The lack of cortisol stimulation by the Ml 
agonist McN -A -343 and the relative ineffective- 
ness of the Ml- specific antagonist, pirenzipine, 
were consistent with an M2 or M3 receptor sub- 
type. M2 receptor stimulation would be expected 
to lead to a decrease in cAMP formation (Levine 
and Birdsall, 1989), while Ml and M3 receptors 
promote phosphoinositide hydrolysis (Fukuda et 
al., 1988). AcCh had no effect upon cAMP forma- 
tion, in agreement with the findings of Hadjian et 
al. (1982) and Kojima et al. (1986), using bovine 
ZFR and ZG cells, respectively. In contrast, AcCh 
stimulation of ZFR cells led to catabolism of 
[3H]phosphoinositides through activation of a 
phospholipase C with the dose -dependent forma- 
tion of phosphoinositols which closely paralleled 
cortisol production (Fig. 4). The pharmacological 
evidence against an M1 receptor, the lack of effect 
on cAMP formation and the clear activation of 
phospholipase C therefore strongly support the 
involvement of the M3 receptor subtype in this 
response. 
Further evidence for AcCh acting through the 
M3 receptor was obtained using the M3 receptor 
antagonist, hexahydro -sila -difenidol. Lambrecht 
and Mutschier (1985) presented evidence that 
hexahydro -sila -difenidol has high antimuscarinic 
potency at M3 receptors on the smooth muscle of 
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ileum and urinary bladder, but low potency at 
myocardial M2 receptors. This antagonist pro- 
duced a dose -dependent inhibition of the cortisol 
response to AcCh; there was little or no effect of 
the drug on basal cortisol output over the con- 
centration range used, arguing against a non- 
specific toxic effect (Fig. 3). 
While M3 receptors are clearly present on 
bovine ZFR cells, the question arises as to whether 
additional nicotinic receptors are also expressed. 
Nicotine -induced stimulation of steroidogenesis 
has been reported in dispersed cat adrenocortical 
cells but only at nicotine concentrations of 6 x 
10 -5 M and above. The relative magnitude of any 
possible muscarinic response was not investigated 
(Rubin and Warner, 1975). Although nicotine in- 
duced cortisol secretion in bovine ZFR cells, this 
was only observed in two out of five experiments, 
and the response was much less than that to 
AcCh. Furthermore, a response was only observed 
at 10 -5 M nicotine or above (Fig. 2). Concentra- 
tions of nicotine > 10 -5 M were less potent and 
associated with morphological evidence of cell 
damage. L-( + )-tubocurarine also failed to antago- 
nise AcCh -stimulated cortisol secretion, except at 
concentrations of 10 -4 M or above. Together these 
results suggest a non -specific effect of nicotine, 
and the absence of a separate nicotinic, cholinergic 
receptor. 
Earlier work on the involvement of membrane 
phosphoinositides in the cholinergic response of 
ZFR cells has been restricted to a measurement of 
increased 32P labelling of phosphatidylinositol in 
response to AcCh. The data were insufficient to 
demonstrate clearly the involvement of phos- 
pholipase C in this response and the substrate 
specificity of the enzyme was not investigated. In 
bovine ZG cells, Kojima et al. (1986) investigated 
the time -course of appearance of [3H] -phos- 
phoinositols from pre -labelled bovine ZG cells 
and found a rapid (within 5 s) increased labelling 
of [3H]inositol trisphosphate in response to 
carbachol. The use of a low- resolution chromato- 
graphic method by Kojima et al. (1986) precluded 
identification of inositol trisphosphate isomers and 
a study of the metabolic fate of the earliest formed 
inositol trisphosphate. 
The earliest response to AcCh in ZFR cells is 
an increased labelling (within 5 s) of Ins(1,4,5)P3 
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(Fig. 7) consistent with the earliest post- receptor 
event being a phospholipase C- dependent hydrol- 
ysis of Ptdlns(4,5)P2. At later time -points, 
Ins(1,3,4)P3 formation increases (along with InsP2 
and InsP) and this isomer became the major con- 
tributor to total InsP3 labelling. These observa- 
tions confirm that PtdIns(4,5)P2 catabolism is sus- 
tained throughout stimulation, and support the 
existence of the `alternative' pathway in these 
cells, with activation of Ins(1,4,5)P3 3- kinase and 
production of Ins(1,3,4,5)P4 as an intermediate 
step. 
The formation of Ins(1,4,5)P3 results in many 
cells in the release of Cat+ from an intracellular 
pool. In the studies using fura -2 loaded ZFR cells, 
basal [Ca2+]; was 75 nM and increased 1.6 -fold in 
the presence of 10 -4 M AcCh. The same cells also 
responded to All with an increase in [Ca2 +]; of 
1.8 -fold (Fig. 8). The response to AcCh, but not 
the response to All was specifically blocked by 
10 -6 M atropine, confirming that the two agonists 
act through distinct receptors (Fig. 8). The initial 
rise in Ca2+ was shown to occur even in medium 
with [Ca2 +] buffered to 120 nM (i.e., in the ab- 
sence of Ca2+ influx) suggesting that mobilisation 
of an intracellular Cat+ pool does indeed occur in 
these cells. 
Cholinergic regulation of cortisol secretion has 
previously received little attention in vitro or in 
vivo. An unanswered question is the possible ef- 
fect of AcCh on adrenocortical cell growth. 
Ashkenazi et al. (1989) reported that AcCh ana- 
logues stimulated DNA synthesis in astrocytes 
and transfected CHO cells expressing muscarinic 
receptors; the stimulation of DNA synthesis was 
specifically mediated via muscarinic receptor sub- 
types linked to phosphoinositide hydrolysis. The 
possible effects of AcCh on adrenocortical cell 
growth are currently under investigation. 
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